
[AnnotationDefinition]
Keyword=bao
TypeString=list
DescriptionString=The BioAssay Ontology (BAO) describes biological screening assays and their results including high-throughput screening (HTS) data for the purpose of categorizing assays and data analysis. BAO is an extensible, knowledge-based, highly expressive (currently SHOIQ(D)) description of biological assays making use of descriptive logic based features of the Web Ontology Language (OWL). BAO currently has over 700 classes and also makes use of several other ontologies. It describes several concepts related to biological screening, including Perturbagen, Format, Meta Target, Design, Detection Technology, and Endpoint. Perturbagens are perturbing agents that are screened in an assay; they are mostly small molecules. Assay Meta Target describes what is known about the biological system and / or its components interrogated in the assay (and influenced by the Perturbagen). Meta target can be directly described as a molecular entity (e.g. a purified protein or a protein complex), or indirectly by a biological process or event (e.g. phosphorylation). Format describes the biological or chemical features common to each test condition in the assay and includes biochemical, cell-based, organism-based, and variations thereof. The assay Design describes the assay methodology and implementation of how the perturbation of the biological system is translated into a detectable signal. Detection Technology relates to the physical method and technical details to detect and record a signal. Endpoints are the final HTS results as they are usually published (such as IC50, percent inhibition, etc). BAO has been designed to accommodate multiplexed assays. All main BAO components include multiple levels of sub-categories and specification classes, which are linked via object property relationships forming an expressive knowledge-based representation.
UsageString=The BioAssay Ontology (BAO) describes biological screening assays and their results including high-throughput screening (HTS) data for the purpose of categorizing assays and data analysis. BAO is an extensible, knowledge-based, highly expressive (currently SHOIQ(D)) description of biological assays making use of descriptive logic based features of the Web Ontology Language (OWL). BAO currently has over 700 classes and also makes use of several other ontologies. It describes several concepts related to biological screening, including Perturbagen, Format, Meta Target, Design, Detection Technology, and Endpoint. Perturbagens are perturbing agents that are screened in an assay; they are mostly small molecules. Assay Meta Target describes what is known about the biological system and / or its components interrogated in the assay (and influenced by the Perturbagen). Meta target can be directly described as a molecular entity (e.g. a purified protein or a protein complex), or indirectly by a biological process or event (e.g. phosphorylation). Format describes the biological or chemical features common to each test condition in the assay and includes biochemical, cell-based, organism-based, and variations thereof. The assay Design describes the assay methodology and implementation of how the perturbation of the biological system is translated into a detectable signal. Detection Technology relates to the physical method and technical details to detect and record a signal. Endpoints are the final HTS results as they are usually published (such as IC50, percent inhibition, etc). BAO has been designed to accommodate multiplexed assays. All main BAO components include multiple levels of sub-categories and specification classes, which are linked via object property relationships forming an expressive knowledge-based representation.
VersionString=20251027
CreatedDateTime=2025-10-27T20:04:51


[Author]
NameString=Karim Shalaby
CopyrightString=Creative Commons by 4.0
ContactInfoString=karim.shalaby@scai.fraunhofer.de

[Citation]
NameString=BioAssay Ontology

[Processing]
CaseSensitiveFlag=no
DelimiterString=|
CacheableFlag=no

[Values]
(2-hept-2-ynylsulfanylphenyl) acetate|OGRPBCAM
(S)-Mephenytoin|OGRPBCAM
1, 4 methyllumbelliferone|OGRPBCAM
1-D extent|OGRPBCAM
1-aminoanthracene|OGRPBCAM
100 percent growth inhibition|OGRPBCAM
12 well plate|OGRPBCAM
14LckpCAP394 peptide|OGRPBCAM
15 cm dish|OGRPBCAM
1536 well plate|OGRPBCAM
16-well electronic plate|OGRPBCAM
17a-hydroxy-5a-pregnane-3,20-dione|OGRPBCAM
2 color apoptosis assay|OGRPBCAM
2-D extent|OGRPBCAM
2-aminoethyl hydrogen sulfate|OGRPBCAM
2-hydroxyglutaric aciduria|OGRPBCAM
24 well plate|OGRPBCAM
293T/17 cell|OGRPBCAM
2B4/BCL-2 cell|OGRPBCAM
2B4/MCL-1 cell|OGRPBCAM
2D structure prediction|OGRPBCAM
2D structure similarity search|OGRPBCAM
3 color apoptosis assay|OGRPBCAM
3 parameter Hill equation|OGRPBCAM
3,4,5-tri-O-galloylquinic acid|OGRPBCAM
3-D extent|OGRPBCAM
3-Methylcrotonyl-CoA carboxylase deficiency|OGRPBCAM
3-O-methyl-fluorescein|OGRPBCAM
3-O-methylfluorescein phosphate|OGRPBCAM
3-aminopropyl(methyl)phosphinic acid|OGRPBCAM
3-isobutyl-1-methylanxthine|OGRPBCAM
35S|OGRPBCAM
384 well plate|OGRPBCAM
3D structure prediction|OGRPBCAM
3D structure similarity search|OGRPBCAM
3H|OGRPBCAM
3i Marianas|OGRPBCAM
4 methylumbelliferyl-D-pyranoside|OGRPBCAM
4 parameter Hill equation|OGRPBCAM
5-carboxamidotryptamine|OGRPBCAM
5-hydroxytryptamine 2A receptor agonist|OGRPBCAM
5-hydroxytryptamine 2A receptor inverse agonist|OGRPBCAM
5-hydroxytryptamine 2B receptor agonist|OGRPBCAM
5-hydroxytryptamine 2C receptor agonist|OGRPBCAM
5/6 TAMRA|OGRPBCAM
50 percent activation|OGRPBCAM
50 percent cell viability|OGRPBCAM
50 percent cytotoxicity|OGRPBCAM
50 percent growth inhibition|OGRPBCAM
50 percent inhibition|OGRPBCAM
5a,20a-tetrahydroprogesterone|OGRPBCAM
6 well plate|OGRPBCAM
6,8-difluoro-4-methylumbelliferyl phosphate|OGRPBCAM
6,8-difluoro-7-hydroxy-4-methylcoumarin|OGRPBCAM
697 cell|OGRPBCAM
7-amino-4-methylcoumarin|OGRPBCAM
7-amino-4-trifluoromethylcoumarin|OGRPBCAM
80 percent inhibition|OGRPBCAM
8453 UV-Visible Spectrophotometer|OGRPBCAM
90 percent inhibition|OGRPBCAM
96 well plate|OGRPBCAM
A23187|OGRPBCAM
A549 cell|OGRPBCAM
AAT Bioquest|OGRPBCAM
AB SCIEX|OGRPBCAM
ABCD syndrome|OGRPBCAM
ABD Bioquest|OGRPBCAM
AC10 absolute|OGRPBCAM
AC1000 absolute|OGRPBCAM
AC26 absolute|OGRPBCAM
AC35 absolute|OGRPBCAM
AC40 absolute|OGRPBCAM
AC50|OGRPBCAM
AC50 Ratio|OGRPBCAM
AC500 absolute|OGRPBCAM
ACHN cell|OGRPBCAM
ACP-tag|OGRPBCAM
ACTH-secreting pituitary adenoma|OGRPBCAM
ACTOne Membrane Potential Dye|OGRPBCAM
ACTOne cAMP biosensor assay (BD Biosciences; CodexBIosolutions)|OGRPBCAM
ADAM docking method|OGRPBCAM
ADME|OGRPBCAM
ADP Glo Kinase Assay|OGRPBCAM
ADP Hunter Plus|OGRPBCAM
ADP coupled enzyme activity measurement method|OGRPBCAM
ADULT syndrome|OGRPBCAM
AGAT deficiency|OGRPBCAM
AK-1|OGRPBCAM
AK295 peptide|OGRPBCAM
AKT1 kinase inhibitor|OGRPBCAM
ALT_DEFINITION|OGRPBCAM
AMBER force field simulation|OGRPBCAM
AMBER polarizable|OGRPBCAM
AMINCO-Bowman Series 2 Luminescence Spectrometer|OGRPBCAM
AML12 cell|OGRPBCAM
AMPA receptor agonist|OGRPBCAM
AMPA receptor antagonist|OGRPBCAM
AOX reaction phenotyping|OGRPBCAM
AP-1 antagonist|OGRPBCAM
API 4000 LC/MS/MS System|OGRPBCAM
AR-9281|OGRPBCAM
ARC syndrome|OGRPBCAM
ATAC-seq epigenetic profiling assay|OGRPBCAM
ATP coupled enzyme activity measurement method|OGRPBCAM
ATP quantitation|OGRPBCAM
ATP quantitation using luciferase|OGRPBCAM
ATP synthase inhibitor|OGRPBCAM
ATP-binding cassette sub-family C member 2|OGRPBCAM
ATP-binding cassette sub-family C member 3|OGRPBCAM
ATP-dependent translocase ABCB1|OGRPBCAM
ATP/ADP translocase inhibitor|OGRPBCAM
ATPLite Luminescence Assay System|OGRPBCAM
ATPase motor cytoplasmic dynein inhibitor|OGRPBCAM
AUC|OGRPBCAM
AUC(iv)|OGRPBCAM
AUC(oral)|OGRPBCAM
AVA5 cell|OGRPBCAM
AVID sequence alignment|OGRPBCAM
Aarskog syndrome|OGRPBCAM
Ac-DEVD-AFC|OGRPBCAM
Ac-DEVD-CHO|OGRPBCAM
Ac-LEHD-AMC|OGRPBCAM
Ac-WEHD-AFC|OGRPBCAM
Ac-WEHD-CHO|OGRPBCAM
Acapella|OGRPBCAM
Acinetobacter|OGRPBCAM
Acumen|OGRPBCAM
Adapta Universal Kinase Assay Kit|OGRPBCAM
Addison's disease|OGRPBCAM
Adenosine diphosphate|OGRPBCAM
Adenosine triphosphate|OGRPBCAM
Aequorea victoria|OGRPBCAM
Affinity|OGRPBCAM
African tick-bite fever|OGRPBCAM
Agilent 1100 series LC-MSD SL|OGRPBCAM
Agilent Technologies|OGRPBCAM
Aicardi syndrome|OGRPBCAM
Aicardi-Goutieres syndrome|OGRPBCAM
Alagille syndrome|OGRPBCAM
Aland Island eye disease|OGRPBCAM
Aldehyde oxidase|OGRPBCAM
Alexa555|OGRPBCAM
Alexa568|OGRPBCAM
Alexander disease|OGRPBCAM
Allan-Herndon-Dudley syndrome|OGRPBCAM
Alpers-Huttenlocher syndrome|OGRPBCAM
Alpha Screen Assay Kit (PerkinElmer)|OGRPBCAM
Alpha-D-glucose|OGRPBCAM
AlphaQuest reader|OGRPBCAM
AlphaScreen Beads|OGRPBCAM
AlphaScreen GST detection kit|OGRPBCAM
AlphaScreen IgG detection kit|OGRPBCAM
AlphaScreen Phosphotyrosine Assay Kit|OGRPBCAM
AlphaScreen cAMP assay kit|OGRPBCAM
AlphaScreen cGMP Detection|OGRPBCAM
Alphascreen second messenger IP1 detection kit|OGRPBCAM
Alport syndrome|OGRPBCAM
Alstrom syndrome|OGRPBCAM
Alzheimer's disease|OGRPBCAM
Ames test|OGRPBCAM
Amine oxidase [flavin-containing] A|OGRPBCAM
Amine oxidase [flavin-containing] B|OGRPBCAM
Amnis|OGRPBCAM
Amplex Red Glucose/Glucose Oxidase Assay Kit|OGRPBCAM
Amplex red reagent|OGRPBCAM
AnaSpec|OGRPBCAM
Analyst AD (Molecular Devices)|OGRPBCAM
Analyst HT|OGRPBCAM
Analytical Luminescence Laboratory|OGRPBCAM
Angelman syndrome|OGRPBCAM
Annexin A5|OGRPBCAM
Annexin V apoptosis assay|OGRPBCAM
Anti-MPM-2|OGRPBCAM
Antigen KI-67|OGRPBCAM
Antley-Bixler syndrome|OGRPBCAM
Apelin-13|OGRPBCAM
Appled Biosystems Real-Time PCR System (ThermoFisher)|OGRPBCAM
Applied Biosystems|OGRPBCAM
Applied biosystems 8200|OGRPBCAM
Arabidopsis thaliana|OGRPBCAM
Arabidopsis thaliana metabolite|OGRPBCAM
Argentine hemorrhagic fever|OGRPBCAM
Ariadne Pathway Studio|OGRPBCAM
ArrayScan 3.1 HCS Reader|OGRPBCAM
ArrayScan 4.0 HCS Reader|OGRPBCAM
ArrayScan II HCS Reader|OGRPBCAM
ArrayScan VTI HCS Reader|OGRPBCAM
Arrestin2 recruitment assay|OGRPBCAM
Arts syndrome|OGRPBCAM
Asperger syndrome|OGRPBCAM
Aspergillus metabolite|OGRPBCAM
Atto 495|OGRPBCAM
Aurora Biomed|OGRPBCAM
Aurora kinase inhibitor|OGRPBCAM
AutoDock docking method|OGRPBCAM
AutoDock3 docking method|OGRPBCAM
AutoDock3 scoring function|OGRPBCAM
Avance III|OGRPBCAM
Axenfeld-Rieger syndrome|OGRPBCAM
AxioVert 200M Fluorescence Light Microscope|OGRPBCAM
Axopatch 200B amplifier (Molecular Devices)|OGRPBCAM
B cell deficiency|OGRPBCAM
B-Raf inhibitor|OGRPBCAM
B-cell acute lymphoblastic leukemia|OGRPBCAM
B-cell lymphoma|DOID_707
B-cell lymphoma 2 inhibitor|OGRPBCAM
B-lymphoblastic leukemia/lymphoma|OGRPBCAM
B-score|OGRPBCAM
BA/F3 cell|OGRPBCAM
BAO|OGRPBCAM
BCL-2 1863 cell|OGRPBCAM
BCRP inhibition assay|OGRPBCAM
BCRP substrate assay|OGRPBCAM
BD AttoVision|OGRPBCAM
BD Biosciences|OGRPBCAM
BD FACSAria flow cytometer (BD Biosciences)|OGRPBCAM
BD Pathway 435|OGRPBCAM
BD Pathway 855|OGRPBCAM
BET bromodomain inhibitor|OGRPBCAM
BIS-TRIS|OGRPBCAM
BIX-01294 trihydrochloride|OGRPBCAM
BJ|OGRPBCAM
BJeH cell|OGRPBCAM
BJeLR cell|OGRPBCAM
BMG Labtech|OGRPBCAM
BMG PHERAstar FSX plate reader (BMG Labtech, Cary NC)|OGRPBCAM
BODIPY GTP|OGRPBCAM
BRL-54443|OGRPBCAM
BSA binding asssay|OGRPBCAM
BSC-1|OGRPBCAM
BSEP inhibition assay|OGRPBCAM
BSR|OGRPBCAM
BT-549 cell|OGRPBCAM
BTC AM Fluorescent Dye Indicator|OGRPBCAM
BacTiter-Glo Microbial Cell Viability Assay|OGRPBCAM
Bachem|OGRPBCAM
Bacillus anthracis|OGRPBCAM
Baller-Gerold syndrome|OGRPBCAM
Bamforth-Lazarus syndrome|OGRPBCAM
Bannayan-Riley-Ruvalcaba syndrome|OGRPBCAM
Bardet-Biedl syndrome|OGRPBCAM
Barrett's esophagus|OGRPBCAM
Bart-Pumphrey syndrome|OGRPBCAM
Barth syndrome|OGRPBCAM
Bartter disease|DOID_445
Bead-based immunoassay for protein state|OGRPBCAM
Beare-Stevenson cutis gyrata syndrome|OGRPBCAM
Becker muscular dystrophy|OGRPBCAM
Beckwith-Wiedemann syndrome|OGRPBCAM
Becton Dickinson (BD) LSRII FACS|OGRPBCAM
Bell's palsy|OGRPBCAM
BellBrook Labs|OGRPBCAM
Bernard-Soulier syndrome|OGRPBCAM
Beta-Glo Assay System|OGRPBCAM
Beta-galactosidase|OGRPBCAM
Beta-galactosidase activity measurement method|OGRPBCAM
Beta-lactamase|OGRPBCAM
Bethlem myopathy|OGRPBCAM
Biacore 3000 SPR System (GE Healthcare)|OGRPBCAM
Bile salt export pump|OGRPBCAM
Bio-Tek Instruments|OGRPBCAM
BioAssay Ontology|OGRPBCAM
BioAssay Systems|OGRPBCAM
BioFlux 1000|OGRPBCAM
BioImageXD|OGRPBCAM
Bioassay ontology|OGRPBCAM
Birk-Barel syndrome|OGRPBCAM
Birt-Hogg-Dube syndrome|OGRPBCAM
Bisulfite Sequencing assay|OGRPBCAM
Blau syndrome|OGRPBCAM
Bleeding Time|OGRPBCAM
Bloom syndrome|OGRPBCAM
Bluetongue virus 10|OGRPBCAM
Bmax|OGRPBCAM
Boc-Gln-Gly-Arg-AMC|OGRPBCAM
Boc-Leu-Gly-Arg-AMC|OGRPBCAM
Boc-Val-Pro-Arg-AMC|OGRPBCAM
Boomerang dysplasia|OGRPBCAM
Borjeson-Forssman-Lehmann syndrome|OGRPBCAM
Bos taurus|OGRPBCAM
Bowen-Conradi syndrome|OGRPBCAM
Bowtie|OGRPBCAM
Bradford protein assay|OGRPBCAM
Brassica napus metabolite|OGRPBCAM
Bright-Glo Luciferase Assay System|OGRPBCAM
Brij-35|OGRPBCAM
Broad substrate specificity ATP-binding cassette transporter ABCG2|OGRPBCAM
Bronsted acid|OGRPBCAM
Bronsted base|OGRPBCAM
Brooke-Spiegler syndrome|OGRPBCAM
Brown-Vialetto-Van Laere syndrome|OGRPBCAM
Brugada syndrome|OGRPBCAM
Bruker|OGRPBCAM
Budd-Chiari syndrome|OGRPBCAM
Burkitt lymphoma|OGRPBCAM
Buruli ulcer disease|OGRPBCAM
C-33 A cell|OGRPBCAM
C-X-C chemokine receptor type 4 antagonist|OGRPBCAM
C1 inhibitor deficiency|OGRPBCAM
C17.2 cell|OGRPBCAM
C2C12|OGRPBCAM
C3a receptor antagonist|OGRPBCAM
C5a receptor antagonist|OGRPBCAM
C6|OGRPBCAM
CADASIL|OGRPBCAM
CAKI-1 cell|OGRPBCAM
CAT ELISA (Roche/ Sigma-Aldrich)|OGRPBCAM
CB1 receptor agonist|OGRPBCAM
CB1 receptor antagonist|OGRPBCAM
CB2 receptor agonist|OGRPBCAM
CB2 receptor antagonist|OGRPBCAM
CBF-his/runx1-biotin protein complex|OGRPBCAM
CC50|OGRPBCAM
CCD Luminometer|OGRPBCAM
CCRF-CEM cell|OGRPBCAM
CD4-TLR4|OGRPBCAM
CD40|OGRPBCAM
CD40 ligand deficiency|OGRPBCAM
CDP-ME|OGRPBCAM
CDP-Star alkaline phosphatase assay system|OGRPBCAM
CEM21 cell|OGRPBCAM
CEREP assay|OGRPBCAM
CES reaction phenotyping|OGRPBCAM
CETP inhibitor|OGRPBCAM
CFF force field simulation|OGRPBCAM
CFTR potentiator|OGRPBCAM
CGP-54626|OGRPBCAM
CHAPS|OGRPBCAM
CHARMM force field simulation|OGRPBCAM
CHARMM polarizable|OGRPBCAM
CHL-1 cell|OGRPBCAM
CHO cell|OGRPBCAM
CHO-K1 cell|OGRPBCAM
CHO-S cell|OGRPBCAM
CL(hepatic)|OGRPBCAM
CL(renal)|OGRPBCAM
CLL/SLL|OGRPBCAM
CLint|OGRPBCAM
COLO 205 cell|OGRPBCAM
CONCORD structure generation|OGRPBCAM
CORINA structure generation|OGRPBCAM
COS-7 cell|OGRPBCAM
CP-115953|OGRPBCAM
CPSF3 inhibitor|OGRPBCAM
CRISPR/Cas9 method|OGRPBCAM
CSM14.1|OGRPBCAM
CXCR2 antagonist|OGRPBCAM
CYP chemical inhibition assay|OGRPBCAM
CYP cocktail IC50 assay|OGRPBCAM
CYP induction assay|OGRPBCAM
CYP induction screen|OGRPBCAM
CYP inhibition assay|OGRPBCAM
CYP mAb inhibition|OGRPBCAM
CYP metabolite formation kinetics|OGRPBCAM
CYP reaction phenotyping assay|OGRPBCAM
CYP single point inhibition assay|OGRPBCAM
CYP time dependent inhibition IC50 shift assay|OGRPBCAM
CYP time dependent inhibition kinact/KI assay|OGRPBCAM
CYP time dependent inhibition single point assay|OGRPBCAM
CYP time-dependent inhibition assay|OGRPBCAM
CYP1A2 induction assay|OGRPBCAM
CYP1A2 inhibition assay|OGRPBCAM
CYP2B6 induction assay|OGRPBCAM
CYP2B6 inhibition assay|OGRPBCAM
CYP2C19 induction assay|OGRPBCAM
CYP2C19 inhibition assay|OGRPBCAM
CYP2C8 induction assay|OGRPBCAM
CYP2C8 inhibition assay|OGRPBCAM
CYP2C9 induction assay|OGRPBCAM
CYP2C9 inhibition assay|OGRPBCAM
CYP3A4 induction assay|OGRPBCAM
CYP3A4 inhibition assay|OGRPBCAM
Caco-2 cell|OGRPBCAM
Caco-2 permeability assay|OGRPBCAM
Caenorhabditis elegans|OGRPBCAM
Caenorhabditis elegans metabolite|OGRPBCAM
Caffey disease|OGRPBCAM
Caki-1 cell|OGRPBCAM
Calbiochem|OGRPBCAM
Calcium 5 Assay Kit|OGRPBCAM
Calcium Assay Kit|OGRPBCAM
Calu-1 cell|OGRPBCAM
Cambrex|OGRPBCAM
Camellia sinensis metabolite|OGRPBCAM
Camurati-Engelmann disease|OGRPBCAM
Canavan disease|OGRPBCAM
Candida albicans|OGRPBCAM
Canis lupus familiaris|OGRPBCAM
Capgras syndrome|OGRPBCAM
Carney complex|OGRPBCAM
Carrion's disease|OGRPBCAM
Caspase Glo 3/7 Assay|OGRPBCAM
Caspase-3|OGRPBCAM
Caspase-Glo 6 Assay System (Promega)|OGRPBCAM
Catalyst modeling|OGRPBCAM
Cauda equina syndrome|OGRPBCAM
Cavia porcellus|OGRPBCAM
Celigo S Imaging Cell Cytometer|OGRPBCAM
Cell Painting Profile|OGRPBCAM
Cell Signaling|OGRPBCAM
Cell Voyager 1000|OGRPBCAM
Cell Voyager 6000|OGRPBCAM
Cell Voyager 7000|OGRPBCAM
CellInsight NXT HCS Platform|OGRPBCAM
CellProfiler|OGRPBCAM
CellTiter-Blue Cell Viability Assay (Promega)|OGRPBCAM
CellTiter-Fluor Cell Viability Assay Kit|OGRPBCAM
CellTiter-Glo Luminescent Cell Viability Assay|OGRPBCAM
CellWoRx HCS Reader|OGRPBCAM
Cellarium metabolomic profiling assay|OGRPBCAM
Cellomics ArrayScan|OGRPBCAM
Cellomics Beta-Catenin Activation Kit|OGRPBCAM
Cellomics BioApplication|OGRPBCAM
Cellomics BrdU and Ki67 Cell Proliferation Kit|OGRPBCAM
Cellomics Caspase3 Activation Kit|OGRPBCAM
Cellomics Caspase9 Activation Kit|OGRPBCAM
Cellomics Cell Motility Kit|OGRPBCAM
Cellomics Cell Viability Kit|OGRPBCAM
Cellomics Cytoskeletal Rearrangement Kit|OGRPBCAM
Cellomics Mitotic Index Kit|OGRPBCAM
Cellomics Multiparameter Cytotoxicity 1 Kit|OGRPBCAM
Cellomics Multiplexed NFκB and c-Jun Activation Kit|OGRPBCAM
Cellomics Multiplexed p53 and p21 Detection Kit|OGRPBCAM
Cellomics c-Jun Activation Kit|OGRPBCAM
Cellomics p38 MAPK Activation Kit|OGRPBCAM
ChEMBL|OGRPBCAM
ChIP-seq assay|OGRPBCAM
Chaetomium metabolite|OGRPBCAM
Chagas disease|OGRPBCAM
Charcot-Marie-Tooth disease|OGRPBCAM
Charcot-Marie-Tooth disease type 1|OGRPBCAM
Charcot-Marie-Tooth disease type 3|OGRPBCAM
Chediak-Higashi syndrome|OGRPBCAM
Chem-X structure generation|OGRPBCAM
ChemBridge|OGRPBCAM
ChemDiv|OGRPBCAM
ChemiDoc XRS Imaging System (BioRad)|OGRPBCAM
Cherenkov counting method|OGRPBCAM
Chlorocebus aethiops|OGRPBCAM
Chroma-Glo Luciferase Assay System|OGRPBCAM
Churg-Strauss syndrome|OGRPBCAM
Cisbio|OGRPBCAM
Clostridium botulinum|OGRPBCAM
Clouston syndrome|OGRPBCAM
Clustal sequence alignment|OGRPBCAM
ClustalW sequence alignment|OGRPBCAM
ClustalX sequence alignment|OGRPBCAM
Cmax|OGRPBCAM
CoMFA pharmacophore search|OGRPBCAM
Coats disease|OGRPBCAM
Cockayne syndrome|OGRPBCAM
Coffin-Lowry syndrome|OGRPBCAM
Coffin-Siris syndrome|OGRPBCAM
Colorado tick fever|OGRPBCAM
CompuCyte|OGRPBCAM
Conn's syndrome|OGRPBCAM
Contributing_Source|OGRPBCAM
Coomassie dye protein staining|OGRPBCAM
Cor pulmonale|OGRPBCAM
Cornelia de Lange syndrome|OGRPBCAM
Corning|OGRPBCAM
Coronavirus infectious disease|OGRPBCAM
Cos-7|OGRPBCAM
Costello syndrome|OGRPBCAM
Countess  automatic cell counter|OGRPBCAM
Cowden syndrome|OGRPBCAM
Cp|OGRPBCAM
Cq|OGRPBCAM
Creatine kinase|OGRPBCAM
Creutzfeldt-Jakob disease|OGRPBCAM
Cri-Du-Chat syndrome|OGRPBCAM
Crimean-Congo hemorrhagic fever|OGRPBCAM
Crohn's disease|OGRPBCAM
Cryptococcus neoformans|OGRPBCAM
Ct|OGRPBCAM
Cue Signal Response assay|OGRPBCAM
Cuffcompare|OGRPBCAM
Cuffdiff|OGRPBCAM
Cufflinks|OGRPBCAM
Cy5|OGRPBCAM
CyAn Flow Cytometer|OGRPBCAM
CyQUANT Cell Proliferation Assay Kit|OGRPBCAM
Cyclic adenosine monophosphate|OGRPBCAM
Cyclic guanosine monophosphate|OGRPBCAM
Cyntellect|OGRPBCAM
CytoTox-Glo (Promega)|OGRPBCAM
Cytochrome P450 1A2|OGRPBCAM
Cytochrome P450 2B6|OGRPBCAM
Cytochrome P450 2C19|OGRPBCAM
Cytochrome P450 2C8|OGRPBCAM
Cytochrome P450 2C9|OGRPBCAM
Cytochrome P450 2D11|OGRPBCAM
Cytochrome P450 2D12|OGRPBCAM
Cytochrome P450 2D6|OGRPBCAM
Cytochrome P450 2D9|OGRPBCAM
Cytochrome P450 3A10|OGRPBCAM
Cytochrome P450 3A4|OGRPBCAM
Cytochrome P450 3A5|OGRPBCAM
Cytochrome P450 3A7|OGRPBCAM
Cytoscape network analysis|OGRPBCAM
D-2-hydroxyglutaric aciduria|OGRPBCAM
D-galactose|OGRPBCAM
D1 dopamine receptor binding|OGRPBCAM
D5 dopamine receptor binding|OGRPBCAM
DABCYL-Thr-Pro-Leu-Lys~Ser-Pro-Pro-Pro-Ser-Pro-Arg-EDANS|OGRPBCAM
DAMGO|OGRPBCAM
DAPI|OGRPBCAM
DARWIN docking method|OGRPBCAM
DCILabs|OGRPBCAM
DEVD-NucView 488|OGRPBCAM
DIALIGN sequence alignment|OGRPBCAM
DISCOtech modeling|OGRPBCAM
DIVERSet|OGRPBCAM
DLD-1 cell|OGRPBCAM
DMSO|OGRPBCAM
DNA|OGRPBCAM
DNA aptamer|OGRPBCAM
DNA construct|OGRPBCAM
DNA ligase IV deficiency|OGRPBCAM
DNA or RNA abundance method|OGRPBCAM
DNA polymerase inhibitor|OGRPBCAM
DNA region|OGRPBCAM
DNA repair|OGRPBCAM
DNA synthesis inhibitor|OGRPBCAM
DNA tag|OGRPBCAM
DNA vector|OGRPBCAM
DNA-RNA interaction assay|OGRPBCAM
DOCK docking method|OGRPBCAM
DOCK4 docking method|OGRPBCAM
DPX2 cell|OGRPBCAM
DRD cell|OGRPBCAM
DTT|OGRPBCAM
DU 145 cell|OGRPBCAM
DUB-IN-2|OGRPBCAM
DYRKtide peptide|OGRPBCAM
Dahl salt-sensitive rat model|OGRPBCAM
Dako|OGRPBCAM
Dandy-Walker syndrome|OGRPBCAM
Danio rerio|OGRPBCAM
Danon disease|OGRPBCAM
Daphnia galeata metabolite|OGRPBCAM
Daphnia magna metabolite|OGRPBCAM
Daphnia metabolite|OGRPBCAM
Daphnia pulex metabolite|OGRPBCAM
Daphnia tenebrosa metabolite|OGRPBCAM
Denys-Drash syndrome|OGRPBCAM
DesignNote|NCIT_P98
DiFMUP (Molecular Probes)|OGRPBCAM
DiGeorge syndrome|OGRPBCAM
Diamond-Blackfan anemia|OGRPBCAM
DiscoveRx|OGRPBCAM
Display_Name|OGRPBCAM
Donohue syndrome|OGRPBCAM
Dose Response Study|OGRPBCAM
Double stranded DNA|OGRPBCAM
Down syndrome|OGRPBCAM
Dravet syndrome|OGRPBCAM
Drosophila melanogaster|OGRPBCAM
DrugScore scoring function|OGRPBCAM
Dual-Luciferase Reporter Assay System|OGRPBCAM
Duane retraction syndrome|OGRPBCAM
Dubin-Johnson syndrome|OGRPBCAM
Dubowitz syndrome|OGRPBCAM
Duchenne muscular dystrophy|OGRPBCAM
Dy647-pS136-Bad peptide|OGRPBCAM
E-selectin|OGRPBCAM
EC 1.* (oxidoreductase) inhibitor|OGRPBCAM
EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor|OGRPBCAM
EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor|OGRPBCAM
EC 1.1.1.1 (alcohol dehydrogenase) inhibitor|OGRPBCAM
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor|OGRPBCAM
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor|OGRPBCAM
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor|OGRPBCAM
EC 1.1.1.159 (7alpha-hydroxysteroid dehydrogenase) inhibitor|OGRPBCAM
EC 1.1.1.170 [3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating)] inhibitor|OGRPBCAM
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor|OGRPBCAM
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor|OGRPBCAM
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor|OGRPBCAM
EC 1.1.1.205 (IMP dehydrogenase) inhibitor|OGRPBCAM
EC 1.1.1.21 (aldehyde reductase) inhibitor|OGRPBCAM
EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor|OGRPBCAM
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor|OGRPBCAM
EC 1.1.1.267 (1-deoxy-D-xylulose-5-phosphate reductoisomerase) inhibitor|OGRPBCAM
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor|OGRPBCAM
EC 1.1.1.37 (malate dehydrogenase) inhibitor|OGRPBCAM
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor|OGRPBCAM
EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor|OGRPBCAM
EC 1.1.3.* (oxidoreductase acting on donor CH-OH group, oxygen as acceptor) inhibitor|OGRPBCAM
EC 1.1.3.13 (alcohol oxidase) inhibitor|OGRPBCAM
EC 1.1.3.9 (galactose oxidase) inhibitor|OGRPBCAM
EC 1.1.5.* (oxidoreductase acting on donor CH-OH group, quinone or similar compound as acceptor) inhibitor|OGRPBCAM
EC 1.1.5.3 (glycerol-3-phosphate dehydrogenase) inhibitor|OGRPBCAM
EC 1.10.* (oxidoreductase acting on diphenols and related substances as donors) inhibitor|OGRPBCAM
EC 1.10.2.* (oxidoreductase acting on diphenols and related substances as donors with a cytochrome as acceptor) inhibitor|OGRPBCAM
EC 1.10.2.2 (quinol--cytochrome-c reductase) inhibitor|OGRPBCAM
EC 1.10.3.* (oxidoreductase acting on diphenols and related substances as donors with oxygen as acceptor) inhibitor|OGRPBCAM
EC 1.10.3.1 (catechol oxidase) inhibitor|OGRPBCAM
EC 1.10.3.2 (laccase) inhibitor|OGRPBCAM
EC 1.10.99.* (oxidoreductases acting on diphenols and related substances as donors, other acceptors) inhibitor|OGRPBCAM
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor|OGRPBCAM
EC 1.11.* (oxidoreductase acting on peroxide as donors) inhibitor|OGRPBCAM
EC 1.11.1.* (peroxidases) inhibitor|OGRPBCAM
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor|OGRPBCAM
EC 1.11.1.6 (catalase) inhibitor|OGRPBCAM
EC 1.11.1.7 (peroxidase) inhibitor|OGRPBCAM
EC 1.11.1.9 (glutathione peroxidase) inhibitor|OGRPBCAM
EC 1.11.2.* (oxidoreductase with H2O2 as acceptor, incorporating 1 O atom into product) inhibitor|OGRPBCAM
EC 1.11.2.2 (myeloperoxidase) inhibitor|OGRPBCAM
EC 1.12.* (oxidoreductase acting on hydrogen as donors) inhibitor|OGRPBCAM
EC 1.13.* [oxidoreductase acting on single donors with incorporation of molecular oxygen (oxygenases)] inhibitor|OGRPBCAM
EC 1.13.11.* (oxidoreductase acting on single donors and incorporating 2 O atoms) inhibitor|OGRPBCAM
EC 1.13.11.11 (tryptophan 2,3-dioxygenase) inhibitor|OGRPBCAM
EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor|OGRPBCAM
EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor|OGRPBCAM
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor|OGRPBCAM
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor|OGRPBCAM
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor|OGRPBCAM
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor|OGRPBCAM
EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor|OGRPBCAM
EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor|OGRPBCAM
EC 1.14.11.1 (gamma-butyrobetaine dioxygenase) inhibitor|OGRPBCAM
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor|OGRPBCAM
EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitor|OGRPBCAM
EC 1.14.11.68 ([histone H3]-trimethyl-L-lysine(27) demethylase) inhibitor|OGRPBCAM
EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor|OGRPBCAM
EC 1.14.13.132 (squalene monooxygenase) inhibitor|OGRPBCAM
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor|OGRPBCAM
EC 1.14.13.39 (nitric oxide synthase) inhibitor|OGRPBCAM
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor|OGRPBCAM
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor|OGRPBCAM
EC 1.14.13.72 (methylsterol monooxygenase) inhibitor|OGRPBCAM
EC 1.14.13.78 (ent-kaurene oxidase) inhibitor|OGRPBCAM
EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor|OGRPBCAM
EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor|OGRPBCAM
EC 1.14.14.1 (unspecific monooxygenase) inhibitor|OGRPBCAM
EC 1.14.14.14 (aromatase) inhibitor|OGRPBCAM
EC 1.14.14.154 (sterol 14alpha-demethylase) inhibitor|OGRPBCAM
EC 1.14.14.91 ( trans-cinnamate 4-monooxygenase) inhibitor|OGRPBCAM
EC 1.14.14.94 (leukotriene-B4 20-monooxygenase) inhibitor|OGRPBCAM
EC 1.14.15.* (oxidoreductase acting on paired donors, with reduced Fe-S protein as one donor, incorporating 1 O atom) inhibitor|OGRPBCAM
EC 1.14.15.3 (alkane 1-monooxygenase) inhibitor|OGRPBCAM
EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor|OGRPBCAM
EC 1.14.15.6 cholesterol monooxygenase (side-chain-cleaving) inhibitor|OGRPBCAM
EC 1.14.16.* (oxidoreductase acting on paired donors, reduced pteridine as one donor, incorporating 1 atom of oxygen) inhibitor|OGRPBCAM
EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor|OGRPBCAM
EC 1.14.17.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen and with reduced ascorbate as one donor, and incorporation of one atom of oxygen) inhibitor|OGRPBCAM
EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor|OGRPBCAM
EC 1.14.18.* (oxidoreductase acting on paired donors, miscellaneous compound as one donor, incorporating 1 atom of oxygen) inhibitor|OGRPBCAM
EC 1.14.18.1 (tyrosinase) inhibitor|OGRPBCAM
EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor|OGRPBCAM
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor|OGRPBCAM
EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor|OGRPBCAM
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor|OGRPBCAM
EC 1.15.* (oxidoreductase acting on superoxide as acceptor) inhibitor|OGRPBCAM
EC 1.15.1.1 (superoxide dismutase) inhibitor|OGRPBCAM
EC 1.16.* (oxidoreductase oxidising metal ions) inhibitor|OGRPBCAM
EC 1.17.* (oxidoreductase acting on CH or CH2) inhibitor|OGRPBCAM
EC 1.17.3.* (oxidoreductase acting on CH or CH2 with oxygen as acceptor) inhibitor|OGRPBCAM
EC 1.17.3.2 (xanthine oxidase) inhibitor|OGRPBCAM
EC 1.17.4.* (oxidoreductase acting on CH or CH2 with a disulfide as acceptor) inhibitor|OGRPBCAM
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor|OGRPBCAM
EC 1.18.* (oxidoreductase acting on Fe-S proteins as donors) inhibitor|OGRPBCAM
EC 1.19.* (oxidoreductase acting on reduced flavodoxin as donor) inhibitor|OGRPBCAM
EC 1.2.* (oxidoreductase acting on donor aldehyde/oxo group) inhibitor|OGRPBCAM
EC 1.2.1.* (oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor) inhibitor|OGRPBCAM
EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor|OGRPBCAM
EC 1.2.1.12 [glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)] inhibitor|OGRPBCAM
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor|OGRPBCAM
EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitor|OGRPBCAM
EC 1.2.3.* (oxidoreductase acting on donor aldehyde/oxo group with oxygen as acceptor) inhibitor|OGRPBCAM
EC 1.2.3.1 (aldehyde oxidase) inhibitor|OGRPBCAM
EC 1.20.* (oxidoreductase acting on P or As in donors) inhibitor|OGRPBCAM
EC 1.21.* (oxidoreductase acting on X-H and Y-H to form an X-Y bond) inhibitor|OGRPBCAM
EC 1.21.3.* (oxidoreductase acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor) inhibitor|OGRPBCAM
EC 1.21.3.3 (reticuline oxidase) inhibitor|OGRPBCAM
EC 1.22.* (oxidoreductase acting on halogen in donors) inhibitor|OGRPBCAM
EC 1.23.* (oxidoreductase acting on C-O-C group as acceptor) inhibitor|OGRPBCAM
EC 1.3.* (oxidoreductase acting on donor CH-CH group) inhibitor|OGRPBCAM
EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD(+) or NADP(+) as acceptor) inhibitor|OGRPBCAM
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor|OGRPBCAM
EC 1.3.1.43 (arogenate dehydrogenase) inhibitor|OGRPBCAM
EC 1.3.1.6 (fumarate reductase (NADH)) inhibitor|OGRPBCAM
EC 1.3.1.70 (Delta(14)-sterol reductase) inhibitor|OGRPBCAM
EC 1.3.1.72 (Delta(24)-sterol reductase) inhibitor|OGRPBCAM
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor|OGRPBCAM
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor|OGRPBCAM
EC 1.3.3.* (oxidoreductase acting on donor CH-CH group, oxygen as acceptor) inhibitor|OGRPBCAM
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor|OGRPBCAM
EC 1.3.5.* (oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor) inhibitor|OGRPBCAM
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor|OGRPBCAM
EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor|OGRPBCAM
EC 1.3.98.* (oxidoreductase acting on donor CH-CH group, with other, known, acceptors) inhibitor|OGRPBCAM
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor|OGRPBCAM
EC 1.3.99.* (oxidoreductase acting on donor CH-CH group, with other acceptors) inhibitor|OGRPBCAM
EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor|OGRPBCAM
EC 1.4.* (oxidoreductase acting on donor CH-NH2 group) inhibitor|OGRPBCAM
EC 1.4.1.* (oxidoreductase acting on donor CH-NH2 group; NAD(+) or NADP(+) as acceptor) inhibitor|OGRPBCAM
EC 1.4.1.3 {glutamate dehydrogenase [NAD(P)(+)]} inhibitor|OGRPBCAM
EC 1.4.3.* (oxidoreductase acting on donor CH-NH2 group, oxygen as acceptor) inhibitor|OGRPBCAM
EC 1.4.3.2 (L-amino-acid oxidase) inhibitor|OGRPBCAM
EC 1.4.3.22 (diamine oxidase) inhibitor|OGRPBCAM
EC 1.4.3.3 (D-amino-acid oxidase) inhibitor|OGRPBCAM
EC 1.4.3.4 (monoamine oxidase) inhibitor|OGRPBCAM
EC 1.4.4.* (oxidoreductase acting on donor CH-NH2 group, a disulfide as acceptor) inhibitor|OGRPBCAM
EC 1.4.4.2 [glycine dehydrogenase (aminomethyl-transferring)] inhibitor|OGRPBCAM
EC 1.4.7.* (oxidoreductase acting on donor CH-NH2 group, Fe-S protein as acceptor) inhibitor|OGRPBCAM
EC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor|OGRPBCAM
EC 1.5.* (oxidoreductase acting on donor CH-NH group) inhibitor|OGRPBCAM
EC 1.5.1.* (oxidoreductase acting on donor CH-NH group, NAD(+) or NADP(+) as acceptor) inhibitor|OGRPBCAM
EC 1.5.1.3 (dihydrofolate reductase) inhibitor|OGRPBCAM
EC 1.6.* (oxidoreductase acting on NADH or NADPH) inhibitor|OGRPBCAM
EC 1.6.3.* (oxidoreductase acting on NADH or NADPH with oxygen as acceptor) inhibitor|OGRPBCAM
EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor|OGRPBCAM
EC 1.6.5.* (oxidoreductase acting on NADH or NADPH with a quinone or similar as acceptor) inhibitor|OGRPBCAM
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor|OGRPBCAM
EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor|OGRPBCAM
EC 1.7.* (oxidoreductase acting on other nitrogenous compounds as donors) inhibitor|OGRPBCAM
EC 1.8.* (oxidoreductase acting on sulfur group of donors) inhibitor|OGRPBCAM
EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD(+) or NADP(+) as acceptor) inhibitor|OGRPBCAM
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor|OGRPBCAM
EC 1.8.1.4 (dihydrolipoyl dehydrogenase) inhibitor|OGRPBCAM
EC 1.8.1.9 (thioredoxin reductase) inhibitor|OGRPBCAM
EC 1.8.5.* (oxidoreductase acting on sulfur group donors, quinone or similar as acceptor) inhibitor|OGRPBCAM
EC 1.8.5.4 (sulfide:quinone reductase) inhibitor|OGRPBCAM
EC 1.9.* (oxidoreductase acting on donor heme group) inhibitor|OGRPBCAM
EC 1.9.3.* (oxidoreductase acting on donor heme group, oxygen as acceptor) inhibitor|OGRPBCAM
EC 1.9.3.1 (cytochrome c oxidase) inhibitor|OGRPBCAM
EC 1.97.* (other oxidoreductase) inhibitor|OGRPBCAM
EC 1.98.* (enzymes using H2 as reductant) inhibitor|OGRPBCAM
EC 1.99.* (other oxidoreductases using O2 as oxidant) inhibitor|OGRPBCAM
EC 2.* (transferase) inhibitor|OGRPBCAM
EC 2.1.* (C1-transferase) inhibitor|OGRPBCAM
EC 2.1.1.* (methyltransferases) inhibitor|OGRPBCAM
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor|OGRPBCAM
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor|OGRPBCAM
EC 2.1.1.348 (mRNA m6A methyltransferase) inhibitor|OGRPBCAM
EC 2.1.1.354 ([histone H3]-lysine(4) N-trimethyltransferase) inhibitor|OGRPBCAM
EC 2.1.1.37 [DNA (cytosine-5-)-methyltransferase] inhibitor|OGRPBCAM
EC 2.1.1.4 (acetylserotonin O-methyltransferase) inhibitor|OGRPBCAM
EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor|OGRPBCAM
EC 2.1.1.45 (thymidylate synthase) inhibitor|OGRPBCAM
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor|OGRPBCAM
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor|OGRPBCAM
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor|OGRPBCAM
EC 2.1.1.8 (histamine N-methyltransferase) inhibitor|OGRPBCAM
EC 2.1.2.* (hydroxymethyl-, formyl- and related transferases) inhibitor|OGRPBCAM
EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor|OGRPBCAM
EC 2.1.2.2 (phosphoribosylglycinamide formyltransferase) inhibitor|OGRPBCAM
EC 2.1.3.* (carboxy- and carbamoyltransferases) inhibitor|OGRPBCAM
EC 2.1.3.3 (ornithine carbamoyltransferase) inhibitor|OGRPBCAM
EC 2.10.* (Mo- or W-containing group transferase) inhibitor|OGRPBCAM
EC 2.2.* (aldehyde or ketone transferase) inhibitor|OGRPBCAM
EC 2.2.1.* (transketolase/transaldolase) inhibitor|OGRPBCAM
EC 2.2.1.6 (acetolactate synthase) inhibitor|OGRPBCAM
EC 2.3.* (acyltransferase) inhibitor|OGRPBCAM
EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor|OGRPBCAM
EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor|OGRPBCAM
EC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor|OGRPBCAM
EC 2.3.1.24 (sphingosine N-acyltransferase) inhibitor|OGRPBCAM
EC 2.3.1.26 (sterol O-acyltransferase) inhibitor|OGRPBCAM
EC 2.3.1.48 (histone acetyltransferase) inhibitor|OGRPBCAM
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor|OGRPBCAM
EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor|OGRPBCAM
EC 2.3.1.85 (fatty acid synthase) inhibitor|OGRPBCAM
EC 2.3.1.97 (glycylpeptide N-tetradecanoyltransferase) inhibitor|OGRPBCAM
EC 2.3.2.* (aminoacyltransferase) inhibitor|OGRPBCAM
EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor|OGRPBCAM
EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor|OGRPBCAM
EC 2.3.3.* (acyltransferase converting acyl to alkyl group on transfer) inhibitor|OGRPBCAM
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor|OGRPBCAM
EC 2.3.3.8 (ATP citrate synthase) inhibitor|OGRPBCAM
EC 2.4.* (glycosyltransferase) inhibitor|OGRPBCAM
EC 2.4.1.* (hexosyltransferase) inhibitor|OGRPBCAM
EC 2.4.1.1 (glycogen phosphorylase) inhibitor|OGRPBCAM
EC 2.4.1.109 (dolichyl-phosphate-mannose-protein mannosyltransferase) inhibitor|OGRPBCAM
EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor|OGRPBCAM
EC 2.4.1.16 (chitin synthase) inhibitor|OGRPBCAM
EC 2.4.1.17 (glucuronosyltransferase) inhibitor|OGRPBCAM
EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitor|OGRPBCAM
EC 2.4.1.255 (protein O-GlcNAc transferase) inhibitor|OGRPBCAM
EC 2.4.1.34 (1,3-beta-glucan synthase) inhibitor|OGRPBCAM
EC 2.4.1.64 (alpha,alpha-trehalose phosphorylase) inhibitor|OGRPBCAM
EC 2.4.1.80 (ceramide glucosyltransferase) inhibitor|OGRPBCAM
EC 2.4.2.* (pentosyltransferase) inhibitor|OGRPBCAM
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor|OGRPBCAM
EC 2.4.2.12 (nicotinamide phosphoribosyltransferase) inhibitor|OGRPBCAM
EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor|OGRPBCAM
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor|OGRPBCAM
EC 2.4.2.4 (thymidine phosphorylase) inhibitor|OGRPBCAM
EC 2.4.2.8 (hypoxanthine phosphoribosyltransferase) inhibitor|OGRPBCAM
EC 2.4.99.* (glycosyltransferases transferring other glycosyl groups) inhibitor|OGRPBCAM
EC 2.5.* (non-methyl-alkyl or aryl transferase) inhibitor|OGRPBCAM
EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor|OGRPBCAM
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor|OGRPBCAM
EC 2.5.1.117 (homogentisate solanesyltransferase) inhibitor|OGRPBCAM
EC 2.5.1.15 (dihydropteroate synthase) inhibitor|OGRPBCAM
EC 2.5.1.18 (glutathione transferase) inhibitor|OGRPBCAM
EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor|OGRPBCAM
EC 2.5.1.21 (squalene synthase) inhibitor|OGRPBCAM
EC 2.5.1.29 (geranylgeranyl diphosphate synthase) inhibitor|OGRPBCAM
EC 2.5.1.31 {ditrans,polycis-undecaprenyl-diphosphate synthase [(2E,6E)-farnesyl-diphosphate specific]} inhibitor|OGRPBCAM
EC 2.5.1.46 (deoxyhypusine synthase) inhibitor|OGRPBCAM
EC 2.5.1.48 (cystathionine gamma-synthase) inhibitor|OGRPBCAM
EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitor|OGRPBCAM
EC 2.5.1.58 (protein farnesyltransferase) inhibitor|OGRPBCAM
EC 2.5.1.59 (protein geranylgeranyltransferase type I) inhibitor|OGRPBCAM
EC 2.5.1.6 (methionine adenosyltransferase) inhibitor|OGRPBCAM
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor|OGRPBCAM
EC 2.5.1.9 (riboflavin synthase) inhibitor|OGRPBCAM
EC 2.6.* (nitrogenous group transferase) inhibitor|OGRPBCAM
EC 2.6.1.* (transaminase) inhibitor|OGRPBCAM
EC 2.6.1.11 (acetylornithine transaminase) inhibitor|OGRPBCAM
EC 2.6.1.13 (ornithine aminotransferase) inhibitor|OGRPBCAM
EC 2.6.1.16 (glutamine--fructose-6-phosphate transaminase (isomerizing)) inhibitor|OGRPBCAM
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor|OGRPBCAM
EC 2.6.1.2 (alanine transaminase) inhibitor|OGRPBCAM
EC 2.6.1.40 [(R)-3-amino-2-methylpropionate--pyruvate transaminase] inhibitor|OGRPBCAM
EC 2.7.* (P-containing group transferase) inhibitor|OGRPBCAM
EC 2.7.1.* (phosphotransferases with an alcohol group as acceptor) inhibitor|OGRPBCAM
EC 2.7.1.1 (hexokinase) inhibitor|OGRPBCAM
EC 2.7.1.105 (6-phosphofructo-2-kinase) inhibitor|OGRPBCAM
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor|OGRPBCAM
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor|OGRPBCAM
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor|OGRPBCAM
EC 2.7.1.153 (phosphatidylinositol-4,5-bisphosphate 3-kinase) inhibitor|OGRPBCAM
EC 2.7.1.33 (pantothenate kinase) inhibitor|OGRPBCAM
EC 2.7.1.40 (pyruvate kinase) inhibitor|OGRPBCAM
EC 2.7.1.91 (sphingosine kinase) inhibitor|OGRPBCAM
EC 2.7.10.* (protein-tyrosine kinase) inhibitor|OGRPBCAM
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor|OGRPBCAM
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor|OGRPBCAM
EC 2.7.11.* (protein-serine/threonine kinase) inhibitor|OGRPBCAM
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor|OGRPBCAM
EC 2.7.11.10 (IkappaB kinase) inhibitor|OGRPBCAM
EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor|OGRPBCAM
EC 2.7.11.12 (cGMP-dependent protein kinase) inhibitor|OGRPBCAM
EC 2.7.11.13 (protein kinase C) inhibitor|OGRPBCAM
EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor|OGRPBCAM
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor|OGRPBCAM
EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor|OGRPBCAM
EC 2.7.11.20 (elongation factor 2 kinase) inhibitor|OGRPBCAM
EC 2.7.11.21 (polo kinase) inhibitor|OGRPBCAM
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor|OGRPBCAM
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor|OGRPBCAM
EC 2.7.11.26 (tau-protein kinase) inhibitor|OGRPBCAM
EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitor|OGRPBCAM
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} activator|OGRPBCAM
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor|OGRPBCAM
EC 2.7.12.* [dual-specificity kinases (those acting on Ser/Thr and Tyr residues)] inhibitor|OGRPBCAM
EC 2.7.12.1 (dual-specificity kinase) inhibitor|OGRPBCAM
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor|OGRPBCAM
EC 2.7.3.* (phosphotransferases with a nitrogenous group as acceptor) inhibitor|OGRPBCAM
EC 2.7.3.2 (creatine kinase) inhibitor|OGRPBCAM
EC 2.7.4.* (phosphotransferases with a phosphate group as acceptor) inhibitor|OGRPBCAM
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor|OGRPBCAM
EC 2.7.7.* (nucleotidyltransferase) inhibitor|OGRPBCAM
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor|OGRPBCAM
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor|OGRPBCAM
EC 2.7.7.6 (RNA polymerase) inhibitor|OGRPBCAM
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor|OGRPBCAM
EC 2.7.8.* (transferases for other substituted phosphate groups) inhibitor|OGRPBCAM
EC 2.7.8.15 (UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase) inhibitor|OGRPBCAM
EC 2.8.* (S-containing group transferase) inhibitor|OGRPBCAM
EC 2.9.* (Se-containing group transferase) inhibitor|OGRPBCAM
EC 3.* (hydrolase) inhibitor|OGRPBCAM
EC 3.1.* (ester hydrolase) inhibitor|OGRPBCAM
EC 3.1.1.* (carboxylic ester hydrolase) inhibitor|OGRPBCAM
EC 3.1.1.1 (carboxylesterase) inhibitor|OGRPBCAM
EC 3.1.1.3 (triacylglycerol lipase) inhibitor|OGRPBCAM
EC 3.1.1.4 (phospholipase A2) inhibitor|OGRPBCAM
EC 3.1.1.5 (lysophospholipase) inhibitor|OGRPBCAM
EC 3.1.1.64 (retinoid isomerohydrolase) inhibitor|OGRPBCAM
EC 3.1.1.7 (acetylcholinesterase) inhibitor|OGRPBCAM
EC 3.1.1.8 (cholinesterase) inhibitor|OGRPBCAM
EC 3.1.26.* (endoribonucleases producing 5'-phosphomonoesters) inhibitor|OGRPBCAM
EC 3.1.26.13 (retroviral ribonuclease H) inhibitor|OGRPBCAM
EC 3.1.27.* (endoribonucleases producing other than 5'-phosphomonoesters) inhibitor|OGRPBCAM
EC 3.1.27.3 (ribonuclease T1) inhibitor|OGRPBCAM
EC 3.1.3.* (phosphoric monoester hydrolase) inhibitor|OGRPBCAM
EC 3.1.3.1 (alkaline phosphatase) inhibitor|OGRPBCAM
EC 3.1.3.11 (fructose-bisphosphatase) inhibitor|OGRPBCAM
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor|OGRPBCAM
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor|OGRPBCAM
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor|OGRPBCAM
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor|OGRPBCAM
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor|OGRPBCAM
EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor|OGRPBCAM
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor|OGRPBCAM
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor|OGRPBCAM
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor|OGRPBCAM
EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor|OGRPBCAM
EC 3.10.* (hydrolases acting on S-N bonds) inhibitor|OGRPBCAM
EC 3.11.* (hydrolases acting on C-P bonds) inhibitor|OGRPBCAM
EC 3.11.1.* (hydrolases acting on C-P bonds of phosphono-acetaldehyde, -acetate, or -pyruvate) inhibitor|OGRPBCAM
EC 3.11.1.3 (phosphonopyruvate hydrolase) inhibitor|OGRPBCAM
EC 3.12.* (hydrolases acting on S-S bonds) inhibitor|OGRPBCAM
EC 3.13.* (hydrolases acting on C-S bonds) inhibitor|OGRPBCAM
EC 3.2.* (glycosylase) inhibitor|OGRPBCAM
EC 3.2.1.* (glycosidase) inhibitor|OGRPBCAM
EC 3.2.1.1 (alpha-amylase) inhibitor|OGRPBCAM
EC 3.2.1.10 (oligo-1,6-glucosidase) inhibitor|OGRPBCAM
EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor|OGRPBCAM
EC 3.2.1.166 (heparanase) inhibitor|OGRPBCAM
EC 3.2.1.169 (protein O-GlcNAcase) inhibitor|OGRPBCAM
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor|OGRPBCAM
EC 3.2.1.20 (alpha-glucosidase) inhibitor|OGRPBCAM
EC 3.2.1.23 (beta-galactosidase) inhibitor|OGRPBCAM
EC 3.2.1.24 (alpha-mannosidase) inhibitor|OGRPBCAM
EC 3.2.1.28 (alpha,alpha-trehalase) inhibitor|OGRPBCAM
EC 3.2.1.31 (beta-glucuronidase) inhibitor|OGRPBCAM
EC 3.2.1.45 (glucosylceramidase) inhibitor|OGRPBCAM
EC 3.2.1.48 (sucrose alpha-glucosidase) inhibitor|OGRPBCAM
EC 3.2.1.52 (beta-N-acetylhexosaminidase) inhibitor|OGRPBCAM
EC 3.3.* (ether hydrolase) inhibitor|OGRPBCAM
EC 3.3.2.10 (soluble epoxide hydrolase) inhibitor|OGRPBCAM
EC 3.4.* (hydrolases acting on peptide bond) inhibitor|OGRPBCAM
EC 3.4.11.* (aminopeptidase) inhibitor|OGRPBCAM
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor|OGRPBCAM
EC 3.4.11.18 (methionyl aminopeptidase) inhibitor|OGRPBCAM
EC 3.4.13.* (dipeptidase) inhibitor|OGRPBCAM
EC 3.4.13.19 (membrane dipeptidase) inhibitor|OGRPBCAM
EC 3.4.14.* (dipeptidyl- and tripeptidyl-peptidases) inhibitor|OGRPBCAM
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor|OGRPBCAM
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor|OGRPBCAM
EC 3.4.15.* (peptidyl-dipeptidase) inhibitor|OGRPBCAM
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor|OGRPBCAM
EC 3.4.17* (metallocarboxypeptidase) inhibitor|OGRPBCAM
EC 3.4.17.23 (angiotensin-converting enzyme 2) inhibitor|OGRPBCAM
EC 3.4.19.* (omega-peptidase) inhibitor|OGRPBCAM
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor|OGRPBCAM
EC 3.4.21.* (serine endopeptidase) inhibitor|OGRPBCAM
EC 3.4.21.1 (chymotrypsin) inhibitor|OGRPBCAM
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor|OGRPBCAM
EC 3.4.21.36 (pancreatic elastase) inhibitor|OGRPBCAM
EC 3.4.21.37 (leukocyte elastase) inhibitor|OGRPBCAM
EC 3.4.21.39 (chymase) inhibitor|OGRPBCAM
EC 3.4.21.4 (trypsin) inhibitor|OGRPBCAM
EC 3.4.21.5 (thrombin) inhibitor|OGRPBCAM
EC 3.4.21.6 (coagulation factor Xa) inhibitor|OGRPBCAM
EC 3.4.21.61 (kexin) inhibitor|OGRPBCAM
EC 3.4.21.64 (peptidase K) inhibitor|OGRPBCAM
EC 3.4.21.75 (furin) inhibitor|OGRPBCAM
EC 3.4.21.92 (endopeptidase Clp) inhibitor|OGRPBCAM
EC 3.4.22.* (cysteine endopeptidase) inhibitor|OGRPBCAM
EC 3.4.22.2 (papain) inhibitor|OGRPBCAM
EC 3.4.22.36 (caspase-1) inhibitor|OGRPBCAM
EC 3.4.22.38 (cathepsin K) inhibitor|OGRPBCAM
EC 3.4.22.52 (calpain-1) inhibitor|OGRPBCAM
EC 3.4.22.53 (calpain-2) inhibitor|OGRPBCAM
EC 3.4.22.54 (calpain-3) inhibitor|OGRPBCAM
EC 3.4.22.56 (caspase-3) inhibitor|OGRPBCAM
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor|OGRPBCAM
EC 3.4.23.* (aspartic endopeptidase) inhibitor|OGRPBCAM
EC 3.4.23.15 (renin) inhibitor|OGRPBCAM
EC 3.4.23.46 (memapsin 2) inhibitor|OGRPBCAM
EC 3.4.24.* (metalloendopeptidase) inhibitor|OGRPBCAM
EC 3.4.24.11 (neprilysin) inhibitor|OGRPBCAM
EC 3.4.24.18 (meprin A) inhibitor|OGRPBCAM
EC 3.4.24.24 (gelatinase A) inhibitor|OGRPBCAM
EC 3.4.24.3 (microbial collagenase) inhibitor|OGRPBCAM
EC 3.4.24.35 (gelatinase B) inhibitor|OGRPBCAM
EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitor|OGRPBCAM
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor|OGRPBCAM
EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor|OGRPBCAM
EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor|OGRPBCAM
EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor|OGRPBCAM
EC 3.5.1.19 (nicotinamidase) inhibitor|OGRPBCAM
EC 3.5.1.2 (glutaminase) inhibitor|OGRPBCAM
EC 3.5.1.23 (ceramidase) inhibitor|OGRPBCAM
EC 3.5.1.4 (amidase) inhibitor|OGRPBCAM
EC 3.5.1.5 (urease) inhibitor|OGRPBCAM
EC 3.5.1.88 (peptide deformylase) inhibitor|OGRPBCAM
EC 3.5.1.98 (histone deacetylase) inhibitor|OGRPBCAM
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor|OGRPBCAM
EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitor|OGRPBCAM
EC 3.5.2.6 (beta-lactamase) inhibitor|OGRPBCAM
EC 3.5.3.* (non-peptide linear amidine C-N hydrolase) inhibitor|OGRPBCAM
EC 3.5.3.1 (arginase) inhibitor|OGRPBCAM
EC 3.5.4.* (non-peptide cyclic amidine C-N hydrolase) inhibitor|OGRPBCAM
EC 3.5.4.1 (cytosine deaminase) inhibitor|OGRPBCAM
EC 3.5.4.4 (adenosine deaminase) inhibitor|OGRPBCAM
EC 3.5.5.* (hydrolase acting on C-N bonds in nitriles) inhibitor|OGRPBCAM
EC 3.5.5.1 (nitrilase) inhibitor|OGRPBCAM
EC 3.6.* (hydrolases acting on acid anhydrides) inhibitor|OGRPBCAM
EC 3.6.1.* (hydrolases acting on acid anhydrides in P-containing anhydrides) inhibitor|OGRPBCAM
EC 3.6.1.3 (adenosinetriphosphatase) inhibitor|OGRPBCAM
EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor|OGRPBCAM
EC 3.6.3.1 (phospholipid-translocating ATPase) inhibitor|OGRPBCAM
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor|OGRPBCAM
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor|OGRPBCAM
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor|OGRPBCAM
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor|OGRPBCAM
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor|OGRPBCAM
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor|OGRPBCAM
EC 3.6.4.* (hydrolases acting on ATP; involved in cellular and subcellular movement) inhibitor|OGRPBCAM
EC 3.6.4.10 (non-chaperonin molecular chaperone ATPase) inhibitor|OGRPBCAM
EC 3.6.5.* (hydrolases acting on GTP; involved in cellular and subcellular movement) inhibitor|OGRPBCAM
EC 3.6.5.2 (small monomeric GTPase) inhibitor|OGRPBCAM
EC 3.6.5.5 (dynamin GTPase) inhibitor|OGRPBCAM
EC 3.7.* (hydrolases acting on C-C bonds) inhibitor|OGRPBCAM
EC 3.8.* (hydrolases acting on halide bonds) inhibitor|OGRPBCAM
EC 3.9.* (hydrolases acting on P-N bonds) inhibitor|OGRPBCAM
EC 4.* (lyase) inhibitor|OGRPBCAM
EC 4.1.* (C-C lyase) inhibitor|OGRPBCAM
EC 4.1.1.* (carboxy-lyase) inhibitor|OGRPBCAM
EC 4.1.1.15 (glutamate decarboxylase) inhibitor|OGRPBCAM
EC 4.1.1.17 (ornithine decarboxylase) inhibitor|OGRPBCAM
EC 4.1.1.19 (arginine decarboxylase) inhibitor|OGRPBCAM
EC 4.1.1.23 (orotidine-5'-phosphate decarboxylase) inhibitor|OGRPBCAM
EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor|OGRPBCAM
EC 4.1.1.39 (ribulose-bisphosphate carboxylase) inhibitor|OGRPBCAM
EC 4.1.1.50 (adenosylmethionine decarboxylase) inhibitor|OGRPBCAM
EC 4.1.2.* (aldehyde-lyase) inhibitor|OGRPBCAM
EC 4.1.2.27 (sphinganine-1-phosphate aldolase) inhibitor|OGRPBCAM
EC 4.2.* (C-O lyase) inhibitor|OGRPBCAM
EC 4.2.1.* (hydro-lyases) inhibitor|OGRPBCAM
EC 4.2.1.1 (carbonic anhydrase) inhibitor|OGRPBCAM
EC 4.2.1.20 (tryptophan synthase) inhibitor|OGRPBCAM
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor|OGRPBCAM
EC 4.2.1.3 (aconitate hydratase) inhibitor|OGRPBCAM
EC 4.2.1.94 (scytalone dehydratase) inhibitor|OGRPBCAM
EC 4.3.* (C-N lyase) inhibitor|OGRPBCAM
EC 4.3.1.* (ammonia-lyase) inhibitor|OGRPBCAM
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor|OGRPBCAM
EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor|OGRPBCAM
EC 4.3.1.24 (phenylalanine ammonia-lyase) inhibitor|OGRPBCAM
EC 4.3.1.3 (histidine ammonia-lyase) inhibitor|OGRPBCAM
EC 4.4.* (C-S lyase) inhibitor|OGRPBCAM
EC 4.4.1.* (C-S lyase) inhibitor|OGRPBCAM
EC 4.4.1.11 (methionine gamma-lyase) inhibitor|OGRPBCAM
EC 4.4.1.14 (1-aminocyclopropane-1-carboxylate synthase) inhibitor|OGRPBCAM
EC 4.5.* (C-halide lyase) inhibitor|OGRPBCAM
EC 4.6.* (P-O lyase) inhibitor|OGRPBCAM
EC 4.6.1.1 (adenylate cyclase) inhibitor|OGRPBCAM
EC 4.6.1.2 (guanylate cyclase) inhibitor|OGRPBCAM
EC 4.7.* (C-P lyase) inhibitor|OGRPBCAM
EC 4.99.* (miscellaneous lyase) inhibitor|OGRPBCAM
EC 5 hour|OGRPBCAM
EC 5.* (isomerase) inhibitor|OGRPBCAM
EC 5.1.* (racemase/epimerase) inhibitor|OGRPBCAM
EC 5.1.1.* (racemases acting on amino acids and derivatives) inhibitor|OGRPBCAM
EC 5.1.1.1 (alanine racemase) inhibitor|OGRPBCAM
EC 5.1.2.* (racemases acting on hydroxy acids and derivatives) inhibitor|OGRPBCAM
EC 5.1.3.* (racemases acting on carbohydrates and derivatives) inhibitor|OGRPBCAM
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor|OGRPBCAM
EC 5.1.99.* (racemases acting on other compounds) inhibitor|OGRPBCAM
EC 5.2.* (cis-trans-isomerase) inhibitor|OGRPBCAM
EC 5.3.* (intramolecular oxidoreductase) inhibitor|OGRPBCAM
EC 5.3.1.* (intramolecular oxidoreductase interconverting aldoses and ketoses) inhibitor|OGRPBCAM
EC 5.3.1.1 (triose-phosphate isomerase) inhibitor|OGRPBCAM
EC 5.3.3.* (intramolecular oxidase transposing C=C bonds) inhibitor|OGRPBCAM
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor|OGRPBCAM
EC 5.4.* (intramolecular transferase) inhibitor|OGRPBCAM
EC 5.4.3.* (intramolecular transferase transferring amino groups) inhibitor|OGRPBCAM
EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitor|OGRPBCAM
EC 5.4.99.* (intramolecular transferase transferring other groups) inhibitor|OGRPBCAM
EC 5.4.99.7 (lanosterol synthase) inhibitor|OGRPBCAM
EC 5.5.* (intramolecular lyase) inhibitor|OGRPBCAM
EC 5.99.* (other isomerases) inhibitor|OGRPBCAM
EC 5.99.1.* (miscellaneous isomerase) inhibitor|OGRPBCAM
EC 5.99.1.2 (DNA topoisomerase) inhibitor|OGRPBCAM
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor|OGRPBCAM
EC 6.* (ligase) inhibitor|OGRPBCAM
EC 6.1.* (C-O bond-forming ligase) inhibitor|OGRPBCAM
EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor|OGRPBCAM
EC 6.1.1.11 (serine--tRNA ligase) inhibitor|OGRPBCAM
EC 6.1.1.12 (aspartate--tRNA ligase) inhibitor|OGRPBCAM
EC 6.1.1.2 (tryptophan--tRNA ligase) inhibitor|OGRPBCAM
EC 6.1.1.4 (leucine--tRNA ligase) inhibitor|OGRPBCAM
EC 6.1.1.6 (lysine--tRNA ligase) inhibitor|OGRPBCAM
EC 6.2.* (C-S bond-forming ligase) inhibitor|OGRPBCAM
EC 6.2.1.* (acid-thiol ligase) inhibitor|OGRPBCAM
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor|OGRPBCAM
EC 6.2.1.45 (E1 ubiquitin-activating enzyme) inhibitor|OGRPBCAM
EC 6.3.* (C-N bond-forming ligase) inhibitor|OGRPBCAM
EC 6.3.1.* (acid-ammonia/amine ligase) inhibitor|OGRPBCAM
EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor|OGRPBCAM
EC 6.3.2.* (acid--D-amino-acid ligase) inhibitor|OGRPBCAM
EC 6.3.2.19 (ubiquitin--protein ligase) inhibitor|OGRPBCAM
EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor|OGRPBCAM
EC 6.3.2.4 (D-alanine--D-alanine ligase) inhibitor|OGRPBCAM
EC 6.3.4.* (other carbon--nitrogen ligases) inhibitor|OGRPBCAM
EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitor|OGRPBCAM
EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitor|OGRPBCAM
EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor|OGRPBCAM
EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor|OGRPBCAM
EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor|OGRPBCAM
EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor|OGRPBCAM
EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitor|OGRPBCAM
EC 6.4.* (C-C bond-forming ligase) inhibitor|OGRPBCAM
EC 6.4.1.* (carboxylase) inhibitor|OGRPBCAM
EC 6.4.1.1 (pyruvate carboxylase) inhibitor|OGRPBCAM
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor|OGRPBCAM
EC 6.5.* (phosphoric ester bond-forming ligase) inhibitor|OGRPBCAM
EC 6.5.1.* (DNA/RNA repair enzymes) inhibitor|OGRPBCAM
EC 6.5.1.1 [DNA ligase (ATP)] inhibitor|OGRPBCAM
EC 6.6.* (N-metal bond-forming ligase) inhibitor|OGRPBCAM
EC10|OGRPBCAM
EC150|OGRPBCAM
EC20|OGRPBCAM
EC25|OGRPBCAM
EC30|OGRPBCAM
EC50|OGRPBCAM
EC90|OGRPBCAM
ECL peptide assay|OGRPBCAM
ECL western blotting detection kit|OGRPBCAM
ECMax|OGRPBCAM
ECMax_Agonist|OGRPBCAM
ECMax_Tm|OGRPBCAM
ECMax_fold increase|OGRPBCAM
ECMax_percent inhibition|OGRPBCAM
ED|OGRPBCAM
ED25|OGRPBCAM
ED30|OGRPBCAM
ED50|OGRPBCAM
ED80|OGRPBCAM
ED90|OGRPBCAM
EEG recording assay|OGRPBCAM
EGTA acetoxymethyl ester|OGRPBCAM
EHT 1864|OGRPBCAM
ELISA|OGRPBCAM
ELISA cAMP Competition Assay using cAMP-Screen Direct System|OGRPBCAM
ELISA protein secretion profiling assay|OGRPBCAM
ELISA protein state assay|OGRPBCAM
ELx808 Absorbance Microplate Reader|OGRPBCAM
ER-associated misfolded protein catabolic process|OGRPBCAM
ERK dimerisation inhibitor|OGRPBCAM
EST1|OGRPBCAM
EST2|OGRPBCAM
Eastern equine encephalitis|OGRPBCAM
Ebola hemorrhagic fever|OGRPBCAM
Ebstein anomaly|OGRPBCAM
EdU|OGRPBCAM
Edwards syndrome|OGRPBCAM
Ehlers-Danlos syndrome|OGRPBCAM
Ehrlich tumor carcinoma|OGRPBCAM
Ellis-Van Creveld syndrome|OGRPBCAM
Ellman and apos's reagent|OGRPBCAM
Emax|OGRPBCAM
Emery-Dreifuss muscular dystrophy|OGRPBCAM
EnVision Multilabel Reader|OGRPBCAM
Enterococcus faecalis|OGRPBCAM
EnzyChrom Aspartate Transaminase Assay Kit (BioAssay Systems)|OGRPBCAM
Epic reader|OGRPBCAM
Epitope Mapping|OGRPBCAM
Epoxide hydrolase 1|OGRPBCAM
Epstein-Barr virus|OGRPBCAM
Equus caballus|OGRPBCAM
Escherichia coli|OGRPBCAM
Escherichia coli metabolite|OGRPBCAM
Eu3+-cAMP|OGRPBCAM
Ewing sarcoma|OGRPBCAM
F|OGRPBCAM
FA2N-4 cell|OGRPBCAM
FACScalibur flow cytometer (BD Biosciences)|OGRPBCAM
FASTA local sequence alignment|OGRPBCAM
FDA-approved compound library|OGRPBCAM
FDSS6000|OGRPBCAM
FDSS7000|OGRPBCAM
FG syndrome|OGRPBCAM
FITC-RGS12-GoLoco peptide|OGRPBCAM
FLIPR Calcium 3 Assay Kit|OGRPBCAM
FLIPR Calcium 5 Assay Kit|OGRPBCAM
FLIPR Membrane Potential Assay Kit|OGRPBCAM
FLIPR TETRA|OGRPBCAM
FLOG scoring function|OGRPBCAM
FLUOstar Omega microplate reader (BMG Labtech)|OGRPBCAM
FLUXION|OGRPBCAM
FLx800 Fluorescence Microplate Reader|OGRPBCAM
FMO reaction phenotyping|OGRPBCAM
FMO3|OGRPBCAM
Fabry disease|OGRPBCAM
FacSCAN flow cytometer|OGRPBCAM
Fanconi anemia|OGRPBCAM
Fanconi syndrome|OGRPBCAM
Far Eastern spotted fever|OGRPBCAM
Farber lipogranulomatosis|OGRPBCAM
Fasciola hepatica|OGRPBCAM
Fc/FcRN induction assay|OGRPBCAM
Felty's syndrome|OGRPBCAM
Fiji|OGRPBCAM
FlexStation II Microplate Reader|OGRPBCAM
FlexStation III Microplate Reader|OGRPBCAM
FlexX docking method|OGRPBCAM
FlowSight|OGRPBCAM
Fluo-4 Calcium Assay Kit|OGRPBCAM
Fluo-8 No Wash Calcium Assay Kit|OGRPBCAM
FluoZin-2 AM fluorescent assay of zinc concentration|OGRPBCAM
Fluorescein|OGRPBCAM
Fluorescein Di-beta-D-Glucopyranoside|OGRPBCAM
Fluorescence imaging apoptosis assay|OGRPBCAM
Fluorescence imaging cell count assay|OGRPBCAM
Fluorescence imaging cell cycle state assay|OGRPBCAM
Fluorescence imaging cell growth inhibition assay|OGRPBCAM
Fluorescence imaging morphology assay|OGRPBCAM
Fluorescence imaging multiplex cytological profiling assay|OGRPBCAM
Fluorescence imaging protein state assay|OGRPBCAM
Fluormone ES2 Green|OGRPBCAM
Fluormone PL Far Red|OGRPBCAM
Fluorogenic triple-helical peptide 3|OGRPBCAM
Fluorometer|OGRPBCAM
Fluoroskan Ascent FL Microplate Fluorometer and Luminometer (ThermoFisher)|OGRPBCAM
FluxOR Thallium Detection Kit|OGRPBCAM
Fox-Fordyce disease|OGRPBCAM
Frasier syndrome|OGRPBCAM
Frey syndrome|OGRPBCAM
Friedreich ataxia|OGRPBCAM
FuGENE 6|OGRPBCAM
Fuchs' endothelial dystrophy|OGRPBCAM
Fuchs' heterochromic uveitis|OGRPBCAM
Fukuyama congenital muscular dystrophy|OGRPBCAM
Furafylline|OGRPBCAM
G alpha O-Alexa Fluor 488|OGRPBCAM
G protein|OGRPBCAM
G protein coupled receptor|OGRPBCAM
G protein-coupled receptor signaling pathway|OGRPBCAM
G-protein coupled receptor signaling|OGRPBCAM
G-protein-coupled receptor agonist|OGRPBCAM
G-protein-coupled receptor antagonist|OGRPBCAM
G1 phase|OGRPBCAM
G2 phase|OGRPBCAM
G2/mitotic-specific cyclin-B1|OGRPBCAM
GABA agent|OGRPBCAM
GABA agonist|OGRPBCAM
GABA antagonist|OGRPBCAM
GABA modulator|OGRPBCAM
GABA reuptake inhibitor|OGRPBCAM
GABA-gated chloride channel antagonist|OGRPBCAM
GABAA receptor agonist|OGRPBCAM
GABAA receptor antagonist|OGRPBCAM
GABAB receptor agonist|OGRPBCAM
GE Healthcare|OGRPBCAM
GHB receptor agonist|OGRPBCAM
GI50|OGRPBCAM
GM-TriDAP peptide|OGRPBCAM
GM2 gangliosidosis|OGRPBCAM
GNE-3511|OGRPBCAM
GOLD docking method|OGRPBCAM
GOLD scoring function|OGRPBCAM
GOstat enrichment analysis|OGRPBCAM
GPCR arrestin complex|OGRPBCAM
GPCR complex|OGRPBCAM
GPCR signaling assay|OGRPBCAM
GRID pharmacophore search|OGRPBCAM
GROMOS force field simulation|OGRPBCAM
GROW structure design|OGRPBCAM
GSEA-P enrichment analysis|OGRPBCAM
GSH adduct formation|OGRPBCAM
GST tag|OGRPBCAM
GTPase activity|OGRPBCAM
GW5074|OGRPBCAM
GW8510|OGRPBCAM
Gal-Screen Beta-Galactosidase Reporter Gene Assay system|OGRPBCAM
Galanin|OGRPBCAM
Gaucher's disease|OGRPBCAM
Gene Knock-Out Model|OGRPBCAM
GeneBLAzer|OGRPBCAM
GeneTrail enrichment analysis|OGRPBCAM
Geobacillus stearothermophilus|OGRPBCAM
Gerstmann-Straussler-Scheinker syndrome|OGRPBCAM
Gilbert syndrome|OGRPBCAM
Gilles de la Tourette syndrome|OGRPBCAM
Gilson|OGRPBCAM
Gitelman syndrome|OGRPBCAM
Glanzmann's thrombasthenia|OGRPBCAM
GloMax luminometer (Promega)|OGRPBCAM
Glucose|OGRPBCAM
Glucose-6-phosphate|OGRPBCAM
Glutathione|OGRPBCAM
Glycogen|OGRPBCAM
GnRH antagonist|OGRPBCAM
Go6976|OGRPBCAM
Goldenhar syndrome|OGRPBCAM
Golgi apparatus|OGRPBCAM
Good syndrome|OGRPBCAM
Good's buffer substance|OGRPBCAM
Goodpasture syndrome|OGRPBCAM
Gorham's disease|OGRPBCAM
Gram negative|OGRPBCAM
Gram positive|OGRPBCAM
Gram staining|OGRPBCAM
Graves' disease|OGRPBCAM
Grignard reagent|OGRPBCAM
GripTite 293 MSR cell|OGRPBCAM
Groupbuild structure design|OGRPBCAM
Guillain-Barre syndrome|OGRPBCAM
H-4-II-E cell|OGRPBCAM
H-Leu-NHMec|OGRPBCAM
H1-receptor agonist|OGRPBCAM
H1-receptor antagonist|OGRPBCAM
H2-receptor antagonist|OGRPBCAM
H3-receptor agonist|OGRPBCAM
H3-receptor antagonist|OGRPBCAM
H4|OGRPBCAM
H4-receptor agonist|OGRPBCAM
H5N1 subtype|OGRPBCAM
H69AR cell|OGRPBCAM
HA tag|OGRPBCAM
HBL-1 cell|OGRPBCAM
HBSS|OGRPBCAM
HCT 116 cell|OGRPBCAM
HEC-1-A|OGRPBCAM
HEK293|OGRPBCAM
HEL cell|OGRPBCAM
HEPATOPAC® co-culture kit|OGRPBCAM
HEPES|OGRPBCAM
HIF1-alpha assay|OGRPBCAM
HIV fusion inhibitor|OGRPBCAM
HIV protease inhibitor|OGRPBCAM
HIV-1 Tat inhibitor|OGRPBCAM
HIV-1 integrase inhibitor|OGRPBCAM
HIV-1 maturation inhibitor|OGRPBCAM
HIV-1 reverse transcriptase inhibitor|OGRPBCAM
HL-60 cell|OGRPBCAM
HL2/3|OGRPBCAM
HMC-1-8 cell|OGRPBCAM
HMLE_sh_ECAD cell|OGRPBCAM
HMLE_sh_TWIST cell|OGRPBCAM
HMLE_sh_eGFP cell|OGRPBCAM
HMS|OGRPBCAM
HPLC System|OGRPBCAM
HT-1080 cell|OGRPBCAM
HT-29 cell|OGRPBCAM
HTFC Screening System|OGRPBCAM
HTRF KinEASE|OGRPBCAM
HTRF KinEASE-TK|OGRPBCAM
HTRF biomarkers|OGRPBCAM
HTRF cAMP Detection Kit|OGRPBCAM
HTRF cAMP HiRange Detection Kit|OGRPBCAM
HTScan IKK-beta Kinase Assay Kit|OGRPBCAM
HTScan PKC-beta Kinase Assay Kit|OGRPBCAM
HTScan PKC-theta Kinase Assay Kit|OGRPBCAM
HUV-EC-C cell|OGRPBCAM
HYPER flask|OGRPBCAM
Haemonchus contortus|OGRPBCAM
Hailey-Hailey disease|OGRPBCAM
Hajdu-Cheney syndrome|OGRPBCAM
Hallermann-Streiff syndrome|OGRPBCAM
Hamamatsu|OGRPBCAM
Hantavirus hemorrhagic fever with renal syndrome|OGRPBCAM
Harmony|OGRPBCAM
Hartnup disease|OGRPBCAM
Hartree-Fock method|OGRPBCAM
Has_DIPG_DMG_Permissible_Value|NCIT_A40
Has_PCDC_Data_Type|NCIT_A23
Has_PCDC_EWS_Permissible_Value|NCIT_A29
Has_PCDC_GCT_Permissible_Value|NCIT_A34
Has_PCDC_HL_Permissible_Value|NCIT_A39
Has_PCDC_OS_Permissible_Value|NCIT_A38
HeLa cell|OGRPBCAM
HeLa-MAGI-CCR5|OGRPBCAM
HeLa-R5-16|OGRPBCAM
Hedgehog signaling pathway inhibitor|OGRPBCAM
Helicobacter pylori|OGRPBCAM
Henoch-Schoenlein purpura|OGRPBCAM
Hep G2 cell|OGRPBCAM
Hermansky-Pudlak syndrome|OGRPBCAM
Heterotrimeric G-protein dissassociation assay|OGRPBCAM
High Performance PBX Calcium Assay Kit|OGRPBCAM
Hill equation|OGRPBCAM
Hirschsprung's disease|OGRPBCAM
Histology|OGRPBCAM
Histone H3.3|OGRPBCAM
HitHunter Calcium No WashPLUS Assay Kit|OGRPBCAM
HitHunter cAMP Assay Kit|OGRPBCAM
Hodgkin's lymphoma|OGRPBCAM
Hodgkin's lymphoma, nodular sclerosis|OGRPBCAM
Hoechst|OGRPBCAM
Hoechst 33342|OGRPBCAM
Homo sapiens|OGRPBCAM
Horner's syndrome|OGRPBCAM
Hs 578T cell|OGRPBCAM
Hsp70 inducer|OGRPBCAM
Hsp90 inhibitor|OGRPBCAM
Human Cytochrome c ELISA (R&D Systems)|OGRPBCAM
Human gammaherpesvirus 4|OGRPBCAM
Human immunodeficiency virus 1|OGRPBCAM
Human orthopneumovirus|OGRPBCAM
Hummerhead docking method|OGRPBCAM
Huntington's disease|OGRPBCAM
HyperCyt High Throughput Flow Cytometry System|OGRPBCAM
Hypercyt|OGRPBCAM
IAP antagonist|OGRPBCAM
IC20|OGRPBCAM
IC25|OGRPBCAM
IC30|OGRPBCAM
IC50|OGRPBCAM
IC50 absolute|OGRPBCAM
IC50 relative|OGRPBCAM
IC75|OGRPBCAM
IC80|OGRPBCAM
IC90|OGRPBCAM
IC95|OGRPBCAM
ICR 8000 Ion Channel Reader|OGRPBCAM
ICRM12000 atomic absorption spectrometer|OGRPBCAM
ID50|OGRPBCAM
IEC-6 cell|OGRPBCAM
IEDB alternative term|OGRPBCAM
IMAP Assay of phosphoproteins (Molecular Devices)|OGRPBCAM
IN Cell Analyzer|OGRPBCAM
IN Cell Analyzer 1000|OGRPBCAM
IN Cell Analyzer 2000|OGRPBCAM
IN Cell Analyzer 2200|OGRPBCAM
IN Cell Analyzer 2500|OGRPBCAM
IN Cell Analyzer 3000|OGRPBCAM
IN Cell Analyzer 6000|OGRPBCAM
IN Cell Analyzer 6500|OGRPBCAM
IN Cell Investigator|OGRPBCAM
IP-One HTRF Assay|OGRPBCAM
IP1 redistribution assay|OGRPBCAM
IP3 receptor agonist|OGRPBCAM
IP3 receptor antagonist|OGRPBCAM
IPEGAL|OGRPBCAM
IUPHAR|OGRPBCAM
IZ|OGRPBCAM
Icy|OGRPBCAM
IgA|OGRPBCAM
IgA glomerulonephritis|OGRPBCAM
IgD|OGRPBCAM
IgE|OGRPBCAM
IgG|OGRPBCAM
IgM|OGRPBCAM
Illumina|OGRPBCAM
ImageJ|OGRPBCAM
ImageStreamX Mark II Imaging Flow Cytometer|OGRPBCAM
ImageXpress Micro|OGRPBCAM
ImageXpress Ultra|OGRPBCAM
ImageXpress Velos Laser Scanning Cytometer|OGRPBCAM
Increase|OGRPBCAM
Infectious bronchitis virus|OGRPBCAM
Infinite F200|OGRPBCAM
Infinite F500|OGRPBCAM
Infinite M1000|OGRPBCAM
Infinite PF200|OGRPBCAM
Infinte M200 plate reader (Tecan)|OGRPBCAM
IntelliCyt Corporation|OGRPBCAM
Interferon gamma|OGRPBCAM
Interleukin-3|OGRPBCAM
Interleukin-6|OGRPBCAM
Interleukin-8|OGRPBCAM
Invitrogen|OGRPBCAM
IonWorks Quattro|OGRPBCAM
IonWorks automated electrophysiology system (Molecular Devices)|OGRPBCAM
Is_Value_For_GDC_Property|NCIT_A32
JAligner sequence alignment|OGRPBCAM
JMP syndrome|OGRPBCAM
JURKAT cell|OGRPBCAM
Jacobaea metabolite|OGRPBCAM
Japanese encephalitis|OGRPBCAM
Japanese spotted fever|OGRPBCAM
Johanson-Blizzard syndrome|OGRPBCAM
K-ATP channel agonist|OGRPBCAM
KBG syndrome|OGRPBCAM
KINOMEScan assay|OGRPBCAM
KINOMEscan kit|OGRPBCAM
KOPN-8|OGRPBCAM
KPT-350|OGRPBCAM
Ka|OGRPBCAM
Kallmann syndrome|OGRPBCAM
Kaposi's sarcoma|OGRPBCAM
Karl Fischer titration|OGRPBCAM
Kawasaki disease|OGRPBCAM
Kd|OGRPBCAM
Kearns-Sayre syndrome|OGRPBCAM
Kemptide peptide|OGRPBCAM
Kennedy's disease|OGRPBCAM
Keshan disease|OGRPBCAM
Ki|OGRPBCAM
KiNativ assay|OGRPBCAM
Kimura disease|OGRPBCAM
Kinactivation|OGRPBCAM
Kinase NanoBRET Assay|OGRPBCAM
Kinase-Glo Luminescent Kinase Assay|OGRPBCAM
Kinase-Glo Plus Luminescent Kinase Assay|OGRPBCAM
KineticScan HCS Reader|OGRPBCAM
Klatskin's tumor|OGRPBCAM
Klebsiella pneumoniae|OGRPBCAM
Kleine-Levin syndrome|OGRPBCAM
Klinefelter syndrome|OGRPBCAM
Klippel-Feil syndrome|OGRPBCAM
Klippel-Trenaunay syndrome|OGRPBCAM
Kniest dysplasia|OGRPBCAM
Korean hemorrhagic fever|OGRPBCAM
Kp|OGRPBCAM
Krabbe disease|OGRPBCAM
Kuhnt-Junius degeneration|OGRPBCAM
Kyasanur forest disease|OGRPBCAM
L-2-hydroxyglutaric aciduria|OGRPBCAM
L-AP4|OGRPBCAM
L1000 mRNA profiling assay|OGRPBCAM
L6 cell|OGRPBCAM
LADD syndrome|OGRPBCAM
LANCE cAMP Detection Kit|OGRPBCAM
LC50|OGRPBCAM
LD10|OGRPBCAM
LD50|OGRPBCAM
LDH release assay|OGRPBCAM
LDV peptide|OGRPBCAM
LEADING LIGHT Wnt Reporter cell line cell|OGRPBCAM
LEADseeker Imaging system|OGRPBCAM
LEGEND structure design|OGRPBCAM
LI-COR Biosciences|OGRPBCAM
LIM kinase inhibitor|OGRPBCAM
LINCS ID|OGRPBCAM
LJL BioSystems|OGRPBCAM
LJL reader|OGRPBCAM
LLC-PK subscript(1) cell|OGRPBCAM
LLC-PK1 monolayer permeability assay|OGRPBCAM
LNA|OGRPBCAM
LOPAC 1280|OGRPBCAM
LRH-1 agonist|OGRPBCAM
LRH-1 antagonist|OGRPBCAM
LTQ-Orbitrap Velos (Thermo Scientific)|OGRPBCAM
LUDI structure design|OGRPBCAM
LYMP1-002|OGRPBCAM
LYMP1-003|OGRPBCAM
LYMP2-001|OGRPBCAM
LYMP2-002|OGRPBCAM
LYMP2-003|OGRPBCAM
LYMP2-004|OGRPBCAM
LYMP2-005|OGRPBCAM
LYMP2-006|OGRPBCAM
LYMP2-007|OGRPBCAM
LYMP2-008|OGRPBCAM
LYMP2-009|OGRPBCAM
LYMP2-010|OGRPBCAM
LYMP2-011|OGRPBCAM
LYMP2-012|OGRPBCAM
LYMP2-013|OGRPBCAM
LYMP2-014|OGRPBCAM
LYMP2-015|OGRPBCAM
LYMP2-016|OGRPBCAM
LYMP2-017|OGRPBCAM
LYMP2-018|OGRPBCAM
LYMP2-019|OGRPBCAM
LYMP2-020|OGRPBCAM
LYMP2-021|OGRPBCAM
LYMP2-022|OGRPBCAM
LYMP2-023|OGRPBCAM
LYMP2-024|OGRPBCAM
LYMP2-025|OGRPBCAM
LYMP2-026|OGRPBCAM
La Crosse encephalitis|OGRPBCAM
LabChip 3000|OGRPBCAM
LabChip EZ Reader|OGRPBCAM
Lactate kit|OGRPBCAM
Lambert-Eaton myasthenic syndrome|OGRPBCAM
Landau-Kleffner syndrome|OGRPBCAM
Langendorff assay|OGRPBCAM
Langerhans cell sarcoma|OGRPBCAM
Langerhans-cell histiocytosis|OGRPBCAM
LanthaScreen Co-Factor Interaction Assay|OGRPBCAM
LanthaScreen Competetive Binding Assay|OGRPBCAM
LanthaScreen Tb-Streptavidin Binding Assay|OGRPBCAM
LanthaScreen Tb-Ubiquitin Assay|OGRPBCAM
LanthaScreen kinase activity assay kit|OGRPBCAM
Laron syndrome|OGRPBCAM
Larsen syndrome|OGRPBCAM
Lassa fever|OGRPBCAM
Laurence-Moon syndrome|OGRPBCAM
Leber congenital amaurosis|OGRPBCAM
Leber hereditary optic neuropathy|DOID_705
Legacy Concept Name|OGRPBCAM
Legg-Calve-Perthes disease|OGRPBCAM
Legionnaires' disease|OGRPBCAM
Leica Microsystems|OGRPBCAM
Leigh disease|OGRPBCAM
Leishmania major|OGRPBCAM
Leishmania mexicana|OGRPBCAM
Lennox-Gastaut syndrome|OGRPBCAM
Lesch-Nyhan syndrome|OGRPBCAM
Leuconostoc mesenteroides|OGRPBCAM
Lewis acid|OGRPBCAM
Lewis base|OGRPBCAM
Lewy body dementia|OGRPBCAM
Leydig cell tumor|OGRPBCAM
Li-Fraumeni syndrome|OGRPBCAM
Liddle syndrome|OGRPBCAM
Life Technologies Corporation|OGRPBCAM
LightCycler 480 Real-Time PCR detection instrument|OGRPBCAM
Lipinski rule of 5 filtering|OGRPBCAM
Liquid Chromatography/Mass Spectroscopy (LC/MS) protein quantification|OGRPBCAM
LiveBLAzer FRET - B/G Loading Kit|OGRPBCAM
Loeys-Dietz syndrome|OGRPBCAM
Lonza|OGRPBCAM
Lowry assay|OGRPBCAM
Luciferase-based ('Glo') Assay System (Promega)|OGRPBCAM
Luciferin 4-monooxygenase|OGRPBCAM
Luminex|OGRPBCAM
Luminex 200 Flow Cytometer|OGRPBCAM
Lyme disease|OGRPBCAM
Lynch syndrome|OGRPBCAM
LysoTracker Red|OGRPBCAM
M phase|OGRPBCAM
M phase assessment method|OGRPBCAM
M phase mitotic cell phenotype|OGRPBCAM
MACCS key|OGRPBCAM
MAD score|OGRPBCAM
MAIT cell agonist|OGRPBCAM
MALDI matrix material|OGRPBCAM
MAO reaction phenotyping assay|OGRPBCAM
MATE1 inhibition assay|OGRPBCAM
MATE1 substrate assay|OGRPBCAM
MATE2 inhibition assay|OGRPBCAM
MATE2 substrate assay|OGRPBCAM
MATLAB|OGRPBCAM
MAVID sequence alignment|OGRPBCAM
MCF7 cell|OGRPBCAM
MCL-1 1780 cell|OGRPBCAM
MDA-MB-231 cell|OGRPBCAM
MDCK cell|OGRPBCAM
MDCK permeability assay|OGRPBCAM
MDCK-BCRP permeability assay|OGRPBCAM
MDCK-II cell|OGRPBCAM
MDCKII monolayer permeability assay|OGRPBCAM
MDCKII-LE cell|OGRPBCAM
ME-180 cell|OGRPBCAM
MELAS syndrome|OGRPBCAM
MEMA cell growth assay|OGRPBCAM
MES|OGRPBCAM
MET immunoassay|OGRPBCAM
MG213 cell|OGRPBCAM
MHC class I deficiency|OGRPBCAM
MIC|OGRPBCAM
MIC50|OGRPBCAM
MIC80|OGRPBCAM
MIC90|OGRPBCAM
ML-2|OGRPBCAM
ML309|OGRPBCAM
MLSCN center at columbia university|OGRPBCAM
MLSMR library|OGRPBCAM
MM4 force field simulation|OGRPBCAM
MMFF force field simulation|OGRPBCAM
MODELLER homology modeling|OGRPBCAM
MOPS|OGRPBCAM
MRC-5 cell|OGRPBCAM
MRI contrast agent|OGRPBCAM
MRP2 inhibition assay|OGRPBCAM
MRP2 substrate assay|OGRPBCAM
MS protein quantification assay|OGRPBCAM
MS protein state assay|OGRPBCAM
MSC 80|OGRPBCAM
MSD SECTOR instrument|OGRPBCAM
MTD|OGRPBCAM
MTP inhibitor|OGRPBCAM
MTS reduction assay|OGRPBCAM
MTT reduction assay|OGRPBCAM
MV-4-11|OGRPBCAM
Macaca fascicularis|OGRPBCAM
Machado-Joseph disease|OGRPBCAM
Macrophage inflammatory protein 3 alpha|OGRPBCAM
Maillard reaction product|OGRPBCAM
Mannose-6-phosphate|OGRPBCAM
Maps_To|OGRPBCAM
Marburg hemorrhagic fever|OGRPBCAM
Marfan syndrome|OGRPBCAM
Masters-Allen syndrome|OGRPBCAM
McCune Albright syndrome|OGRPBCAM
Meige syndrome|OGRPBCAM
Melanin-concentrating hormone|OGRPBCAM
Melkersson-Rosenthal syndrome|OGRPBCAM
Meniere's disease|OGRPBCAM
Menkes disease|OGRPBCAM
Merkel cell carcinoma|OGRPBCAM
Meso Scale Discovery|OGRPBCAM
Mesquite phylogenetic analysis|OGRPBCAM
MetaDiscovery pathway analysis|OGRPBCAM
MetaMorph|OGRPBCAM
MetaXpress|OGRPBCAM
MicroBeta TriLux|OGRPBCAM
MicroCal|OGRPBCAM
MicroSource Discovery Systems|OGRPBCAM
Microarray|OGRPBCAM
Microtubule-associated protein tau|OGRPBCAM
Microtubule-associated proteins 1A/1B light chain 3B|OGRPBCAM
Microwestern|OGRPBCAM
Migration Assay|OGRPBCAM
Mikulicz disease|OGRPBCAM
Miller Fisher syndrome|OGRPBCAM
MinED|OGRPBCAM
Mirus Bio LLC|OGRPBCAM
MitoTEMPO|OGRPBCAM
Mitogen-activated protein kinase 1|OGRPBCAM
Mitogen-activated protein kinase 14|OGRPBCAM
Mobius syndrome|OGRPBCAM
Molecular Devices|OGRPBCAM
Molecular Devices SpectraMax Plate reader|OGRPBCAM
Molecular Devices Vmax plate reader|OGRPBCAM
Molecular Probes|OGRPBCAM
Monolight 2010 Luminometer|OGRPBCAM
Monte Carlo minimization method|OGRPBCAM
Monte Carlo simulated annealing|OGRPBCAM
Monte Carlo simulation|OGRPBCAM
Mooren's ulcer|OGRPBCAM
Morgagni cataract|OGRPBCAM
Moyamoya disease|OGRPBCAM
Muir-Torre syndrome|OGRPBCAM
Multidrug and toxin extrusion protein 1|OGRPBCAM
Multidrug and toxin extrusion protein 2|OGRPBCAM
Multidrug resistance-associated protein 2|OGRPBCAM
Multiskan EX plate reader (Thermo Scientific)|OGRPBCAM
MurNAc-L-Ala-gamma-D-Glu-mDAP|OGRPBCAM
Muramyl dipeptide|OGRPBCAM
Murray Valley encephalitis|OGRPBCAM
Mus musculus|OGRPBCAM
Mv 1 Lu cell|OGRPBCAM
Mx3005P RT-PCR instrument (Agilent Technologies)|OGRPBCAM
Mx3005P qPCR System|OGRPBCAM
Mycobacterium avium complex disease|OGRPBCAM
Mycobacterium tuberculosis|OGRPBCAM
Mycoplasma genitalium metabolite|OGRPBCAM
N syndrome|OGRPBCAM
N-methyl-4-phenylpyridinium iodide|OGRPBCAM
N-terminal ligand covalent binding method|OGRPBCAM
N2a|OGRPBCAM
NADPH|OGRPBCAM
NBD C6-HPC|OGRPBCAM
NCI_META_CUI|OGRPBCAM
NF-KappaB p65 translocation|OGRPBCAM
NF-KappaB p65 translocation phenotype|OGRPBCAM
NF-kappaB inhibitor|OGRPBCAM
NGS Instrument|OGRPBCAM
NHK 477|OGRPBCAM
NIH chemical genomics center|OGRPBCAM
NIH-3T3 cell|OGRPBCAM
NINDS library|OGRPBCAM
NLRP3 inhibitor|OGRPBCAM
NMDA receptor agonist|OGRPBCAM
NMDA receptor antagonist|OGRPBCAM
NMR chemical shift reference compound|OGRPBCAM
NMR shift reagent|OGRPBCAM
NMR solvent|OGRPBCAM
NOD1|OGRPBCAM
NOD1 agonist|OGRPBCAM
NOD2|OGRPBCAM
NP-40|OGRPBCAM
NanoBIT|OGRPBCAM
NanoBRET|OGRPBCAM
Nanostring|OGRPBCAM
Nelson syndrome|OGRPBCAM
Netherton syndrome|OGRPBCAM
Neuropeptide S|OGRPBCAM
Neuropeptide W|OGRPBCAM
Neuropeptide Y|OGRPBCAM
Newcastle disease|OGRPBCAM
Newton-Raphson method|OGRPBCAM
Nezelof syndrome|OGRPBCAM
Niemann-Pick disease|OGRPBCAM
Nijmegen breakage syndrome|OGRPBCAM
Noonan syndrome|OGRPBCAM
Noonan syndrome with multiple lentigines|OGRPBCAM
Norum disease|OGRPBCAM
O-methyl-fluorescein phosphate|OGRPBCAM
OAT1 inhibition assay|OGRPBCAM
OAT1 substrate assay|OGRPBCAM
OAT2 inhibition assay|OGRPBCAM
OAT2 substrate assay|OGRPBCAM
OAT3 inhibition assay|OGRPBCAM
OAT3 substrate assay|OGRPBCAM
OATP1B1 inhibition assay|OGRPBCAM
OATP1B1 substrate assay|OGRPBCAM
OATP1B3 inhibition assay|OGRPBCAM
OATP1B3 substrate assay|OGRPBCAM
OATP2B1 substrate assay|OGRPBCAM
OCI-Ly3|OGRPBCAM
OCT1 inhibition assay|OGRPBCAM
OCT1 substrate assay|OGRPBCAM
OCT2 inhibition assay|OGRPBCAM
OCT2 substrate assay|OGRPBCAM
OLIG2 inhibitor|OGRPBCAM
ONE-Glo Luciferase Assay System|OGRPBCAM
Odyssey Infrared Imager|OGRPBCAM
Odyssey Plate Reader|OGRPBCAM
Ollier disease|OGRPBCAM
Olympus|OGRPBCAM
Omenn syndrome|OGRPBCAM
Onto-Express enrichment analysis|OGRPBCAM
Opera|OGRPBCAM
Opera QEHS|OGRPBCAM
Operetta|OGRPBCAM
OptEIA Human IL-8 ELISA Set|OGRPBCAM
OptEIA human IL-2 ELISA (BD Biosciences)|OGRPBCAM
Orexin A|OGRPBCAM
Oryza sativa Japonica Group|OGRPBCAM
Osgood-Schlatter's disease|OGRPBCAM
Oxytocin|OGRPBCAM
P-gp inhibition assay|OGRPBCAM
P-gp substrate assay|OGRPBCAM
P-selectin glycoprotein ligand 1|OGRPBCAM
P100 phosphoprotein quantification assay|OGRPBCAM
P100 protein profiling assay|OGRPBCAM
P2Y12 receptor antagonist|OGRPBCAM
P2Y14 receptor antagonist|OGRPBCAM
P2Y2 receptor agonist|OGRPBCAM
P450 inhibitor|OGRPBCAM
P450-Glo CYP1A2 Screening System|OGRPBCAM
P450-Glo CYP2C19 Screening System|OGRPBCAM
P450-Glo CYP2C9 Screening System|OGRPBCAM
P450-Glo CYP2D6 Screening System|OGRPBCAM
P450-Glo CYP3A4 Screening System|OGRPBCAM
PAGE|OGRPBCAM
PAR Immunoassay|OGRPBCAM
PAR2 negative allosteric modulator|OGRPBCAM
PBPK modeling|OGRPBCAM
PCNA inhibitor|OGRPBCAM
PD biomarker assay|OGRPBCAM
PDSP|OGRPBCAM
PERK inhibitor|OGRPBCAM
PHERAstar FSX|OGRPBCAM
PHERAstar Plus|OGRPBCAM
PIPES|OGRPBCAM
PKLight|OGRPBCAM
PNA|OGRPBCAM
PNU-74654|OGRPBCAM
POEMS syndrome|OGRPBCAM
PPAR modulator|OGRPBCAM
PPARalpha agonist|OGRPBCAM
PPARbeta/delta agonist|OGRPBCAM
PPARgamma agonist|OGRPBCAM
PPC-1|OGRPBCAM
PREDATOR structure prediction|OGRPBCAM
PRESTO-TANGO|OGRPBCAM
PTZ-induced convulsion assay|OGRPBCAM
Packard Fusion Microplate Reader|OGRPBCAM
Paget's disease of bone|OGRPBCAM
Pallister-Hall syndrome|OGRPBCAM
Pancreatic trypsin inhibitor|OGRPBCAM
Papillon-Lefevre disease|OGRPBCAM
Papio hamadryas metabolite|OGRPBCAM
Pariser Parr Pople method|OGRPBCAM
Parkinson's disease|OGRPBCAM
Partington syndrome|OGRPBCAM
Partition Coefficient|OGRPBCAM
Patau syndrome|OGRPBCAM
PathHunter Beta-Arrestin Assay|OGRPBCAM
PathHunter CHO-K1 DRD2L Beta-Arrestin cell|OGRPBCAM
PathHunter CHO-K1 DRD3 Beta-Arrestin cell|OGRPBCAM
PathHunter U2OS Keap1-NRF2 Nuclear Translocation Assay (DiscoverX)|OGRPBCAM
PathScan Apoptosis and Proliferation Multiplex IF Kit|OGRPBCAM
PathScan EGF Receptor Activation Multiplex IF Kit|OGRPBCAM
PathScan EMT Duplex IF Kit|OGRPBCAM
PathScan Multi-Target HCA DNA Damage Kit|OGRPBCAM
PathScan Multi-Target HCA Stress and Apoptosis Kit|OGRPBCAM
PathScan Signaling Nodes Multiplex IF Kit|OGRPBCAM
Patient Derived Xenograft|OGRPBCAM
Pearson syndrome|OGRPBCAM
Pelger-Huet anomaly|OGRPBCAM
Pelizaeus-Merzbacher disease|OGRPBCAM
Penicillium metabolite|OGRPBCAM
Perkin Elmer|OGRPBCAM
Peutz-Jeghers syndrome|OGRPBCAM
Peyronie's disease|OGRPBCAM
Phlebotomus fever|OGRPBCAM
Phospho(Thr180/Tyr182)/Total p38 Assay Whole Cell Lysate Kit|OGRPBCAM
Phospho-ERK1/2 (Thr202/Tyr204) Cellular Assay Kit (Cisbio)|OGRPBCAM
Photinus pyralis|OGRPBCAM
Photon Technology International|OGRPBCAM
Photuris pensylvanica|OGRPBCAM
Pick's disease|OGRPBCAM
Pico patch clamp amplifier (Tecella)|OGRPBCAM
Pierce|OGRPBCAM
Plasmodium falciparum|OGRPBCAM
Plummer's disease|OGRPBCAM
Polar Screen PPARg Competitor Assay, Green (Invitrogen)|OGRPBCAM
PolarScreen Competitor Assay Kit|OGRPBCAM
Ponceau S protein staining|OGRPBCAM
Pontiac fever|OGRPBCAM
Potency Assay|OGRPBCAM
Potter's syndrome|OGRPBCAM
Prader-Willi syndrome|OGRPBCAM
PredictProtein structure prediction|OGRPBCAM
Preferred_Name|OGRPBCAM
Promega|OGRPBCAM
Proteasome-Glo Chymotrypsin-Like Assay|OGRPBCAM
Protein-Protein NanoBRET Assay|OGRPBCAM
Protein-Small Molecule NanoBRET Assay|OGRPBCAM
Proteus syndrome|OGRPBCAM
Pseudomonas aeruginosa PAO1|OGRPBCAM
Pthirus pubis infestation|OGRPBCAM
PubChem|OGRPBCAM
PubChem AID|OGRPBCAM
PubChem endpoint name|OGRPBCAM
Pyr-RTKR-AMC|OGRPBCAM
Q fever|OGRPBCAM
QT interval assay|OGRPBCAM
QUANTI-Blue (InvivoGen)|OGRPBCAM
Qpatch automated patch clamp system (Biolin)|OGRPBCAM
QuantaBlu|OGRPBCAM
QuantiChrom Assay Kit|OGRPBCAM
QuantiTect SYBR Green PCR Kits (Qiagen/Thermo-Fisher)|OGRPBCAM
Quantitative Autoradiography|OGRPBCAM
Queensland tick typhus|OGRPBCAM
R18 peptide|OGRPBCAM
RAPTOR protein threading|OGRPBCAM
RASopathy|OGRPBCAM
RAW-Blue cell|OGRPBCAM
RBL-2H3|OGRPBCAM
RD-HGA16|OGRPBCAM
RNA|OGRPBCAM
RNA aptamer|OGRPBCAM
RNA interference|OGRPBCAM
RNA interference construct|OGRPBCAM
RNA interference construct preparation method|OGRPBCAM
RNA modification method|OGRPBCAM
RNA-seq gene expression profiling assay|OGRPBCAM
RPPA protein profiling assay|OGRPBCAM
RPPA protein state assay|OGRPBCAM
RRCK permeability assay|OGRPBCAM
RS repeat peptide|OGRPBCAM
RS-11846 cell|OGRPBCAM
RUNX1 inhibitor|OGRPBCAM
Rac1 inhibitor|OGRPBCAM
Raman imaging|OGRPBCAM
RapidFire Mass Spec|OGRPBCAM
Rattus norvegicus|OGRPBCAM
Raynaud disease|OGRPBCAM
Refsum disease|OGRPBCAM
Relative Induction Score|OGRPBCAM
Relative Induction Score determination|OGRPBCAM
Renilla-Glo luciferase assay system (Promega)|OGRPBCAM
Resorufin alpha-D-pyranoside|OGRPBCAM
Resorufin beta-D-glucopyranoside|OGRPBCAM
Retinoblastoma-associated protein|OGRPBCAM
Rett syndrome|OGRPBCAM
Reverse Transcription Kit (Applied Biosystems or ABI)|OGRPBCAM
Reye syndrome|OGRPBCAM
Rh isoimmunization|OGRPBCAM
RhoA inhibitor|OGRPBCAM
RhoC inhibitor|OGRPBCAM
Rhodamine-RGS12-GoLoco peptide|OGRPBCAM
Rift Valley fever|OGRPBCAM
Riley-Day syndrome|OGRPBCAM
Ritter's disease|OGRPBCAM
Ro 20-1724|OGRPBCAM
Roberts syndrome|OGRPBCAM
Rothmund-Thomson syndrome|OGRPBCAM
Rubinstein-Taybi syndrome|OGRPBCAM
S phase|OGRPBCAM
S phase assessment method|OGRPBCAM
S phase mitotic cell phenotype|OGRPBCAM
S-adenosyl methionine|OGRPBCAM
S100 calcium-binding protein B inhibitor|OGRPBCAM
S16 cell|OGRPBCAM
S6 peptide|OGRPBCAM
S9 fraction format|OGRPBCAM
S9 stability assay|OGRPBCAM
SAPHO syndrome|OGRPBCAM
SAR by NMR|OGRPBCAM
SAR-AD81|OGRPBCAM
SERCA activator|OGRPBCAM
SFdock docking method|OGRPBCAM
SH-SY5Y cell|OGRPBCAM
SK-BR-3|OGRPBCAM
SK-MEL-5 cell|OGRPBCAM
SK-N-SH cell|OGRPBCAM
SLIDE docking method|OGRPBCAM
SM-AHNMD|OGRPBCAM
SMO receptor agonist|OGRPBCAM
SMO receptor antagonist|OGRPBCAM
SNB75 cell|OGRPBCAM
SNC80|OGRPBCAM
SOST-related sclerosing bone dysplasia|OGRPBCAM
SPROUT pharmacophore search|OGRPBCAM
SPROUT structure design|OGRPBCAM
STAT3 inhibitor|OGRPBCAM
SU-DHL-10 cell|OGRPBCAM
SU-DHL-6 cell|OGRPBCAM
SW1 cell|OGRPBCAM
SW403 cell|OGRPBCAM
SWATH MS protein profiling assay|OGRPBCAM
SWATH-MS protein quantification assay|OGRPBCAM
SYBR Green I DNA staining|OGRPBCAM
SYPRO orange dye|OGRPBCAM
Saccharomyces cerevisiae|OGRPBCAM
Saccharomyces cerevisiae metabolite|OGRPBCAM
Safire|OGRPBCAM
Salmonella enterica subsp. enterica serovar Typhi|OGRPBCAM
Salmonella enterica subsp. enterica serovar Typhimurium|OGRPBCAM
Sandhoff disease|OGRPBCAM
Scheuermann's disease|OGRPBCAM
Schistosoma mansoni|OGRPBCAM
Schneider's Drosophila Line 2|OGRPBCAM
Schnitzler syndrome|OGRPBCAM
Seckel syndrome|OGRPBCAM
Sector imager 6000|OGRPBCAM
Semantic_Type|OGRPBCAM
Sensolyte 520 HCV Protease Assay Kit (AnaSpec)|OGRPBCAM
Sensor chip CM5|OGRPBCAM
Sertoli cell tumor|OGRPBCAM
Sertoli cell-only syndrome|OGRPBCAM
Sertoli-Leydig cell tumor|OGRPBCAM
Serum albumin|OGRPBCAM
Sezary's disease|OGRPBCAM
Sigma-Aldrich|OGRPBCAM
Silver-Russell syndrome|OGRPBCAM
Sir1 inhibitor|OGRPBCAM
Sir2 inhibitor|OGRPBCAM
Sjogren's syndrome|OGRPBCAM
SlideBook software|OGRPBCAM
Smad3 inhibitor|OGRPBCAM
Smith-Lemli-Opitz syndrome|OGRPBCAM
Sodium/bile acid cotransporter|OGRPBCAM
Solute carrier family 15 member 1|OGRPBCAM
Solute carrier family 22 member 1|OGRPBCAM
Solute carrier family 22 member 6|OGRPBCAM
Solute carrier family 22 member 7|OGRPBCAM
Solute carrier family 22 member 8|OGRPBCAM
Solute carrier organic anion transporter family member 1B1|OGRPBCAM
Solute carrier organic anion transporter family member 1B3|OGRPBCAM
Solute carrier organic anion transporter family member 2B1|OGRPBCAM
Sotos syndrome|OGRPBCAM
SpectraFluor Plus Microplate Reader (Tecan)|OGRPBCAM
SpectraMax 190 Microplate Reader|OGRPBCAM
SpectraMax Gemini XS microplate fluorometer (Molecular Devices)|OGRPBCAM
SpectraMax M5 Multi-Mode Microplate Reader|OGRPBCAM
SpectraMax Plus384|OGRPBCAM
Spectramax L|OGRPBCAM
Sphingosine 1-phosphate|OGRPBCAM
SplitsTree phylogenetic analysis|OGRPBCAM
St. Louis encephalitis|OGRPBCAM
Staphylococcus aureus|OGRPBCAM
Steady-Glo Luciferase Assay System|OGRPBCAM
StemLight Pluripotency Antibody Kit|OGRPBCAM
Steroid transmembrane transporter SLC22A24|OGRPBCAM
Stevens-Johnson syndrome|OGRPBCAM
Stickler syndrome|OGRPBCAM
Stiff-Person syndrome|OGRPBCAM
Storm PhosphorImager (Molecular Dynamics/ GE)|OGRPBCAM
Streptococcus pneumoniae D39|OGRPBCAM
Streptococcus pneumoniae metabolite|OGRPBCAM
Suc-Ala-Ala-Pro-Phe-AMC|OGRPBCAM
Suc-LLVY-aminoluciferin|OGRPBCAM
Sufu-KO-LIGHT cell|OGRPBCAM
Sus scrofa|OGRPBCAM
SwissModel homology modeling|OGRPBCAM
Synergy 2 Multi-Mode Reader (BioTek)|OGRPBCAM
Synergy HT Multi-Mode Reader (BioTek)|OGRPBCAM
Syto 60|OGRPBCAM
Sytox Orange|OGRPBCAM
T|OGRPBCAM
T cell deficiency|OGRPBCAM
T-175|OGRPBCAM
T-225|OGRPBCAM
T-25|OGRPBCAM
T-75|OGRPBCAM
T-cell activation assay|OGRPBCAM
T-cell acute lymphoblastic leukemia|OGRPBCAM
T-cell cytotoxicity assay|OGRPBCAM
T-cell engraftment|OGRPBCAM
T-cell lymphoblastic leukemia/lymphoma|DOID_715
T-cell proliferation inhibitor|OGRPBCAM
T-type calcium channel blocker|OGRPBCAM
T1/2|OGRPBCAM
T1/2(in vitro)|OGRPBCAM
T1/2(in vivo)|OGRPBCAM
TAP Biosystems|OGRPBCAM
TC50|OGRPBCAM
TCID50|OGRPBCAM
TD50|OGRPBCAM
TG003|OGRPBCAM
TGFbeta receptor antagonist|OGRPBCAM
TGI|OGRPBCAM
THP-1 cell|OGRPBCAM
TMD8 cell|OGRPBCAM
TMR-pS259-Raf peptide|OGRPBCAM
TO-PRO3|OGRPBCAM
TRANSCREENER ADP2 FP Kinase Assay (BellBrook Labs)|OGRPBCAM
TRANSCREENER AMP2/GMP2 FP Assay (BellBrook Labs)|OGRPBCAM
TRP channel blocker|OGRPBCAM
TRP channel modulator|OGRPBCAM
TRPA1 channel agonist|OGRPBCAM
TRPM4 channel inhibitor|OGRPBCAM
TRPV channel modulator|OGRPBCAM
TRPV1 agonist|OGRPBCAM
TRPV4 agonist|OGRPBCAM
TRUPath|OGRPBCAM
TSH producing pituitary tumor|OGRPBCAM
TSQ Quantum Triple Quadrupole LC-MS (Thermo Scientific)|OGRPBCAM
TTP LabTech|OGRPBCAM
Takayasu's arteritis|OGRPBCAM
Tali Image Cytometer|OGRPBCAM
Tandem Mass Tag (TMT) MS Protein Quantification|OGRPBCAM
Tangier disease|OGRPBCAM
Tango GPCR Assay System|OGRPBCAM
Tango cell|OGRPBCAM
TaqMan Real-Time PCR assays (Thermo-Fisher)|OGRPBCAM
Tay-Sachs disease|OGRPBCAM
Taylor's syndrome|OGRPBCAM
Tecan|OGRPBCAM
Tecan Ultra|OGRPBCAM
The NatProd Collection|OGRPBCAM
Thermo Fisher Scientific|OGRPBCAM
Thrombin Receptor Activator Peptide 6|OGRPBCAM
Thrombopoietin|OGRPBCAM
Thyroid-stimulating hormone|OGRPBCAM
Thyrotropin-releasing hormone|OGRPBCAM
Timothy syndrome|OGRPBCAM
Tissue Slice Technology|OGRPBCAM
Tm|OGRPBCAM
Tmax|OGRPBCAM
Toll-like receptor 2 agonist|OGRPBCAM
TopCount NXT Microplate Scintillation Luminescence Counter|OGRPBCAM
TopHat|OGRPBCAM
Total Topoisomerase I assay|OGRPBCAM
Tox21 Compound Library|OGRPBCAM
ToxiLight BioAssay Kit (Lonza)|OGRPBCAM
TransAM Kit for NF-kB Family (Active Motif) |OGRPBCAM
TransIT-CHO kit|OGRPBCAM
TransIT-LT1|OGRPBCAM
Transcreener assay kit|OGRPBCAM
Transcription factor AP-1|OGRPBCAM
Transcription factor p65|OGRPBCAM
Transwell chamber format|OGRPBCAM
Treacher Collins syndrome|OGRPBCAM
Treefinder phylogenetic analysis|OGRPBCAM
TruPoint assay kit|OGRPBCAM
Trypanosoma brucei|OGRPBCAM
Trypanosoma cruzi|OGRPBCAM
Tubulin beta-3 chain|OGRPBCAM
Tumor necrosis factor|OGRPBCAM
Turner syndrome|OGRPBCAM
Typhoon FLA 9000 laser scanner (GE Healthcare)|OGRPBCAM
Typhoon Trio variable-mode imager (Amersham/ GE LifeSciences)|OGRPBCAM
U-2 OS cell|OGRPBCAM
U3A|OGRPBCAM
U87-EGFRvIII cell|OGRPBCAM
U937 (CD59+)|OGRPBCAM
UDP-glucuronosyltransferase 1-6|OGRPBCAM
UDP-glucuronosyltransferase 1A1|OGRPBCAM
UDP-glucuronosyltransferase 1A10|OGRPBCAM
UDP-glucuronosyltransferase 1A3|OGRPBCAM
UDP-glucuronosyltransferase 1A4|OGRPBCAM
UDP-glucuronosyltransferase 1A7|OGRPBCAM
UDP-glucuronosyltransferase 1A8|OGRPBCAM
UDP-glucuronosyltransferase 1A9|OGRPBCAM
UDP-glucuronosyltransferase 2B10|OGRPBCAM
UDP-glucuronosyltransferase 2B15|OGRPBCAM
UDP-glucuronosyltransferase 2B17|OGRPBCAM
UDP-glucuronosyltransferase 2B23|OGRPBCAM
UDP-glucuronosyltransferase 2B4|OGRPBCAM
UDP-glucuronosyltransferase 2B7|OGRPBCAM
UDP-glucuronosyltransferase activator|OGRPBCAM
UGT chemical inhibition assay|OGRPBCAM
UGT induction assay|OGRPBCAM
UGT inhibition assay|OGRPBCAM
UGT metabolite formation kinetics|OGRPBCAM
UGT reaction phenotyping|OGRPBCAM
UGT1A1 with BSA assay|OGRPBCAM
UGT1A1 without BSA assay|OGRPBCAM
UGT1A4 with BSA assay|OGRPBCAM
UGT1A4 without BSA assay|OGRPBCAM
UGT1A6 with BSA assay|OGRPBCAM
UGT1A6 without BSA assay|OGRPBCAM
UGT1A9 with BSA assay|OGRPBCAM
UGT1A9 without BSA assay|OGRPBCAM
UGT2B15 with BSA assay|OGRPBCAM
UGT2B15 without BSA assay|OGRPBCAM
UGT2B7 with BSA assay|OGRPBCAM
UGT2B7 without BSA assay|OGRPBCAM
ULight poly-GT|OGRPBCAM
UMLS_CUI|OGRPBCAM
Ub-CHOP2-Reporter-Kit (LifeSensors Inc.)|OGRPBCAM
Ub-G76V-GFP/HeLa|OGRPBCAM
Ubiquitin vinyl sulfone|OGRPBCAM
Ubiquitin-AMC|OGRPBCAM
Ubiquitin-Rho|OGRPBCAM
Ullrich congenital muscular dystrophy|OGRPBCAM
Ultra-Glo Luciferin Detection (Promega)|OGRPBCAM
Unverricht-Lundborg syndrome|OGRPBCAM
Usher syndrome|OGRPBCAM
Ussing chamber permeability assay|OGRPBCAM
VACTERL association|OGRPBCAM
VE-2 whole-cell patch clamp amplifier (Alembic Instruments)|OGRPBCAM
VEGF activator|OGRPBCAM
VERO 76 cell|OGRPBCAM
VERO C1008 cell|OGRPBCAM
VICTOR X2 Multilabel Plate Reader|OGRPBCAM
VICTOR X3 Multilabel Plate Reader|OGRPBCAM
VIPoma|OGRPBCAM
VP-ITC Isothermal Titration Calorimeter|OGRPBCAM
VU041|OGRPBCAM
Vaccinia virus|OGRPBCAM
Varioskan LUX multimode microplate reader (ThermoFisher)|OGRPBCAM
Vascular cell adhesion protein 1|OGRPBCAM
Vd|OGRPBCAM
Vdss|OGRPBCAM
Velos-MS|OGRPBCAM
Venezuelan equine encephalitis|OGRPBCAM
Venezuelan equine encephalitis virus|OGRPBCAM
Venezuelan hemorrhagic fever|OGRPBCAM
Vero cell|OGRPBCAM
ViaLight Plus kit|OGRPBCAM
Vibrio harveyi|OGRPBCAM
ViewLux CCD Imager|OGRPBCAM
ViewLux ultraHTS Microplate Imager|OGRPBCAM
Vogt-Koyanagi-Harada disease|OGRPBCAM
Volocity 3D Image Analysis Software|OGRPBCAM
Vybrant MTT Cell Proliferation Assay Kit|OGRPBCAM
WAGR syndrome|OGRPBCAM
WAY-100635 maleate|OGRPBCAM
WIN55212|OGRPBCAM
WKYMVm peptide|OGRPBCAM
WNK signaling inhibitor|OGRPBCAM
WRO|OGRPBCAM
WST-1 assay (Roche)|OGRPBCAM
Waardenburg's syndrome|OGRPBCAM
Walker-Warburg syndrome|OGRPBCAM
Wallac 1420 (Victor2) Microplate reader (PerkinElmer)|OGRPBCAM
Wallac MicroBeta Liquid Scintillation Counter|OGRPBCAM
Waterhouse-Friderichsen syndrome|OGRPBCAM
Weaver syndrome|OGRPBCAM
Weill-Marchesani syndrome|OGRPBCAM
Werdnig-Hoffmann disease|OGRPBCAM
Werner syndrome|OGRPBCAM
Wernicke encephalopathy|OGRPBCAM
Wernicke-Korsakoff syndrome|OGRPBCAM
West Nile encephalitis|OGRPBCAM
West Nile fever|OGRPBCAM
West Nile virus|OGRPBCAM
Western equine encephalitis|OGRPBCAM
Whipple disease|OGRPBCAM
Whole Genome Sequencing|OGRPBCAM
Williams-Beuren syndrome|OGRPBCAM
Wilson disease|DOID_893
Wiskott-Aldrich syndrome|OGRPBCAM
Wiskott-Aldrich syndrome protein inhibitor|OGRPBCAM
Wittig reagent|OGRPBCAM
Wnt signalling activator|OGRPBCAM
Wnt signalling inhibitor|OGRPBCAM
Wolf-Hirschhorn syndrome|OGRPBCAM
Wolff-Parkinson-White syndrome|DOID_384
Wolfram syndrome|OGRPBCAM
Wolman disease|OGRPBCAM
X-linked Aarskog syndrome|OGRPBCAM
X-linked agammaglobulinemia|OGRPBCAM
X-linked dominant disease|OGRPBCAM
X-linked dominant hypophosphatemic rickets|OGRPBCAM
X-linked hyper IgM syndrome|OGRPBCAM
X-linked ichthyosis|OGRPBCAM
X-linked monogenic disease|OGRPBCAM
X-linked nonsyndromic deafness|OGRPBCAM
X-linked recessive disease|OGRPBCAM
X-linked severe combined immunodeficiency|OGRPBCAM
X-linked sideroblastic anemia with ataxia|OGRPBCAM
XTT red|OGRPBCAM
XTT reduction assay|OGRPBCAM
Xenograft Model|OGRPBCAM
Xenopus laevis|OGRPBCAM
Yersinia enterocolitica|OGRPBCAM
Yersinia pseudotuberculosis|OGRPBCAM
Yokogawa|OGRPBCAM
Z-Arg-Arg-AMC|OGRPBCAM
Z-Leu-Leu-Leu-al|OGRPBCAM
Z-Phe-Arg-AMC|OGRPBCAM
Z-RLRGG-aminoluciferin|OGRPBCAM
Z-score|OGRPBCAM
Zeiss|OGRPBCAM
Zellweger syndrome|DOID_905
Zerner's intermediate neglect of differential overlap|OGRPBCAM
[125I]Y10-neuropeptide S|OGRPBCAM
[35S]GTP-gamma S|OGRPBCAM
[35S]GTPgammaS radioligand binding assay|OGRPBCAM
[3H]N-methylscopolamine|OGRPBCAM
ab initio quantum chemistry computational method|OGRPBCAM
abdominal aortic aneurysm|OGRPBCAM
abdominal obesity-metabolic syndrome|OGRPBCAM
abdominal obesity-metabolic syndrome 1|OGRPBCAM
abdominal tuberculosis|OGRPBCAM
abetalipoproteinemia|OGRPBCAM
abnormal retinal correspondence|OGRPBCAM
abortifacient|OGRPBCAM
abscisic acid receptor agonist|OGRPBCAM
absence epilepsy|OGRPBCAM
absent|OGRPBCAM
absorbance|OGRPBCAM
absorbance wavelength|OGRPBCAM
academic chemist|OGRPBCAM
acalculous cholecystitis|OGRPBCAM
acanthoma|DOID_174
acanthosis nigricans|OGRPBCAM
acaricide|OGRPBCAM
acaricide drug|OGRPBCAM
acatalasia|OGRPBCAM
acceptor|OGRPBCAM
accommodative esotropia|OGRPBCAM
accumulation assay|OGRPBCAM
aceruloplasminemia|OGRPBCAM
acetylated histone assay|OGRPBCAM
acetylcholine|OGRPBCAM
achalasia|OGRPBCAM
acheiropody|OGRPBCAM
achondrogenesis|OGRPBCAM
achondroplasia|OGRPBCAM
achromatopsia|OGRPBCAM
acid|OGRPBCAM
acid-base indicator|OGRPBCAM
acinar cell carcinoma|OGRPBCAM
acne|OGRPBCAM
acneiform dermatitis|OGRPBCAM
acoustic neuroma|OGRPBCAM
acquired immunodeficiency syndrome|DOID_635
acquired metabolic disease|OGRPBCAM
acral lentiginous melanoma|OGRPBCAM
acrocallosal syndrome|OGRPBCAM
acrocephalosyndactylia|OGRPBCAM
acrodermatitis|OGRPBCAM
acrodermatitis enteropathica|OGRPBCAM
acrodysostosis|OGRPBCAM
acrokeratosis verruciformis|OGRPBCAM
acromegaly|OGRPBCAM
acromesomelic dysplasia|OGRPBCAM
actin polymerisation inducer|OGRPBCAM
actin polymerisation inhibitor|OGRPBCAM
actinic keratosis|OGRPBCAM
actinobacillosis|OGRPBCAM
actinomycosis|OGRPBCAM
action potential duration assay|OGRPBCAM
activated|OGRPBCAM
activation|OGRPBCAM
activator|OGRPBCAM
active|OGRPBCAM
active efflux substrate assay|OGRPBCAM
activity threshold signal direction|OGRPBCAM
activity threshold specification|OGRPBCAM
acute apical periodontitis|OGRPBCAM
acute asthma|OGRPBCAM
acute chest syndrome|OGRPBCAM
acute closed-angle glaucoma|OGRPBCAM
acute conjunctivitis|OGRPBCAM
acute cor pulmonale|OGRPBCAM
acute diarrhea|OGRPBCAM
acute diffuse nephritis|OGRPBCAM
acute disseminated encephalomyelitis|DOID_639
acute frontal sinusitis|OGRPBCAM
acute hemorrhagic conjunctivitis|OGRPBCAM
acute hemorrhagic leukoencephalitis|OGRPBCAM
acute inflammation of lacrimal passage|OGRPBCAM
acute intermittent porphyria|OGRPBCAM
acute leukemia|OGRPBCAM
acute lymphoblastic leukemia|OGRPBCAM
acute maxillary sinusitis|OGRPBCAM
acute megakaryocytic leukemia|OGRPBCAM
acute monocytic leukemia|OGRPBCAM
acute myeloid leukemia|OGRPBCAM
acute myocarditis|OGRPBCAM
acute necrotizing encephalitis|OGRPBCAM
acute orbital inflammation|OGRPBCAM
acute pancreatitis|OGRPBCAM
acute porphyria|OGRPBCAM
acute poststreptococcal glomerulonephritis|OGRPBCAM
acute proliferative glomerulonephritis|OGRPBCAM
acute pulmonary heart disease|OGRPBCAM
acute salpingitis|OGRPBCAM
acute stress disorder|OGRPBCAM
acute tympanitis|OGRPBCAM
acyl donor|OGRPBCAM
acyl-CoA:cholesterol acyltransferase 2 inhibitor|OGRPBCAM
adamantinoma|OGRPBCAM
adenocarcinoma|DOID_299
adenocarcinoma in situ|OGRPBCAM
adenofibroma|OGRPBCAM
adenoiditis|OGRPBCAM
adenoma|DOID_657
adenosarcoma|OGRPBCAM
adenosine A1 receptor agonist|OGRPBCAM
adenosine A1 receptor antagonist|OGRPBCAM
adenosine A2A receptor agonist|OGRPBCAM
adenosine A2A receptor antagonist|OGRPBCAM
adenosine A2B receptor agonist|OGRPBCAM
adenosine A3 receptor agonist|OGRPBCAM
adenosine A3 receptor antagonist|OGRPBCAM
adenosine phosphodiesterase inhibitor|OGRPBCAM
adenosine receptor agonist|OGRPBCAM
adenosine receptor antagonist|OGRPBCAM
adenosquamous carcinoma|OGRPBCAM
adenylate cyclase agonist|OGRPBCAM
adherent|OGRPBCAM
adhesion|OGRPBCAM
adiaspiromycosis|OGRPBCAM
adjustment disorder|DOID_507
adjuvant|OGRPBCAM
adolescence-adult electroclinical syndrome|OGRPBCAM
adrenal adenoma|DOID_656
adrenal carcinoma|OGRPBCAM
adrenal cortex cancer|DOID_660
adrenal cortex disease|OGRPBCAM
adrenal cortical hypofunction|OGRPBCAM
adrenal gland|OGRPBCAM
adrenal gland cancer|OGRPBCAM
adrenal gland disease|OGRPBCAM
adrenal gland hyperfunction|OGRPBCAM
adrenal neuroblastoma|OGRPBCAM
adrenal rest tumor|OGRPBCAM
adrenergic agent|OGRPBCAM
adrenergic agonist|OGRPBCAM
adrenergic antagonist|OGRPBCAM
adrenergic receptor binding|OGRPBCAM
adrenergic uptake inhibitor|OGRPBCAM
adrenocortical carcinoma|OGRPBCAM
adrenoleukodystrophy|OGRPBCAM
adsorption indicator|OGRPBCAM
adult|OGRPBCAM
adult T-cell leukemia|OGRPBCAM
adult acute lymphocytic leukemia|OGRPBCAM
adult cystic nephroma|OGRPBCAM
adult dermatomyositis|OGRPBCAM
adult medulloblastoma|OGRPBCAM
adult respiratory distress syndrome|OGRPBCAM
adult spinal muscular atrophy|OGRPBCAM
adult-onset Still's disease|OGRPBCAM
aetiopathogenetic role|OGRPBCAM
afferent loop syndrome|OGRPBCAM
affinity label|OGRPBCAM
affinity purification method|OGRPBCAM
affinity selection|OGRPBCAM
agammaglobulinemia|OGRPBCAM
agarose gel|OGRPBCAM
age|OGRPBCAM
age related macular degeneration|OGRPBCAM
aggregated|OGRPBCAM
aggressive periodontitis|OGRPBCAM
agnosia|OGRPBCAM
agonism|OGRPBCAM
agonist|OGRPBCAM
agoraphobia|DOID_593
agranulocytosis|OGRPBCAM
agrochemical|OGRPBCAM
air interface objective lens|OGRPBCAM
akinetic mutism|OGRPBCAM
alamarBlue|OGRPBCAM
alarm pheromone|OGRPBCAM
alcohol dependence|OGRPBCAM
alcohol-induced mental disorder|DOID_251
alcohol-related neurodevelopmental disorder|OGRPBCAM
alcoholic hepatitis|OGRPBCAM
alcoholic liver cirrhosis|OGRPBCAM
alcoholic neuropathy|OGRPBCAM
alcoholic pancreatitis|OGRPBCAM
alcoholic psychosis|DOID_252
aldosterone antagonist|OGRPBCAM
alexithymia|OGRPBCAM
algal metabolite|OGRPBCAM
alicyclic antibiotics|OGRPBCAM
aliphatic antibiotics|OGRPBCAM
alkaline phosphatase-cAMP|OGRPBCAM
alkaptonuria|OGRPBCAM
alkylating agent|OGRPBCAM
allelochemical|OGRPBCAM
allergen|OGRPBCAM
allergic conjunctivitis|OGRPBCAM
allergic contact dermatitis|OGRPBCAM
allergic disease|OGRPBCAM
allergic rhinitis|OGRPBCAM
allergic urticaria|OGRPBCAM
allosteric activation|OGRPBCAM
allosteric agonism|OGRPBCAM
allosteric antagonism|OGRPBCAM
allosteric inhibition|OGRPBCAM
allosteric modulation|OGRPBCAM
alopecia|DOID_987
alopecia areata|DOID_986
alpha 1-antitrypsin deficiency|OGRPBCAM
alpha chain disease|OGRPBCAM
alpha thalassemia|OGRPBCAM
alpha-1-microglobulin-Ig alpha complex chromophores|OGRPBCAM
alpha-adrenergic agonist|OGRPBCAM
alpha-adrenergic antagonist|OGRPBCAM
alpha-adrenergic drug|OGRPBCAM
alpha-bungarotoxin|OGRPBCAM
alpha-mannosidosis|OGRPBCAM
alpha-secretase activator|OGRPBCAM
alpha1B-adrenoceptor antagonist|OGRPBCAM
alphascreen|OGRPBCAM
alternate assay conditions|OGRPBCAM
alternate assay format|OGRPBCAM
alternate assay type|OGRPBCAM
alternate cell line assay|OGRPBCAM
alternate confirmatory assay|OGRPBCAM
alternate organism assay|OGRPBCAM
alternate target assay|OGRPBCAM
alternative mRNA splicing, via spliceosome|OGRPBCAM
alternative term|OGRPBCAM
alternative_term|OGRPBCAM
alveolar rhabdomyosarcoma|OGRPBCAM
alveolar soft part sarcoma|OGRPBCAM
alveoli adenoma|OGRPBCAM
amblyopia|OGRPBCAM
amebiasis|OGRPBCAM
amelogenesis imperfecta|OGRPBCAM
amenorrhea|OGRPBCAM
amino acid derivative antibiotics|OGRPBCAM
amino acid metabolic disorder|OGRPBCAM
amino acid substituted|OGRPBCAM
ammonium acetate|OGRPBCAM
ammonium sulfate precipitation method|OGRPBCAM
ammonium tetrathiomolybdate|OGRPBCAM
amnestic disorder|OGRPBCAM
amodiaquine|OGRPBCAM
amphiphile|OGRPBCAM
amphiprotic solvent|OGRPBCAM
amplification curve calculated endpoint|OGRPBCAM
ampulla of Vater cancer|OGRPBCAM
ampulla of Vater carcinoma|OGRPBCAM
amusia|OGRPBCAM
amyloidosis|OGRPBCAM
amyotrophic lateral sclerosis|DOID_332
anabolic agent|OGRPBCAM
anaesthesia adjuvant|OGRPBCAM
anaesthetic|OGRPBCAM
anal Paget's disease|OGRPBCAM
anal canal cancer|OGRPBCAM
anal canal carcinoma|OGRPBCAM
anal carcinoma|OGRPBCAM
anal squamous cell carcinoma|OGRPBCAM
analgesic|OGRPBCAM
analytical array|OGRPBCAM
anaplastic large cell lymphoma|OGRPBCAM
anatomical entity|OGRPBCAM
anatomical structure|OGRPBCAM
anatomical system|OGRPBCAM
ancylostomiasis|OGRPBCAM
androgen|OGRPBCAM
androgen antagonist|OGRPBCAM
androgen insensitivity syndrome|OGRPBCAM
androstane receptor agonist|OGRPBCAM
anemia|OGRPBCAM
anencephaly|OGRPBCAM
angiodysplasia|OGRPBCAM
angioedema|OGRPBCAM
angiogenesis inhibitor|OGRPBCAM
angiogenesis modulating agent|OGRPBCAM
angioid streaks|OGRPBCAM
angiokeratoma|DOID_479
angiolipoma|OGRPBCAM
angioma serpiginosum|OGRPBCAM
angiomyolipoma|OGRPBCAM
angiostrongyliasis|OGRPBCAM
angiotensin II|OGRPBCAM
angiotensin receptor agonist|OGRPBCAM
angiotensin receptor antagonist|OGRPBCAM
angle-closure glaucoma|OGRPBCAM
angstrom|OGRPBCAM
anhidrosis|OGRPBCAM
animal growth promotant|OGRPBCAM
animal metabolite|OGRPBCAM
aniridia|OGRPBCAM
anisakiasis|OGRPBCAM
aniseikonia|OGRPBCAM
anisometropia|OGRPBCAM
ankylosing spondylitis|OGRPBCAM
ankylosis|DOID_227
anogenital venereal wart|OGRPBCAM
anosognosia|OGRPBCAM
anovulation|OGRPBCAM
antacid|OGRPBCAM
antagonism|OGRPBCAM
antagonist|OGRPBCAM
anterior horn cell disease|OGRPBCAM
anterior ischemic optic neuropathy|OGRPBCAM
anterior spinal artery syndrome|OGRPBCAM
anterior uveitis|OGRPBCAM
anteroseptal myocardial infarction|OGRPBCAM
anthelminthic drug|OGRPBCAM
anthracosis|OGRPBCAM
anthrax disease|OGRPBCAM
anti-HBV agent|OGRPBCAM
anti-HIV agent|OGRPBCAM
anti-HIV-1 agent|OGRPBCAM
anti-HIV-2 agent|OGRPBCAM
anti-HSV agent|OGRPBCAM
anti-HSV-1 agent|OGRPBCAM
anti-HSV-2 agent|OGRPBCAM
anti-allergic agent|OGRPBCAM
anti-anaemic agent|OGRPBCAM
anti-arrhythmia drug|OGRPBCAM
anti-asthmatic agent|OGRPBCAM
anti-asthmatic drug|OGRPBCAM
anti-estrogen|OGRPBCAM
anti-inflammatory agent|OGRPBCAM
anti-inflammatory drug|OGRPBCAM
anti-obesity agent|OGRPBCAM
anti-ulcer drug|OGRPBCAM
antiamoebic agent|OGRPBCAM
antiatherogenic agent|OGRPBCAM
antiatherosclerotic agent|OGRPBCAM
antiauxins|OGRPBCAM
antibacterial agent|OGRPBCAM
antibacterial drug|OGRPBCAM
antibiotic acaricide|OGRPBCAM
antibiotic insecticide|OGRPBCAM
antibiotic nematicide|OGRPBCAM
antibiotic pesticide|OGRPBCAM
antibiotic resistance|OGRPBCAM
antibody|OGRPBCAM
antibody isotype|OGRPBCAM
antibody preparation method|OGRPBCAM
antibody role|OGRPBCAM
antibody-based separation method|OGRPBCAM
anticaking agent|OGRPBCAM
anticholesteremic drug|OGRPBCAM
anticoagulant|OGRPBCAM
anticonvulsant|OGRPBCAM
anticoronaviral agent|OGRPBCAM
antidepressant|OGRPBCAM
antidiarrhoeal drug|OGRPBCAM
antidote|OGRPBCAM
antidote to barbiturate poisoning|OGRPBCAM
antidote to benzodiazepine poisoning|OGRPBCAM
antidote to curare poisoning|OGRPBCAM
antidote to cyanide poisoning|OGRPBCAM
antidote to opioid poisoning|OGRPBCAM
antidote to organophosphate poisoning|OGRPBCAM
antidote to paracetamol poisoning|OGRPBCAM
antidote to sarin poisoning|OGRPBCAM
antidyskinesia agent|OGRPBCAM
antiemetic|OGRPBCAM
antifeedant|OGRPBCAM
antifibrinolytic drug|OGRPBCAM
antifibrotic agent|OGRPBCAM
antifoaming agent|OGRPBCAM
antifolate|OGRPBCAM
antifouling biocide|OGRPBCAM
antifungal agent|OGRPBCAM
antifungal agrochemical|OGRPBCAM
antifungal drug|OGRPBCAM
antigen|OGRPBCAM
antigen down assay|OGRPBCAM
antigen-based affinity purification method|OGRPBCAM
antiglaucoma drug|OGRPBCAM
antihyperplasia drug|OGRPBCAM
antihypertensive agent|OGRPBCAM
antihypotensive agent|OGRPBCAM
antiinfective agent|OGRPBCAM
antileishmanial agent|OGRPBCAM
antilipemic drug|OGRPBCAM
antimalarial|OGRPBCAM
antimanic drug|OGRPBCAM
antimetabolite|OGRPBCAM
antimicrobial agent|OGRPBCAM
antimicrobial cosmetic preservative|OGRPBCAM
antimicrobial drug|OGRPBCAM
antimicrobial food preservative|OGRPBCAM
antimineralocorticoid|OGRPBCAM
antimitotic|OGRPBCAM
antimutagen|OGRPBCAM
antimycobacterial drug|OGRPBCAM
antimyopathic agent|OGRPBCAM
antinematodal drug|OGRPBCAM
antineoplastic agent|OGRPBCAM
antinociception assay|OGRPBCAM
antinociceptive agent|OGRPBCAM
antioxidant|OGRPBCAM
antiparasitic agent|OGRPBCAM
antiparathyroid drug|OGRPBCAM
antiparkinson drug|OGRPBCAM
antiphospholipid syndrome|OGRPBCAM
antiplasmodial drug|OGRPBCAM
antiplatyhelmintic drug|OGRPBCAM
antiprotozoal drug|OGRPBCAM
antipruritic drug|OGRPBCAM
antipsoriatic|OGRPBCAM
antipsychotic agent|OGRPBCAM
antipyretic|OGRPBCAM
antirheumatic drug|OGRPBCAM
antiseborrheic|OGRPBCAM
antisense oligonucleotide|OGRPBCAM
antiseptic drug|OGRPBCAM
antisocial personality disorder|OGRPBCAM
antispasmodic drug|OGRPBCAM
antispermatogenic agent|OGRPBCAM
antisyphilitic drug|OGRPBCAM
antithrombin III deficiency|OGRPBCAM
antithyroid drug|OGRPBCAM
antitreponemal drug|OGRPBCAM
antitrichomonal drug|OGRPBCAM
antitubercular agent|OGRPBCAM
antitussive|OGRPBCAM
antiviral agent|OGRPBCAM
antiviral drug|OGRPBCAM
anuria|OGRPBCAM
anus adenocarcinoma|OGRPBCAM
anus benign neoplasm|OGRPBCAM
anus cancer|OGRPBCAM
anus disease|OGRPBCAM
anxiety disorder|OGRPBCAM
anxiogenic|OGRPBCAM
anxiolytic drug|OGRPBCAM
aortic aneurysm|OGRPBCAM
aortic atherosclerosis|OGRPBCAM
aortic disease|DOID_520
aortic valve disease|DOID_62
aortic valve insufficiency|DOID_57
aortic valve stenosis|OGRPBCAM
aortitis|DOID_519
aphasia|OGRPBCAM
aphthous stomatitis|OGRPBCAM
apical‑to‑basolateral permeability (A > B)|OGRPBCAM
aplastic anemia|OGRPBCAM
apocrine adenoma|OGRPBCAM
apocrine sweat gland neoplasm|OGRPBCAM
apoptosis assay|OGRPBCAM
apoptosis inducer|OGRPBCAM
apoptosis inhibitor|OGRPBCAM
apoptotic|OGRPBCAM
apoptotic cell phenotype|OGRPBCAM
apoptotic process|OGRPBCAM
apparent mineralocorticoid excess syndrome|OGRPBCAM
apparent permeability coefficient (Papp)|OGRPBCAM
appendiceal neoplasm|OGRPBCAM
appendicitis|OGRPBCAM
appendix adenocarcinoma|OGRPBCAM
appendix cancer|OGRPBCAM
appendix carcinoma|OGRPBCAM
appendix disease|OGRPBCAM
apperceptive agnosia|OGRPBCAM
appetite depressant|OGRPBCAM
appetite enhancer|OGRPBCAM
appetite regulator|OGRPBCAM
application|OGRPBCAM
apraxia|OGRPBCAM
aprotic solvent|OGRPBCAM
aquaretic|OGRPBCAM
aqueous solubility|OGRPBCAM
arachidonic acid|OGRPBCAM
arc lamp|OGRPBCAM
archaeal metabolite|OGRPBCAM
area|OGRPBCAM
area detector|OGRPBCAM
argininosuccinic aciduria|OGRPBCAM
argon-ion laser|OGRPBCAM
array|OGRPBCAM
arrestin-GFP|OGRPBCAM
arrhythmogenic right ventricular cardiomyopathy|OGRPBCAM
arterial calcification of infancy|OGRPBCAM
arterial tortuosity syndrome|OGRPBCAM
arteriolosclerosis|OGRPBCAM
arteriosclerosis|OGRPBCAM
arteriosclerosis obliterans|OGRPBCAM
arteriosclerotic cardiovascular disease|OGRPBCAM
arteriovenous malformation|OGRPBCAM
artery disease|OGRPBCAM
arthritis|DOID_848
arthropathy|DOID_381
articular cartilage disease|OGRPBCAM
articulation disorder|OGRPBCAM
artifact assay|OGRPBCAM
artificial membrane preparation|OGRPBCAM
artificial regulatory region|OGRPBCAM
aryl hydrocarbon receptor agonist|OGRPBCAM
aryl hydrocarbon receptor antagonist|OGRPBCAM
asbestosis|OGRPBCAM
ascariasis|DOID_456
ascaridiasis|OGRPBCAM
ascending cholangitis|OGRPBCAM
ascending colon cancer|DOID_218
asoxime chloride|OGRPBCAM
aspartylglucosaminuria|OGRPBCAM
aspergillosis|OGRPBCAM
asphyxia neonatorum|OGRPBCAM
asphyxiating thoracic dystrophy|OGRPBCAM
aspiration pneumonia|OGRPBCAM
aspiration pneumonitis|OGRPBCAM
assay bioassay component|OGRPBCAM
assay biology component|OGRPBCAM
assay comment|OGRPBCAM
assay component|OGRPBCAM
assay control|OGRPBCAM
assay data processing method|OGRPBCAM
assay depositor|OGRPBCAM
assay description|OGRPBCAM
assay design method|OGRPBCAM
assay endpoint component|OGRPBCAM
assay footprint|OGRPBCAM
assay format|OGRPBCAM
assay format component|OGRPBCAM
assay kit|OGRPBCAM
assay measurement throughput|OGRPBCAM
assay measurement type|OGRPBCAM
assay medium|OGRPBCAM
assay method|OGRPBCAM
assay method component|OGRPBCAM
assay narrative|OGRPBCAM
assay phase characteristic|OGRPBCAM
assay protocol|OGRPBCAM
assay provider|OGRPBCAM
assay quality assessment method|OGRPBCAM
assay readout content|OGRPBCAM
assay readout content parametricity|OGRPBCAM
assay readout parameter|OGRPBCAM
assay readout type|OGRPBCAM
assay repository|OGRPBCAM
assay result component|OGRPBCAM
assay screened entity component|OGRPBCAM
assay screening campaign stage|OGRPBCAM
assay screening throughput|OGRPBCAM
assay serum|OGRPBCAM
assay supporting method|OGRPBCAM
assay title|OGRPBCAM
associative agnosia|OGRPBCAM
astereognosia|OGRPBCAM
asthma|OGRPBCAM
astigmatism|OGRPBCAM
astringent|OGRPBCAM
astroblastoma|OGRPBCAM
astrocytoma|OGRPBCAM
ataxia telangiectasia|OGRPBCAM
ataxia with oculomotor apraxia type 2|OGRPBCAM
ataxic cerebral palsy|OGRPBCAM
atelosteogenesis|OGRPBCAM
atherosclerosis|OGRPBCAM
atomic absorption spectrophotometry|OGRPBCAM
atomic force microscopy|OGRPBCAM
atopic dermatitis|OGRPBCAM
atransferrinemia|OGRPBCAM
atrial fibrillation|OGRPBCAM
atrial heart septal defect|OGRPBCAM
atrioventricular block|OGRPBCAM
atrioventricular septal defect|OGRPBCAM
atrophic gastritis|OGRPBCAM
atrophy of testis|OGRPBCAM
attention deficit hyperactivity disorder|OGRPBCAM
atypical autism|OGRPBCAM
atypical teratoid rhabdoid tumor|OGRPBCAM
auditory agnosia|OGRPBCAM
auditory system benign neoplasm|OGRPBCAM
auditory system cancer|DOID_833
auditory system disease|OGRPBCAM
austin model 1|OGRPBCAM
autism spectrum disorder|OGRPBCAM
autistic disorder|OGRPBCAM
autoimmune disease|DOID_417
autoimmune disease of blood|OGRPBCAM
autoimmune disease of cardiovascular system|OGRPBCAM
autoimmune disease of central nervous system|OGRPBCAM
autoimmune disease of endocrine system|OGRPBCAM
autoimmune disease of exocrine system|OGRPBCAM
autoimmune disease of gastrointestinal tract|OGRPBCAM
autoimmune disease of musculoskeletal system|OGRPBCAM
autoimmune disease of peripheral nervous system|OGRPBCAM
autoimmune disease of skin and connective tissue|OGRPBCAM
autoimmune disease of the nervous system|DOID_438
autoimmune disease of urogenital tract|OGRPBCAM
autoimmune hemolytic anemia|DOID_718
autoimmune hepatitis|OGRPBCAM
autoimmune lymphoproliferative syndrome|OGRPBCAM
autoimmune polyendocrine syndrome|OGRPBCAM
autoimmune polyendocrine syndrome type 1|OGRPBCAM
autoimmune polyendocrine syndrome type 2|OGRPBCAM
autoimmune thrombocytopenic purpura|OGRPBCAM
autoimmune thyroiditis|OGRPBCAM
autoinducer|OGRPBCAM
automated cytometer|OGRPBCAM
automatic pathway analysis|OGRPBCAM
autonomic nervous system benign neoplasm|OGRPBCAM
autonomic nervous system disease|OGRPBCAM
autonomic nervous system neoplasm|OGRPBCAM
autonomic neuropathy|OGRPBCAM
autophagic cell phenotype|OGRPBCAM
autophagosome|OGRPBCAM
autophagy|OGRPBCAM
autophagy inducer|OGRPBCAM
autophagy inhibitor|OGRPBCAM
autoradiography|OGRPBCAM
autosomal dominant cerebellar ataxia|OGRPBCAM
autosomal dominant disease|OGRPBCAM
autosomal dominant microcephaly|OGRPBCAM
autosomal dominant non-syndromic intellectual disability|OGRPBCAM
autosomal dominant polycystic kidney disease|DOID_898
autosomal genetic disease|OGRPBCAM
autosomal recessive cerebellar ataxia|OGRPBCAM
autosomal recessive congenital ichthyosis|OGRPBCAM
autosomal recessive disease|OGRPBCAM
auxin|OGRPBCAM
avian influenza|OGRPBCAM
avicide|OGRPBCAM
avoidant personality disorder|OGRPBCAM
axin stabilizer|OGRPBCAM
axiom_lost_from_external_ontology|OGRPBCAM
axon|OGRPBCAM
axon bundle defasciculation|OGRPBCAM
axon collateral|OGRPBCAM
axon fasciculation|OGRPBCAM
axon microtubule bundle|OGRPBCAM
axonal neuropathy|OGRPBCAM
azoospermia|OGRPBCAM
b-score normalization|OGRPBCAM
babesiosis|OGRPBCAM
background control|OGRPBCAM
background correction|OGRPBCAM
bacterial conjunctivitis|OGRPBCAM
bacterial infection method|OGRPBCAM
bacterial infectious disease|DOID_104
bacterial metabolite|OGRPBCAM
bacterial pneumonia|DOID_874
bacterial vaginosis|OGRPBCAM
bacterial xenobiotic metabolite|OGRPBCAM
bacterium|OGRPBCAM
bacteriuria|OGRPBCAM
balanitis|OGRPBCAM
balanitis xerotica obliterans|OGRPBCAM
band keratopathy|OGRPBCAM
bandwidth|OGRPBCAM
barbiturate dependence|OGRPBCAM
bartonellosis|OGRPBCAM
basal cell carcinoma|OGRPBCAM
basal ganglia disease|DOID_679
basaloid squamous cell carcinoma|OGRPBCAM
base|OGRPBCAM
based on normalization|OGRPBCAM
basic local alignment search tool|OGRPBCAM
basilar artery occlusion|OGRPBCAM
basolateral‑to‑apical permeability (B > A)|OGRPBCAM
bathophenanthrolinedisulfonic acid disodium salt|OGRPBCAM
bead|OGRPBCAM
bearer of|OGRPBCAM
beetle luciferin|OGRPBCAM
benign ependymoma|OGRPBCAM
benign epilepsy with centrotemporal spikes|OGRPBCAM
benign familial infantile epilepsy|OGRPBCAM
benign giant cell tumor|DOID_200
benign glioma|OGRPBCAM
benign meningioma|OGRPBCAM
benign mesothelioma|OGRPBCAM
benign neonatal seizures|OGRPBCAM
benign neoplasm|OGRPBCAM
benign paroxysmal positional nystagmus|OGRPBCAM
benign perivascular tumor|OGRPBCAM
benign teratoma|OGRPBCAM
benign vascular tumor|OGRPBCAM
benzoquinonium dibromide|OGRPBCAM
beriberi|OGRPBCAM
bestrophinopathy|OGRPBCAM
beta galactosidase enzyme activity assay|OGRPBCAM
beta galactosidase gene|OGRPBCAM
beta galactosidase induction|OGRPBCAM
beta galactosidase reporter gene assay|OGRPBCAM
beta lactamase induction|OGRPBCAM
beta lactamase reporter gene assay|OGRPBCAM
beta-adrenergic agonist|OGRPBCAM
beta-adrenergic antagonist|OGRPBCAM
beta-adrenergic drug|OGRPBCAM
beta-adrenergic receptor activity|OGRPBCAM
beta-arrestin clustering assay|OGRPBCAM
beta-hydroxybutyryl coenzyme A|OGRPBCAM
beta-ketothiolase deficiency|OGRPBCAM
beta-mannosidosis|OGRPBCAM
beta-mercaptoethanol|OGRPBCAM
bias factor|OGRPBCAM
bicinchoninic acid assay|OGRPBCAM
bilateral retinoblastoma|OGRPBCAM
bile acid metabolite|OGRPBCAM
bile duct adenocarcinoma|OGRPBCAM
bile duct adenoma|OGRPBCAM
bile duct cancer|OGRPBCAM
bile duct carcinoma|OGRPBCAM
bile duct disease|OGRPBCAM
bile reflux|OGRPBCAM
bile therapy drug|OGRPBCAM
biliary atresia|OGRPBCAM
biliary dyskinesia|OGRPBCAM
biliary excretion assay|OGRPBCAM
biliary papillomatosis|OGRPBCAM
biliary tract benign neoplasm|OGRPBCAM
biliary tract cancer|OGRPBCAM
biliary tract disease|OGRPBCAM
bilirubin metabolic disorder|OGRPBCAM
binary endpoint|OGRPBCAM
binary unit|OGRPBCAM
binding|OGRPBCAM
binding assay|OGRPBCAM
binding assessment method|OGRPBCAM
binding constant|OGRPBCAM
binding site|OGRPBCAM
binding type|OGRPBCAM
binocular vision disease|OGRPBCAM
bio layer interferometry|OGRPBCAM
bioassay|OGRPBCAM
bioassay ontology|OGRPBCAM
bioassay specification|OGRPBCAM
bioassay type|OGRPBCAM
bioavailability assay|OGRPBCAM
biochemical format|OGRPBCAM
biochemical phenotype|OGRPBCAM
biochemical role|OGRPBCAM
biofilm formation|OGRPBCAM
bioinformatics method|OGRPBCAM
biological ligand|OGRPBCAM
biological macromolecule|OGRPBCAM
biological pigment|OGRPBCAM
biological process|OGRPBCAM
biological role|OGRPBCAM
biological sex|OGRPBCAM
biologics and screening manufacturer|OGRPBCAM
bioluminescence|OGRPBCAM
bioluminescence resonance energy transfer|OGRPBCAM
biomarker|OGRPBCAM
biophysical role|OGRPBCAM
biosensor method|OGRPBCAM
biotin-responsive basal ganglia disease|OGRPBCAM
biotinidase deficiency|DOID_856
bipolar I disorder|OGRPBCAM
bipolar disorder|OGRPBCAM
bisindolylmaleimide|OGRPBCAM
bivalent small molecule-peptide|OGRPBCAM
blackwater fever|OGRPBCAM
bladder adenocarcinoma|OGRPBCAM
bladder benign neoplasm|OGRPBCAM
bladder carcinoma|OGRPBCAM
bladder carcinoma in situ|OGRPBCAM
bladder disease|DOID_365
bladder diverticulum|OGRPBCAM
bladder leiomyoma|OGRPBCAM
bladder neck obstruction|OGRPBCAM
bladder papillary transitional cell neoplasm|OGRPBCAM
bladder transitional cell papilloma|OGRPBCAM
bladder urothelial carcinoma|OGRPBCAM
blastoma|OGRPBCAM
blastomycosis|OGRPBCAM
bleaching agent|OGRPBCAM
bleb|OGRPBCAM
blebbed axon  phenotype|OGRPBCAM
blebbed dendrite  phenotype|OGRPBCAM
blebbed neurite phenotype|OGRPBCAM
blepharitis|OGRPBCAM
blepharochalasis|DOID_348
blepharophimosis|OGRPBCAM
blepharophimosis, ptosis, and epicanthus inversus syndrome|OGRPBCAM
blepharospasm|DOID_529
blind loop syndrome|OGRPBCAM
blindness|OGRPBCAM
blistered|OGRPBCAM
blood|OGRPBCAM
blood coagulation disease|OGRPBCAM
blood format|OGRPBCAM
blood group incompatibility|OGRPBCAM
blood plasma|OGRPBCAM
blood platelet disease|OGRPBCAM
blood protein disease|DOID_620
blood serum|OGRPBCAM
blood substitute|OGRPBCAM
blood to plasma ratio|OGRPBCAM
blood to plasma ratio assay|OGRPBCAM
blue color blindness|OGRPBCAM
blue cone monochromacy|OGRPBCAM
blurry|OGRPBCAM
body dysmorphic disorder|OGRPBCAM
bolaamphiphile|OGRPBCAM
bone benign neoplasm|OGRPBCAM
bone cancer|DOID_184
bone density conservation agent|OGRPBCAM
bone deterioration disease|OGRPBCAM
bone development disease|OGRPBCAM
bone disease|OGRPBCAM
bone element|OGRPBCAM
bone giant cell tumor|OGRPBCAM
bone inflammation disease|OGRPBCAM
bone marrow cancer|OGRPBCAM
bone marrow disease|OGRPBCAM
bone morphogenetic protein receptor antagonist|OGRPBCAM
bone osteosarcoma|OGRPBCAM
bone remodeling disease|OGRPBCAM
bone resorption disease|OGRPBCAM
bone sarcoma|OGRPBCAM
bone structure disease|OGRPBCAM
borderline personality disorder|OGRPBCAM
borna disease|OGRPBCAM
botulism|OGRPBCAM
boutonneuse fever|OGRPBCAM
bowel dysfunction|OGRPBCAM
brachial plexus lesion|OGRPBCAM
brachial plexus neuritis|OGRPBCAM
brachial plexus neuropathy|OGRPBCAM
brachydactyly|OGRPBCAM
brachydactyly-syndactyly syndrome|OGRPBCAM
brachyolmia|OGRPBCAM
bradykinin receptor B2 agonist|OGRPBCAM
bradykinin receptor agonist|OGRPBCAM
bradykinin receptor antagonist|OGRPBCAM
brain|OGRPBCAM
brain angioma|OGRPBCAM
brain cancer|OGRPBCAM
brain compression|OGRPBCAM
brain disease|DOID_936
brain edema|OGRPBCAM
brain glioma|OGRPBCAM
brain infarction|OGRPBCAM
brain ischemia|OGRPBCAM
brain stem cancer|OGRPBCAM
brain stem glioma|OGRPBCAM
branch retinal artery occlusion|OGRPBCAM
branched|OGRPBCAM
branched neurite phenotype|OGRPBCAM
branchiooculofacial syndrome|OGRPBCAM
branchiootorenal syndrome|OGRPBCAM
brassinosteroid biosynthesis inhibitor|OGRPBCAM
breast|OGRPBCAM
breast adenocarcinoma|OGRPBCAM
breast adenoma|OGRPBCAM
breast adenomyoepithelioma|OGRPBCAM
breast benign neoplasm|OGRPBCAM
breast cancer|OGRPBCAM
breast cancer resistance protein inhibitor|OGRPBCAM
breast carcinoma|OGRPBCAM
breast carcinoma in situ|OGRPBCAM
breast cyst|OGRPBCAM
breast disease|OGRPBCAM
breast fibroadenoma|OGRPBCAM
breast giant fibroadenoma|OGRPBCAM
breast leiomyosarcoma|OGRPBCAM
breast lipoma|OGRPBCAM
breast lobular carcinoma|OGRPBCAM
breast lymphoma|OGRPBCAM
breast malignant phyllodes tumor|OGRPBCAM
breast metaplastic carcinoma|OGRPBCAM
breast myoepithelial neoplasm|OGRPBCAM
breast papillary carcinoma|OGRPBCAM
breast pericanalicular fibroadenoma|OGRPBCAM
breast sarcoma|OGRPBCAM
bridged diphenyl acaricide|OGRPBCAM
brightfield microscopy|OGRPBCAM
britelite plus|OGRPBCAM
broad institute|OGRPBCAM
bromodomain-containing protein 4 inhibitor|OGRPBCAM
bronchial benign neoplasm|OGRPBCAM
bronchial disease|OGRPBCAM
bronchiectasis|OGRPBCAM
bronchiolitis|OGRPBCAM
bronchiolitis obliterans|OGRPBCAM
bronchitis|OGRPBCAM
bronchoconstriction assay|OGRPBCAM
bronchoconstrictor agent|OGRPBCAM
bronchodilator agent|OGRPBCAM
bronchopneumonia|OGRPBCAM
bronchus cancer|OGRPBCAM
bronchus carcinoma|OGRPBCAM
brucellosis|OGRPBCAM
buffer|OGRPBCAM
bullous keratopathy|OGRPBCAM
bullous pemphigoid|OGRPBCAM
bullous skin disease|OGRPBCAM
bupropion|OGRPBCAM
burnham center for chemical genomics|OGRPBCAM
bursitis|OGRPBCAM
byssinosis|OGRPBCAM
c-Jun N-terminal kinase inhibitor|OGRPBCAM
c-Met tyrosine kinase inhibitor|OGRPBCAM
cAMP accumulation assay|OGRPBCAM
cAMP redistribution assay|OGRPBCAM
cAMP-mediated|OGRPBCAM
cAMP-screen direct system|OGRPBCAM
cDNA|OGRPBCAM
cGMP redistribution assay|OGRPBCAM
calcaneonavicular coalition|OGRPBCAM
calcific tendinitis|OGRPBCAM
calcimimetic|OGRPBCAM
calcinosis|DOID_182
calcitonin gene-related peptide receptor antagonist|OGRPBCAM
calcium|OGRPBCAM
calcium channel agonist|OGRPBCAM
calcium channel blocker|OGRPBCAM
calcium channel modulator|OGRPBCAM
calcium chelator|OGRPBCAM
calcium ionophore|OGRPBCAM
calcium metabolism disease|OGRPBCAM
calcium redistribution assay|OGRPBCAM
calcium-dependent antibiotics|OGRPBCAM
calcium-mediated signaling using intracellular calcium|OGRPBCAM
calculated value|OGRPBCAM
calmodulin antagonist|OGRPBCAM
calpain inhibitor|OGRPBCAM
campomelic dysplasia|OGRPBCAM
campylobacteriosis|OGRPBCAM
cancer|DOID_162
candidiasis|OGRPBCAM
cannabinoid receptor agonist|OGRPBCAM
cannabinoid receptor antagonist|OGRPBCAM
cannabis abuse|OGRPBCAM
cannabis dependence|OGRPBCAM
capillariasis|OGRPBCAM
capillary disease|OGRPBCAM
capillary hemangioma|OGRPBCAM
capillary leak syndrome|OGRPBCAM
capsaicin receptor agonist|OGRPBCAM
capsaicin receptor antagonist|OGRPBCAM
carbachol|OGRPBCAM
carbamate insecticide|OGRPBCAM
carbamoyl phosphate synthetase I deficiency disease|OGRPBCAM
carbamylphosphate synthetase I activator|OGRPBCAM
carbohydrate|OGRPBCAM
carbohydrate allergen|OGRPBCAM
carbohydrate metabolic disorder|OGRPBCAM
carbohydrate metabolism disease|OGRPBCAM
carbon nanotube based sensor|OGRPBCAM
carboxylic acid protecting group|OGRPBCAM
carcinogenic agent|OGRPBCAM
carcinoma|DOID_305
carcinosarcoma|OGRPBCAM
cardia cancer|OGRPBCAM
cardiac sarcoidosis|OGRPBCAM
cardiac tamponade|DOID_115
cardiomyocyte repolarization assay|OGRPBCAM
cardiomyopathy|OGRPBCAM
cardioprotective agent|OGRPBCAM
cardiotonic drug|OGRPBCAM
cardiotoxic agent|OGRPBCAM
cardiovascular cancer|DOID_176
cardiovascular drug|OGRPBCAM
cardiovascular organ benign neoplasm|OGRPBCAM
cardiovascular system disease|OGRPBCAM
carotenoid biosynthesis inhibitor|OGRPBCAM
carotid artery disease|OGRPBCAM
carotid artery dissection|OGRPBCAM
carotid artery occlusion|DOID_807
carotid stenosis|OGRPBCAM
carotogenesis inhibitor|OGRPBCAM
carpal tunnel syndrome|OGRPBCAM
carrier|OGRPBCAM
cartesian conformational search|OGRPBCAM
cartilage disease|OGRPBCAM
cartilage-hair hypoplasia|OGRPBCAM
cascade stomach|OGRPBCAM
caspase activity determination|OGRPBCAM
cat-scratch disease|OGRPBCAM
catalyst|OGRPBCAM
catalytic (activity) concentration unit|OGRPBCAM
catalytic activity|OGRPBCAM
catalyzed by|OGRPBCAM
cataract|DOID_83
categorical endpoint|OGRPBCAM
categorical purity|OGRPBCAM
cathartic|OGRPBCAM
cathepsin B inhibitor|OGRPBCAM
cathepsin L (EC 3.4.22.15) inhibitor|OGRPBCAM
cavernous hemangioma|DOID_483
cecal disease|OGRPBCAM
cecum cancer|OGRPBCAM
cecum carcinoma|OGRPBCAM
celiac disease|OGRPBCAM
cell based format|OGRPBCAM
cell binding assay|OGRPBCAM
cell body|OGRPBCAM
cell concentration unit|OGRPBCAM
cell count|OGRPBCAM
cell culture method|OGRPBCAM
cell culture substrate|OGRPBCAM
cell cycle|OGRPBCAM
cell cycle arrest|OGRPBCAM
cell cycle assay|OGRPBCAM
cell cycle phase|OGRPBCAM
cell cycle phase phenotype|OGRPBCAM
cell cycle progression assessment method|OGRPBCAM
cell cycle state assay|OGRPBCAM
cell death|OGRPBCAM
cell dedifferentiation agent|OGRPBCAM
cell density determination|OGRPBCAM
cell fixation method|OGRPBCAM
cell fusion method|OGRPBCAM
cell growth assay|OGRPBCAM
cell growth property|OGRPBCAM
cell homogenate stability assay|OGRPBCAM
cell line|OGRPBCAM
cell line cell|OGRPBCAM
cell line modification method|OGRPBCAM
cell membrane format|OGRPBCAM
cell morphology assay|OGRPBCAM
cell motility assay|OGRPBCAM
cell movement measurement method|OGRPBCAM
cell number determination|OGRPBCAM
cell permeability assay|OGRPBCAM
cell phenotype|OGRPBCAM
cell population proliferation|OGRPBCAM
cell processing method|OGRPBCAM
cell profile|OGRPBCAM
cell proliferation assay|OGRPBCAM
cell separation method|OGRPBCAM
cell surface|OGRPBCAM
cell type benign neoplasm|OGRPBCAM
cell type cancer|OGRPBCAM
cell viability ATP quantitation assay|OGRPBCAM
cell viability assay|OGRPBCAM
cell-based format|OGRPBCAM
cell-free format|OGRPBCAM
cells per microliter|OGRPBCAM
cells per milliliter|OGRPBCAM
cells per well|OGRPBCAM
cellular component|OGRPBCAM
cellular morphology assessment method|OGRPBCAM
cellular organisms|OGRPBCAM
cellular quality|OGRPBCAM
cellular state phenotype|OGRPBCAM
cellulose synthesis inhibitor|OGRPBCAM
centimeter|OGRPBCAM
central core myopathy|OGRPBCAM
central nervous system benign neoplasm|OGRPBCAM
central nervous system cancer|OGRPBCAM
central nervous system depressant|OGRPBCAM
central nervous system disease|DOID_331
central nervous system drug|OGRPBCAM
central nervous system germ cell tumor|OGRPBCAM
central nervous system hematologic cancer|OGRPBCAM
central nervous system leukemia|OGRPBCAM
central nervous system lymphoma|OGRPBCAM
central nervous system mesenchymal non-meningothelial tumor|DOID_502
central nervous system origin vertigo|OGRPBCAM
central nervous system primitive neuroectodermal neoplasm|OGRPBCAM
central nervous system stimulant|OGRPBCAM
central nervous system teratoma|OGRPBCAM
central neurocytoma|OGRPBCAM
central pontine myelinolysis|DOID_636
central retinal artery occlusion|OGRPBCAM
central retinal vein occlusion|OGRPBCAM
central sleep apnea|OGRPBCAM
centrifugation|OGRPBCAM
centronuclear myopathy|OGRPBCAM
century|OGRPBCAM
ceramide allergen|OGRPBCAM
ceramide mimetic|OGRPBCAM
cercarial dermatitis|OGRPBCAM
cerebellar astrocytoma|OGRPBCAM
cerebellar ataxia|OGRPBCAM
cerebellar disease|OGRPBCAM
cerebellar liponeurocytoma|OGRPBCAM
cerebellopontine angle tumor|OGRPBCAM
cerebellum cancer|OGRPBCAM
cerebral amyloid angiopathy|OGRPBCAM
cerebral angioma|OGRPBCAM
cerebral arterial disease|OGRPBCAM
cerebral arteritis|OGRPBCAM
cerebral atherosclerosis|OGRPBCAM
cerebral creatine deficiency syndrome|OGRPBCAM
cerebral degeneration|OGRPBCAM
cerebral infarction|OGRPBCAM
cerebral lipidosis|OGRPBCAM
cerebral palsy|OGRPBCAM
cerebral ventricle cancer|OGRPBCAM
cerebrotendinous xanthomatosis|OGRPBCAM
cerebrovascular benign neoplasm|OGRPBCAM
cerebrovascular disease|OGRPBCAM
cerebrum cancer|DOID_368
cervical adenitis|OGRPBCAM
cervical adenosquamous carcinoma|OGRPBCAM
cervical cancer|OGRPBCAM
cervical incompetence|OGRPBCAM
cervical squamous cell carcinoma|OGRPBCAM
cervicitis|OGRPBCAM
cervix carcinoma|OGRPBCAM
cervix disease|OGRPBCAM
cervix endometriosis|DOID_361
cervix small cell carcinoma|OGRPBCAM
cervix uteri carcinoma in situ|OGRPBCAM
chain carrier|OGRPBCAM
chancroid|OGRPBCAM
channel blocker|OGRPBCAM
chaperone|OGRPBCAM
chaperone activity assay|OGRPBCAM
chaperone coupled enzyme activity measurement method|OGRPBCAM
charge coupled device|OGRPBCAM
checkerboard titration|OGRPBCAM
chelator|OGRPBCAM
chemical complementation|OGRPBCAM
chemical denaturation|OGRPBCAM
chemical hybridisation agent|OGRPBCAM
chemical nociception assay|OGRPBCAM
chemical role|OGRPBCAM
chemical stability assay|OGRPBCAM
chemical tracer|OGRPBCAM
chemiluminescence|OGRPBCAM
chemiluminescence resonance energy transfer|OGRPBCAM
chemiluminescence-linked immunosorbent assay|OGRPBCAM
chemiluminescent labeling method|OGRPBCAM
cheminformatics method|OGRPBCAM
chemist|OGRPBCAM
chemokine receptor 2 antagonist|OGRPBCAM
chemokine receptor 5 antagonist|OGRPBCAM
chemosensitiser|OGRPBCAM
chemosterilant|OGRPBCAM
chemotaxis assay|OGRPBCAM
cherubism|OGRPBCAM
chickenpox|OGRPBCAM
chikungunya|OGRPBCAM
childhood absence epilepsy|OGRPBCAM
childhood disintegrative disease|OGRPBCAM
childhood electroclinical syndrome|OGRPBCAM
childhood kidney cancer|OGRPBCAM
childhood medulloblastoma|OGRPBCAM
childhood spinal muscular atrophy|OGRPBCAM
chip|OGRPBCAM
chiral reagent|OGRPBCAM
chitin synthesis inhibitor|OGRPBCAM
chloramphenicol acetyl transferase gene|OGRPBCAM
chloramphenicol acetyltransferase induction|OGRPBCAM
chloramphenicol acetyltransferase reporter gene assay|OGRPBCAM
chloride transport|OGRPBCAM
choanal atresia|OGRPBCAM
cholangiocarcinoma|OGRPBCAM
cholangitis|OGRPBCAM
cholecystitis|OGRPBCAM
cholecystokinin antagonist|OGRPBCAM
cholecystolithiasis|OGRPBCAM
choledocholithiasis|OGRPBCAM
cholelithiasis|OGRPBCAM
cholera|OGRPBCAM
cholestasis|OGRPBCAM
cholesteatoma|DOID_869
cholesterol ester storage disease|OGRPBCAM
cholinergic agonist|OGRPBCAM
cholinergic antagonist|OGRPBCAM
cholinergic drug|OGRPBCAM
cholinergic urticaria|OGRPBCAM
cholinesterase reactivator|OGRPBCAM
chondroblastoma|OGRPBCAM
chondrocalcinosis|OGRPBCAM
chondrodysplasia punctata|OGRPBCAM
chondroma|OGRPBCAM
chondromalacia|OGRPBCAM
chondromalacia patellae|OGRPBCAM
chondrosarcoma|OGRPBCAM
chordoid glioma|OGRPBCAM
chordoma|OGRPBCAM
choreaacanthocytosis|OGRPBCAM
chorioamnionitis|OGRPBCAM
choriocarcinoma|OGRPBCAM
chorioretinal scar|OGRPBCAM
chorioretinitis|OGRPBCAM
choroid cancer|OGRPBCAM
choroid disease|OGRPBCAM
choroid plexus cancer|OGRPBCAM
choroid plexus carcinoma|OGRPBCAM
choroid plexus papilloma|OGRPBCAM
choroidal sclerosis|DOID_980
choroideremia|OGRPBCAM
chromatin acessibility method|OGRPBCAM
chromatin condensation visualization|OGRPBCAM
chromatographic reagent|OGRPBCAM
chromium-doped lithium strontium aluminum fluoride laser|OGRPBCAM
chromoblastomycosis|OGRPBCAM
chromogenic compound|OGRPBCAM
chromophobe renal cell carcinoma|OGRPBCAM
chromophore|OGRPBCAM
chromosomal deletion syndrome|OGRPBCAM
chromosomal disease|OGRPBCAM
chromosomal duplication syndrome|OGRPBCAM
chromosome mapping|OGRPBCAM
chronic NK-cell lymphocytosis|OGRPBCAM
chronic apical periodontitis|OGRPBCAM
chronic cholangitis|OGRPBCAM
chronic conjunctivitis|OGRPBCAM
chronic dacryocystitis|OGRPBCAM
chronic endophthalmitis|OGRPBCAM
chronic fatigue syndrome|OGRPBCAM
chronic granulomatous disease|OGRPBCAM
chronic inflammation of lacrimal passage|OGRPBCAM
chronic inflammatory demyelinating polyneuritis|OGRPBCAM
chronic inflammatory demyelinating polyradiculoneuropathy|OGRPBCAM
chronic intestinal vascular insufficiency|OGRPBCAM
chronic kidney disease|DOID_784
chronic lymphocytic leukemia|OGRPBCAM
chronic maxillary sinusitis|OGRPBCAM
chronic monocytic leukemia|OGRPBCAM
chronic mucocutaneous candidiasis|OGRPBCAM
chronic myeloid leukemia|OGRPBCAM
chronic obstructive pulmonary disease|OGRPBCAM
chronic polyneuropathy|OGRPBCAM
chronic progressive external ophthalmoplegia|OGRPBCAM
chronic pulmonary heart disease|OGRPBCAM
chronic purulent otitis media|OGRPBCAM
chronic pyelonephritis|OGRPBCAM
chronic tic disorder|OGRPBCAM
chronic ulcer of skin|OGRPBCAM
chronic wasting disease|OGRPBCAM
cicatricial ectropion|OGRPBCAM
cicatricial entropion|OGRPBCAM
cicatricial pemphigoid|OGRPBCAM
ciliopathy|OGRPBCAM
circadian rhythm|OGRPBCAM
circular|OGRPBCAM
circular dichroism|OGRPBCAM
circular fingerprint search|OGRPBCAM
cis-Golgi ArfGEF GBF inhibitor|OGRPBCAM
classical force field simulation|OGRPBCAM
clear cell acanthoma|DOID_172
clear cell adenocarcinoma|OGRPBCAM
clear cell hidradenoma|OGRPBCAM
clear cell renal cell carcinoma|OGRPBCAM
clear cell sarcoma|OGRPBCAM
clearance|OGRPBCAM
clearance assay|OGRPBCAM
cleft lip|OGRPBCAM
cleft palate|DOID_674
cleidocranial dysplasia|OGRPBCAM
cloacogenic carcinoma|OGRPBCAM
clonorchiasis|OGRPBCAM
clubfoot|OGRPBCAM
cm/sec|OGRPBCAM
co-culture|OGRPBCAM
cocaine abuse|DOID_809
cocaine dependence|OGRPBCAM
coccidioidomycosis|OGRPBCAM
coccidiosis|OGRPBCAM
coccidiostat|OGRPBCAM
code|OGRPBCAM
coefficient of variation|OGRPBCAM
coenzyme|OGRPBCAM
coenzyme A|OGRPBCAM
coenzyme Q|OGRPBCAM
coenzyme Q10 deficiency disease|OGRPBCAM
cofactor|OGRPBCAM
cofactor coupled enzyme activity measurement method|OGRPBCAM
cognitive disorder|OGRPBCAM
colitis|OGRPBCAM
collagen cross-linking inhibitor|OGRPBCAM
collagen disease|DOID_854
collecting duct carcinoma|OGRPBCAM
coloboma|OGRPBCAM
colon cancer|DOID_219
colon carcinoma in situ|OGRPBCAM
colonic benign neoplasm|DOID_235
colonic disease|OGRPBCAM
color|OGRPBCAM
color blindness|OGRPBCAM
colorectal cancer|OGRPBCAM
colorimetric cell staining method|OGRPBCAM
colorimetric labeling method|OGRPBCAM
colorimetric protein staining method|OGRPBCAM
colorimetric reagent|OGRPBCAM
colour indicator|OGRPBCAM
combined T cell and B cell immunodeficiency|DOID_628
combined immunodeficiency|OGRPBCAM
commensal bacterial infectious disease|OGRPBCAM
comment|OGRPBCAM
commercial company|OGRPBCAM
commercial vendor|OGRPBCAM
common bile duct disease|OGRPBCAM
common cold|OGRPBCAM
common variable immunodeficiency|OGRPBCAM
common wart|OGRPBCAM
communicating hydrocephalus|OGRPBCAM
communication disorder|OGRPBCAM
comparative molecular field analysis|OGRPBCAM
comparative molecular similarity indices analysis|OGRPBCAM
compatible osmolytes|OGRPBCAM
competitive binding|OGRPBCAM
competitive immunoassay|OGRPBCAM
competitive inhibition|OGRPBCAM
complement component 3 deficiency|OGRPBCAM
complement component 5 inhibitor|OGRPBCAM
complement deficiency|DOID_626
complement factor B inhibitor|OGRPBCAM
complementary metal oxide semiconductor|OGRPBCAM
complementation method|OGRPBCAM
completely randomized design|OGRPBCAM
complex partial epilepsy|OGRPBCAM
complex regional pain syndrome|OGRPBCAM
composite lymphoma|OGRPBCAM
compound aggregation assay|OGRPBCAM
compound fluorescence assay|OGRPBCAM
compound library|OGRPBCAM
compound library manufacturer|OGRPBCAM
compound redox activity assay|OGRPBCAM
compound toxicity assay|OGRPBCAM
computational NMR structure solution|OGRPBCAM
computational X-ray structure solution|OGRPBCAM
computational analysis of gene expression|OGRPBCAM
computational analysis of protein expression|OGRPBCAM
computational electron microscopy structure solution|OGRPBCAM
computational expression analysis|OGRPBCAM
computational method|OGRPBCAM
computational phylogenetic analysis|OGRPBCAM
computational profile endpoint|OGRPBCAM
computational structure analysis|OGRPBCAM
computational structure solution|OGRPBCAM
computer simulation method|OGRPBCAM
computer simulation method by force field|OGRPBCAM
concentration endpoint|OGRPBCAM
concentration profile|OGRPBCAM
concentration response assay|OGRPBCAM
concentration response endpoint|OGRPBCAM
concentration throughput|OGRPBCAM
concentration unit|OGRPBCAM
condensed|OGRPBCAM
conduct disorder|OGRPBCAM
cone-rod dystrophy|OGRPBCAM
configuration interaction method|OGRPBCAM
confirmatory assay|OGRPBCAM
confocal microscope|OGRPBCAM
confocal microscopy|OGRPBCAM
conformation|OGRPBCAM
conformation determination method|OGRPBCAM
conformational search|OGRPBCAM
congenital adrenal insufficiency|OGRPBCAM
congenital afibrinogenemia|OGRPBCAM
congenital aphakia|OGRPBCAM
congenital bile acid synthesis defect|OGRPBCAM
congenital diaphragmatic hernia|OGRPBCAM
congenital disorder of glycosylation|OGRPBCAM
congenital dyserythropoietic anemia|OGRPBCAM
congenital fibrosarcoma|OGRPBCAM
congenital heart block|DOID_990
congenital heart disease|OGRPBCAM
congenital hemolytic anemia|DOID_589
congenital hypogammaglobulinemia|OGRPBCAM
congenital hypoplastic anemia|OGRPBCAM
congenital hypothyroidism|OGRPBCAM
congenital mesoblastic nephroma|OGRPBCAM
congenital muscular dystrophy|OGRPBCAM
congenital muscular dystrophy-dystroglycanopathy type A|OGRPBCAM
congenital myasthenic syndrome|OGRPBCAM
congenital nervous system abnormality|OGRPBCAM
congenital nystagmus|OGRPBCAM
congenital stationary night blindness|OGRPBCAM
congenital structural myopathy|DOID_422
congenital toxoplasmosis|OGRPBCAM
congestive heart failure|OGRPBCAM
conidiobolomycosis|OGRPBCAM
conjugate gaze palsy|OGRPBCAM
conjugate gradient method|OGRPBCAM
conjunctival degeneration|OGRPBCAM
conjunctival disease|OGRPBCAM
conjunctivitis|OGRPBCAM
conjunctivochalasis|OGRPBCAM
connected to|OGRPBCAM
connective tissue benign neoplasm|OGRPBCAM
connective tissue cancer|DOID_201
connective tissue disease|DOID_65
consider|OGRPBCAM
constipation|OGRPBCAM
constraint molecular dynamics simulation|OGRPBCAM
constrictive pericarditis|OGRPBCAM
contact dermatitis|OGRPBCAM
contagious pustular dermatitis|OGRPBCAM
contains process|OGRPBCAM
contraceptive drug|OGRPBCAM
contributor|OGRPBCAM
conventional central osteosarcoma|OGRPBCAM
convulsant|OGRPBCAM
copper chelator|OGRPBCAM
copper deficiency myelopathy|OGRPBCAM
coral metabolite|OGRPBCAM
cornea cancer|OGRPBCAM
corneal abscess|OGRPBCAM
corneal degeneration|OGRPBCAM
corneal disease|OGRPBCAM
corneal dystrophy|OGRPBCAM
corneal ectasia|OGRPBCAM
corneal edema|OGRPBCAM
corneal endothelial dystrophy|OGRPBCAM
corneal staphyloma|OGRPBCAM
corneal ulcer|OGRPBCAM
coronary aneurysm|OGRPBCAM
coronary artery disease|OGRPBCAM
coronary artery vasospasm|OGRPBCAM
coronary restenosis|OGRPBCAM
coronary stenosis|OGRPBCAM
coronin-1A deficiency|OGRPBCAM
corrosion inhibitor|OGRPBCAM
cortical blindness|OGRPBCAM
cortical deafness|OGRPBCAM
cortical thymoma|OGRPBCAM
corticotropin-releasing factor receptor antagonist|OGRPBCAM
cosmetic|OGRPBCAM
counter screening assay|OGRPBCAM
counting parameter|OGRPBCAM
counts per second|OGRPBCAM
coupled cluster method|OGRPBCAM
coupled enzyme|OGRPBCAM
coupled enzyme activity measurement method|OGRPBCAM
coupled substrate|OGRPBCAM
coverslip|OGRPBCAM
cowpox|OGRPBCAM
cranial nerve disease|OGRPBCAM
cranial nerve malignant neoplasm|OGRPBCAM
cranial nerve neoplasm|DOID_338
cranio-facial dystonia|OGRPBCAM
craniocervical region|OGRPBCAM
cranioectodermal dysplasia|OGRPBCAM
craniofrontonasal syndrome|OGRPBCAM
craniometaphyseal dysplasia|OGRPBCAM
craniopharyngioma|OGRPBCAM
craniosynostosis|OGRPBCAM
created_by|OGRPBCAM
creatine phosphate|OGRPBCAM
creation_date|OGRPBCAM
crescentic glomerulonephritis|OGRPBCAM
cribriform carcinoma|OGRPBCAM
cross-linking reagent|OGRPBCAM
croup|OGRPBCAM
crustacean metabolite|OGRPBCAM
cryoglobulinemia|OGRPBCAM
cryptococcosis|OGRPBCAM
cryptogenic organizing pneumonia|OGRPBCAM
cryptorchidism|OGRPBCAM
cryptosporidiosis|OGRPBCAM
crystal violet staining|OGRPBCAM
crystallisation adjutant|OGRPBCAM
culture medium|OGRPBCAM
culture serum|OGRPBCAM
curator note|OGRPBCAM
curator notes|OGRPBCAM
curing agent|OGRPBCAM
current clamp|OGRPBCAM
curve fit method|OGRPBCAM
curve fit model|OGRPBCAM
curve fit specification|OGRPBCAM
cutaneous T cell lymphoma|OGRPBCAM
cutaneous anthrax|OGRPBCAM
cutaneous fibrous histiocytoma|OGRPBCAM
cutaneous ganglioneuroma|OGRPBCAM
cutaneous leishmaniasis|OGRPBCAM
cutaneous lupus erythematosus|OGRPBCAM
cutaneous mucoepidermoid carcinoma|OGRPBCAM
cutaneous mycosis|OGRPBCAM
cutaneous porphyria|OGRPBCAM
cutis laxa|OGRPBCAM
cuvette|OGRPBCAM
cyanotoxin|OGRPBCAM
cybrid cell creation method|OGRPBCAM
cyclin B1-luciferin 4-monooxygenase|OGRPBCAM
cyclooxygenase 1 inhibitor|OGRPBCAM
cyclooxygenase 2 inhibitor|OGRPBCAM
cyclooxygenase 3 inhibitor|OGRPBCAM
cycloplegia|OGRPBCAM
cyclothymic disorder|DOID_845
cystadenocarcinoma|OGRPBCAM
cystadenofibroma|OGRPBCAM
cystadenoma|OGRPBCAM
cysteine|OGRPBCAM
cysteine ligand covalent binding method|OGRPBCAM
cysteine protease inhibitor|OGRPBCAM
cystic fibrosis|OGRPBCAM
cystic kidney disease|OGRPBCAM
cystic lymphangioma|OGRPBCAM
cystic teratoma|OGRPBCAM
cysticercosis|OGRPBCAM
cystinosis|OGRPBCAM
cystinuria|OGRPBCAM
cystitis|OGRPBCAM
cystoid macular edema|OGRPBCAM
cystoisosporiasis|OGRPBCAM
cytochrome P450 enzyme activity assay|OGRPBCAM
cytochrome-b6f complex inhibitor|OGRPBCAM
cytochrome-bc1 complex inhibitor|OGRPBCAM
cytokine|OGRPBCAM
cytokine production|OGRPBCAM
cytokine quantitation method|OGRPBCAM
cytokine secretion assay|OGRPBCAM
cytokine-specific antibody bead-based method|OGRPBCAM
cytokinin|OGRPBCAM
cytoplasm|OGRPBCAM
cytosol|OGRPBCAM
cytosol format|OGRPBCAM
cytosol stability assay|OGRPBCAM
cytosolic protein|OGRPBCAM
cytotoxicity|OGRPBCAM
cytotoxicity assay|OGRPBCAM
dacryoadenitis|DOID_950
dacryocystitis|OGRPBCAM
dacryocystocele|OGRPBCAM
dark field microscopy|OGRPBCAM
data based structure generation|OGRPBCAM
database filtering|OGRPBCAM
database_cross_reference|OGRPBCAM
day|OGRPBCAM
de novo structure design|OGRPBCAM
dead cell phenotype|OGRPBCAM
deafness-dystonia-optic neuronopathy syndrome|OGRPBCAM
deaminating agent|OGRPBCAM
decision tree|OGRPBCAM
decreased intensity|OGRPBCAM
decreased length|OGRPBCAM
decreased width|OGRPBCAM
decubitus ulcer|OGRPBCAM
deep keratitis|OGRPBCAM
defasciculated|OGRPBCAM
defasciculated axon bundles phenotype|OGRPBCAM
deficiency anemia|OGRPBCAM
definition|OGRPBCAM
definition source|OGRPBCAM
definitive CYP IC50|OGRPBCAM
defoliant|OGRPBCAM
degeneration of macula and posterior pole|OGRPBCAM
degenerative disc disease|DOID_90
degree Celsius|OGRPBCAM
degree Fahrenheit|OGRPBCAM
dehydrogenase activity determination|OGRPBCAM
delayed-type hypersensitivity model|OGRPBCAM
deleted|OGRPBCAM
delivery method|OGRPBCAM
delta-opioid agent|OGRPBCAM
delta-opioid receptor agonist|OGRPBCAM
delta-opioid receptor antagonist|OGRPBCAM
delusional disorder|DOID_778
dementia|OGRPBCAM
demyelinating disease|OGRPBCAM
demyelinating polyneuropathy|OGRPBCAM
dendritic branch|OGRPBCAM
dendritic cell sarcoma|OGRPBCAM
dendritic cell thymoma|OGRPBCAM
dengue disease|OGRPBCAM
densitometric parameter|OGRPBCAM
densitometric scan|OGRPBCAM
dental caries|DOID_216
dental enamel hypoplasia|DOID_693
dental fluorosis|OGRPBCAM
dental pulp calcification|OGRPBCAM
dental pulp disease|OGRPBCAM
dental pulp necrosis|OGRPBCAM
dentatorubral-pallidoluysian atrophy|OGRPBCAM
dentin caries|OGRPBCAM
dentin dysplasia|DOID_701
dentin sensitivity|DOID_698
dentine erosion|OGRPBCAM
dentinogenesis imperfecta|OGRPBCAM
denture stomatitis|OGRPBCAM
deoxyluciferin|OGRPBCAM
dependent personality disorder|OGRPBCAM
depersonalization disorder|OGRPBCAM
dephosphorylated|OGRPBCAM
depiction|OGRPBCAM
depigmentation drug|OGRPBCAM
depolarization blocker|OGRPBCAM
depolarizer|OGRPBCAM
derives from|OGRPBCAM
derives into|OGRPBCAM
dermatitis|OGRPBCAM
dermatitis herpetiformis|OGRPBCAM
dermatofibrosarcoma protuberans|OGRPBCAM
dermatologic drug|OGRPBCAM
dermatomycosis|OGRPBCAM
dermatomyositis|OGRPBCAM
dermatophytosis|OGRPBCAM
dermis tumor|OGRPBCAM
dermoid cyst|OGRPBCAM
descriptor matching method|OGRPBCAM
desnitro-imidacloprid|OGRPBCAM
detected entity|OGRPBCAM
detection agent|OGRPBCAM
detection instrument|OGRPBCAM
detects|OGRPBCAM
detects phenotype|OGRPBCAM
detergent|OGRPBCAM
detrusor sphincter dyssynergia|OGRPBCAM
developing neuron|OGRPBCAM
development_notes|OGRPBCAM
developmental coordination disorder|OGRPBCAM
developmental disorder of mental health|OGRPBCAM
dexpramipexole|OGRPBCAM
dextran-coated charcoal method|OGRPBCAM
dextrocardia|OGRPBCAM
dextromethorphan|OGRPBCAM
diabetes insipidus|OGRPBCAM
diabetes mellitus|OGRPBCAM
diabetic angiopathy|OGRPBCAM
diabetic cataract|OGRPBCAM
diabetic macular edema|OGRPBCAM
diabetic neuropathy|OGRPBCAM
diabetic retinopathy|OGRPBCAM
diagnostic agent|OGRPBCAM
diagnostic imaging agent|OGRPBCAM
diameter|OGRPBCAM
diaphragm disease|OGRPBCAM
diaphragmatic eventration|OGRPBCAM
diarrhea|OGRPBCAM
diastolic heart failure|OGRPBCAM
diastrophic dysplasia|OGRPBCAM
diclofenac|OGRPBCAM
diencephalic neoplasm|OGRPBCAM
differential interference contrast microscopy|OGRPBCAM
differentiated thyroid gland carcinoma|OGRPBCAM
differentiating neuroblastoma|OGRPBCAM
differentiation agent|OGRPBCAM
diffuse glomerulonephritis|OGRPBCAM
diffuse idiopathic skeletal hyperostosis|OGRPBCAM
diffuse large B-cell lymphoma|OGRPBCAM
diffuse lipomatosis|OGRPBCAM
dihedral conformational search|OGRPBCAM
dihydropyrimidine dehydrogenase deficiency|OGRPBCAM
dilated cardiomyopathy|OGRPBCAM
dilution method|OGRPBCAM
dimensionless unit|OGRPBCAM
diminazene aceturate|OGRPBCAM
dinitrophenol insecticide|OGRPBCAM
diode laser|OGRPBCAM
diphosphomevalonate|OGRPBCAM
diphtheria|OGRPBCAM
diphyllobothriasis|OGRPBCAM
direct enzyme activity measurement method|OGRPBCAM
dirofilariasis|OGRPBCAM
discrete subaortic stenosis|OGRPBCAM
disease|OGRPBCAM
disease by infectious agent|OGRPBCAM
disease model|OGRPBCAM
disease of anatomical entity|DOID_7
disease of cellular proliferation|OGRPBCAM
disease of mental health|DOID_150
disease of metabolism|OGRPBCAM
dish|OGRPBCAM
disinfectant|OGRPBCAM
disorder of sexual development|OGRPBCAM
disseminated intravascular coagulation|OGRPBCAM
dissociated nystagmus|OGRPBCAM
dissociative amnesia|OGRPBCAM
dissociative disorder|OGRPBCAM
distal arthrogryposis|OGRPBCAM
distal myopathy|OGRPBCAM
distance comparison modeling|OGRPBCAM
distance geometry conformational search|OGRPBCAM
distance matrix alignment|OGRPBCAM
distributed|OGRPBCAM
disuse amblyopia|OGRPBCAM
diuretic|OGRPBCAM
diverticulitis|OGRPBCAM
dna content estimation|OGRPBCAM
dna-coated bead based method|OGRPBCAM
dna-seq method|OGRPBCAM
donor|OGRPBCAM
dopamine|OGRPBCAM
dopamine agonist|OGRPBCAM
dopamine neurotransmitter receptor activity, coupled via Gi/Go|OGRPBCAM
dopamine neurotransmitter receptor activity, coupled via Gs|OGRPBCAM
dopamine receptor D1 agonist|OGRPBCAM
dopamine receptor D2 antagonist|OGRPBCAM
dopamine uptake inhibitor|OGRPBCAM
dopaminergic agent|OGRPBCAM
dopaminergic antagonist|OGRPBCAM
dosage endpoint|OGRPBCAM
dot immunobinding assay|OGRPBCAM
double outlet right ventricle|OGRPBCAM
doxorubicin|OGRPBCAM
doxycycline|OGRPBCAM
dracunculiasis|OGRPBCAM
drug|OGRPBCAM
drug absorption assay|OGRPBCAM
drug abuse assay|OGRPBCAM
drug allergen|OGRPBCAM
drug binding|OGRPBCAM
drug dependence|OGRPBCAM
drug excretion assay|OGRPBCAM
drug interaction assay|OGRPBCAM
drug metabolism assay|OGRPBCAM
drug metabolite|OGRPBCAM
drug psychosis|OGRPBCAM
drug transport|OGRPBCAM
drug-induced mental disorder|OGRPBCAM
dry eye syndrome|OGRPBCAM
drying control chemical additive|OGRPBCAM
ductal carcinoma in situ|OGRPBCAM
dumping syndrome|OGRPBCAM
duodenal obstruction|OGRPBCAM
duodenal ulcer|OGRPBCAM
duodenitis|OGRPBCAM
duodenogastric reflux|OGRPBCAM
duodenum|OGRPBCAM
duodenum adenocarcinoma|OGRPBCAM
duodenum cancer|OGRPBCAM
duodenum disease|OGRPBCAM
dye|OGRPBCAM
dye binding method|OGRPBCAM
dye exclusion method|OGRPBCAM
dye laser|OGRPBCAM
dye redistribution assay|OGRPBCAM
dying cell phenotype|OGRPBCAM
dynorphin A|OGRPBCAM
dyscalculia|OGRPBCAM
dysembryoplastic neuroepithelial tumor|OGRPBCAM
dysentery|OGRPBCAM
dysgammaglobulinemia|OGRPBCAM
dysgerminoma|OGRPBCAM
dysgraphia|OGRPBCAM
dyshormonogenic goiter|OGRPBCAM
dyskeratosis congenita|OGRPBCAM
dyskinesia of esophagus|OGRPBCAM
dyslexia|OGRPBCAM
dysostosis|OGRPBCAM
dysplastic nevus syndrome|OGRPBCAM
dysthymic disorder|OGRPBCAM
dystonia|DOID_543
ear cancer|OGRPBCAM
early infantile epileptic encephalopathy|OGRPBCAM
early myoclonic encephalopathy|DOID_308
early onset absence epilepsy|OGRPBCAM
eating disorder|OGRPBCAM
eccrine acrospiroma|OGRPBCAM
eccrine sweat gland cancer|OGRPBCAM
eccrine sweat gland neoplasm|DOID_173
ecdysone agonist|OGRPBCAM
ecdysone antagonists|OGRPBCAM
echinococcosis|OGRPBCAM
eclampsia|OGRPBCAM
ectodermal dysplasia|OGRPBCAM
ectomesenchymoma|OGRPBCAM
ectoparasiticide|OGRPBCAM
ectopic thymus|OGRPBCAM
ectropion|OGRPBCAM
eczema herpeticum|OGRPBCAM
edge detection|OGRPBCAM
editor note|OGRPBCAM
editor preferred label|OGRPBCAM
editor preferred term|OGRPBCAM
editor preferred term~editor preferred label|OGRPBCAM
eeyarestatin I|OGRPBCAM
effector|OGRPBCAM
efficacy|OGRPBCAM
efflux ratio|OGRPBCAM
efflux transporter inhibition assay|OGRPBCAM
efflux transporter substrate assay|OGRPBCAM
egg allergy|OGRPBCAM
ehrlichiosis|OGRPBCAM
elastin-laminin receptor agonist|OGRPBCAM
electrical current density|OGRPBCAM
electrical endpoint|OGRPBCAM
electrical impedance measurement|OGRPBCAM
electrical sensor|OGRPBCAM
electrical stimulation method|OGRPBCAM
electroclinical syndrome|OGRPBCAM
electron acceptor|OGRPBCAM
electron donor|OGRPBCAM
electron microscopy|OGRPBCAM
electron multiplying charge coupled device|OGRPBCAM
electron-transport chain inhibitor|OGRPBCAM
electrophilic reagent|OGRPBCAM
electrophysiological method|OGRPBCAM
elephantiasis|OGRPBCAM
elicitor|OGRPBCAM
elongated|OGRPBCAM
elongated neurite phenotype|OGRPBCAM
embryo stage|OGRPBCAM
embryonal cancer|DOID_688
embryonal carcinoma|OGRPBCAM
embryonal rhabdomyosarcoma|OGRPBCAM
embryonic day 11.5|OGRPBCAM
embryonic day 12.5|OGRPBCAM
embryonic day 13.5|OGRPBCAM
embryonic day 14.5|OGRPBCAM
embryonic day 15.5|OGRPBCAM
embryonic day 16.5|OGRPBCAM
embryonic day 17.5|OGRPBCAM
embryonic day 18|OGRPBCAM
embryonic day 18.5|OGRPBCAM
emetic|OGRPBCAM
emission filter|OGRPBCAM
emission wavelength|OGRPBCAM
emory university molecular libraries screening center|OGRPBCAM
emphysematous cholecystitis|OGRPBCAM
empirical scoring function|OGRPBCAM
empty sella syndrome|OGRPBCAM
emulsifier|OGRPBCAM
enamel caries|DOID_217
enamel erosion|OGRPBCAM
encephalitis|OGRPBCAM
encephalitozoonosis|OGRPBCAM
encephalomalacia|OGRPBCAM
encephalomyelitis|DOID_640
encodes|OGRPBCAM
end stage renal disease|DOID_783
endemic typhus|OGRPBCAM
endocardial fibroelastosis|OGRPBCAM
endocarditis|OGRPBCAM
endocardium disease|OGRPBCAM
endocervicitis|OGRPBCAM
endocrine disruptor|OGRPBCAM
endocrine gland cancer|DOID_170
endocrine organ benign neoplasm|OGRPBCAM
endocrine pancreas disease|OGRPBCAM
endocrine system disease|DOID_28
endodermal sinus tumor|OGRPBCAM
endogenous|OGRPBCAM
endogenous depression|OGRPBCAM
endogenous ligand|OGRPBCAM
endolymphatic hydrops|OGRPBCAM
endometrial adenocarcinoma|OGRPBCAM
endometrial cancer|OGRPBCAM
endometrial carcinoma|OGRPBCAM
endometrial disease|OGRPBCAM
endometrial stromal nodule|OGRPBCAM
endometrial stromal sarcoma|OGRPBCAM
endometrial stromal tumor|OGRPBCAM
endometrioid ovary carcinoma|OGRPBCAM
endometriosis|DOID_289
endometriosis of uterus|DOID_288
endometritis|OGRPBCAM
endomyocardial fibrosis|OGRPBCAM
endophthalmitis|OGRPBCAM
endoplasmic reticulum|OGRPBCAM
endosalpingiosis|OGRPBCAM
endothelin A receptor antagonist|OGRPBCAM
endothelin receptor antagonist|OGRPBCAM
endpoint|OGRPBCAM
endpoint action correlation|OGRPBCAM
endpoint assay|OGRPBCAM
endpoint correction|OGRPBCAM
endpoint modifier|OGRPBCAM
endpoint normalization method|OGRPBCAM
endpoint qualifier|OGRPBCAM
energy minimization method|OGRPBCAM
engineered|OGRPBCAM
enlarged vestibular aqueduct|OGRPBCAM
enophthalmos|OGRPBCAM
enterobiasis|OGRPBCAM
enthesopathy|DOID_204
entropion|OGRPBCAM
environmental contaminant|OGRPBCAM
environmental food contaminant|OGRPBCAM
enzymatic stability assay|OGRPBCAM
enzyme|OGRPBCAM
enzyme activator|OGRPBCAM
enzyme activity assay|OGRPBCAM
enzyme activity measurement method|OGRPBCAM
enzyme complementation|OGRPBCAM
enzyme fragment complementation|OGRPBCAM
enzyme induction assay|OGRPBCAM
enzyme inhibition assay|OGRPBCAM
enzyme inhibitor|OGRPBCAM
enzyme kinetic constant|OGRPBCAM
enzyme mimic|OGRPBCAM
enzyme reaction phenotyping|OGRPBCAM
enzyme reactivator|OGRPBCAM
enzyme regulator|OGRPBCAM
enzyme-linked immunosorbent spot assay|OGRPBCAM
enzyme-multiplied immunoassay technique|OGRPBCAM
eosinophilia-myalgia syndrome|DOID_998
eosinophilic esophagitis|OGRPBCAM
eosinophilic gastroenteritis|OGRPBCAM
eosinophilic pneumonia|OGRPBCAM
ependymoblastoma|OGRPBCAM
epicondylitis|OGRPBCAM
epidemic pleurodynia|OGRPBCAM
epidermal appendage tumor|OGRPBCAM
epidermal growth factor receptor antagonist|OGRPBCAM
epidermodysplasia verruciformis|OGRPBCAM
epidermolysis bullosa|OGRPBCAM
epidermolysis bullosa acquisita|OGRPBCAM
epidermolysis bullosa simplex|OGRPBCAM
epidermolytic acanthoma|OGRPBCAM
epidermolytic hyperkeratosis|OGRPBCAM
epididymis disease|OGRPBCAM
epididymitis|OGRPBCAM
epididymo-orchitis|OGRPBCAM
epidural abscess|OGRPBCAM
epigenetic assay|OGRPBCAM
epigenetic modification detection method|OGRPBCAM
epigenetic profile|OGRPBCAM
epigenetic profiling assay|OGRPBCAM
epiglottitis|OGRPBCAM
epilepsy|OGRPBCAM
epilepsy with generalized tonic-clonic seizures|OGRPBCAM
episodic ataxia|DOID_963
epithelial malignant thymoma|OGRPBCAM
epithelial-myoepithelial carcinoma|OGRPBCAM
epithelial-stromal TGFBI dystrophy|OGRPBCAM
epithelioid sarcoma|OGRPBCAM
epithelioid trophoblastic tumor|OGRPBCAM
epitope|OGRPBCAM
epulis|OGRPBCAM
equilibrium assay|OGRPBCAM
ergosterol biosynthesis inhibitor|OGRPBCAM
erysipelas|OGRPBCAM
erysipeloid|OGRPBCAM
erythema infectiosum|OGRPBCAM
erythema multiforme|OGRPBCAM
erythrokeratodermia variabilis|OGRPBCAM
erythromelalgia|OGRPBCAM
erythropeotin receptor agonist|OGRPBCAM
erythropoietic protoporphyria|OGRPBCAM
erythropoietin inhibitor|OGRPBCAM
esiRNA|OGRPBCAM
esomeprazole|OGRPBCAM
esophageal atresia|OGRPBCAM
esophageal cancer|OGRPBCAM
esophageal carcinoma|OGRPBCAM
esophageal disease|OGRPBCAM
esophageal varix|DOID_112
esophagitis|OGRPBCAM
esophagus|OGRPBCAM
esophagus squamous cell carcinoma|OGRPBCAM
esotropia|OGRPBCAM
essential thrombocythemia|OGRPBCAM
essential tremor|OGRPBCAM
establishment of cell polarity regulating cell shape|OGRPBCAM
esterase activity determination|OGRPBCAM
esterase chemical inhibition|OGRPBCAM
esterase metabolite formation kinetics|OGRPBCAM
estradiol|OGRPBCAM
estrogen|OGRPBCAM
estrogen antagonist|OGRPBCAM
estrogen receptor agonist|OGRPBCAM
estrogen receptor antagonist|OGRPBCAM
estrogen receptor modulator|OGRPBCAM
estrogen-alexa 633|OGRPBCAM
estrogen-receptor positive breast cancer|OGRPBCAM
estropipate|OGRPBCAM
ethidium bromide DNA staining|OGRPBCAM
ethmoid sinusitis|OGRPBCAM
ethylene glycol ester of luciferin 6' methyl ether|OGRPBCAM
ethylene releasers|OGRPBCAM
ethylenediaminetetraacetic acid|OGRPBCAM
ethyleneglycol-bis(β-aminoethyl)-N,N,N′,N′-tetraacetic acid|OGRPBCAM
eugeroic|OGRPBCAM
eukaryote|OGRPBCAM
eukaryotic initiation factor 4F inhibitor|OGRPBCAM
eukaryotic metabolite|OGRPBCAM
eukaryotic translation elongation factor 1alpha 1 inhibitor|OGRPBCAM
eumycotic mycetoma|OGRPBCAM
eustachian tube disease|OGRPBCAM
euthyroid sick syndrome|OGRPBCAM
ex situ immunoassay|OGRPBCAM
ex vivo|OGRPBCAM
exact match structure search|OGRPBCAM
example of usage|OGRPBCAM
exanthem|OGRPBCAM
exanthema subitum|OGRPBCAM
excessive tearing|OGRPBCAM
excipient|OGRPBCAM
excitation filter|OGRPBCAM
excitation wavelength|OGRPBCAM
excitatory amino acid agonist|OGRPBCAM
excitatory amino acid antagonist|OGRPBCAM
exfoliation syndrome|OGRPBCAM
exhibitionism|OGRPBCAM
exocrine pancreatic insufficiency|OGRPBCAM
exophthalmos|OGRPBCAM
exostosis|DOID_203
exotropia|OGRPBCAM
expectorant|OGRPBCAM
experimental design method|OGRPBCAM
experimental setting|OGRPBCAM
experimental specification|OGRPBCAM
explosive|OGRPBCAM
exportin 1 inhibitor|OGRPBCAM
exposure keratitis|OGRPBCAM
expressive language disorder|OGRPBCAM
external ear cancer|OGRPBCAM
external ear carcinoma|OGRPBCAM
external ear disease|DOID_379
external_definition|OGRPBCAM
external_ontology_notes|OGRPBCAM
extract|OGRPBCAM
extract fraction|OGRPBCAM
extraction from natural source|OGRPBCAM
extragonadal seminoma|OGRPBCAM
extrahepatic bile duct carcinoma|OGRPBCAM
extraosseous Ewing sarcoma|OGRPBCAM
extraosseous chondrosarcoma|OGRPBCAM
extrapulmonary tuberculosis|OGRPBCAM
extraskeletal mesenchymal chondrosarcoma|OGRPBCAM
extraskeletal myxoid chondrosarcoma|OGRPBCAM
extratemporal epilepsy|OGRPBCAM
extrinsic allergic alveolitis|DOID_841
extrinsic cardiomyopathy|OGRPBCAM
exudative vitreoretinopathy|OGRPBCAM
eye accommodation disease|OGRPBCAM
eye degenerative disease|OGRPBCAM
eye disease|OGRPBCAM
eye lymphoma|OGRPBCAM
eyelid carcinoma|OGRPBCAM
eyelid disease|DOID_530
fMLFF peptide|OGRPBCAM
fMLFK-FITC|OGRPBCAM
facial dermatosis|OGRPBCAM
facial hemiatrophy|OGRPBCAM
facial nerve disease|OGRPBCAM
facial paralysis|OGRPBCAM
facioscapulohumeral muscular dystrophy|OGRPBCAM
factor V deficiency|OGRPBCAM
factor VII deficiency|OGRPBCAM
factor VIII deficiency|OGRPBCAM
factor X deficiency|OGRPBCAM
factor XI deficiency|OGRPBCAM
factor XII deficiency|OGRPBCAM
factor XIII deficiency|OGRPBCAM
fallopian tube adenocarcinoma|OGRPBCAM
fallopian tube cancer|OGRPBCAM
fallopian tube carcinoma|OGRPBCAM
fallopian tube disease|OGRPBCAM
familial Mediterranean fever|OGRPBCAM
familial adenomatous polyposis|OGRPBCAM
familial atrial fibrillation|OGRPBCAM
familial chylomicronemia syndrome|OGRPBCAM
familial combined hyperlipidemia|OGRPBCAM
familial hyperlipidemia|OGRPBCAM
familial juvenile hyperuricemic nephropathy|OGRPBCAM
familial lipoprotein lipase deficiency|OGRPBCAM
familial medullary thyroid carcinoma|OGRPBCAM
familial melanoma|OGRPBCAM
familial periodic paralysis|OGRPBCAM
familial retinoblastoma|OGRPBCAM
farmer's lung|OGRPBCAM
farnesoid X receptor agonist|OGRPBCAM
fasciculated|OGRPBCAM
fasciculated axons phenotype|OGRPBCAM
fasciitis|OGRPBCAM
fascioliasis|DOID_885
fasciolopsiasis|DOID_888
fat-soluble vitamin (role)|OGRPBCAM
fatal familial insomnia|OGRPBCAM
fatty acid catabolic process|OGRPBCAM
fatty acid oxidation inhibitor|OGRPBCAM
fatty acid synthesis inhibitor|OGRPBCAM
fatty liver disease|OGRPBCAM
favism|OGRPBCAM
feeder cell|OGRPBCAM
female|OGRPBCAM
female breast carcinoma|OGRPBCAM
female contraceptive drug|OGRPBCAM
female reproductive organ benign neoplasm|OGRPBCAM
female reproductive organ cancer|DOID_120
female reproductive system disease|DOID_229
female stress incontinence|DOID_724
femtomolar|OGRPBCAM
ferroptosis inducer|OGRPBCAM
ferroptosis inhibitor|OGRPBCAM
ferroptosis suppressor protein 1 inhibitor|OGRPBCAM
fertilizer|OGRPBCAM
fetal alcohol spectrum disorder|OGRPBCAM
fetal alcohol syndrome|OGRPBCAM
fetishism|OGRPBCAM
fiber optic waveguide|OGRPBCAM
fibrin modulating drug|OGRPBCAM
fibroblast growth factor receptor antagonist|OGRPBCAM
fibrodysplasia ossificans progressiva|OGRPBCAM
fibrolamellar carcinoma|OGRPBCAM
fibromyalgia|DOID_631
fibrosarcoma|OGRPBCAM
fibrosarcomatous osteosarcoma|OGRPBCAM
fibrous dysplasia|OGRPBCAM
fibrous histiocytoma|OGRPBCAM
fibrous meningioma|OGRPBCAM
fiedler's myocarditis|OGRPBCAM
filariasis|OGRPBCAM
film-forming compound|OGRPBCAM
filter assay|OGRPBCAM
filter assay method|OGRPBCAM
finger agnosia|OGRPBCAM
first generation antipsychotic|OGRPBCAM
fissured tongue|OGRPBCAM
fixative|OGRPBCAM
flame retardant|OGRPBCAM
flavouring agent|OGRPBCAM
flour treatment agent|OGRPBCAM
flow cytometry|OGRPBCAM
fluo-4 AM calcium indicator|OGRPBCAM
fluo-8 calcium indicator|OGRPBCAM
fluorescence anisotropy readout|OGRPBCAM
fluorescence intensity|OGRPBCAM
fluorescence method|OGRPBCAM
fluorescence microscope filter|OGRPBCAM
fluorescence microscopy|OGRPBCAM
fluorescence polarization|OGRPBCAM
fluorescence polarization readout|OGRPBCAM
fluorescence quencher|OGRPBCAM
fluorescence resonance energy transfer|OGRPBCAM
fluorescence-linked immunosorbent assay|OGRPBCAM
fluorescent DNA hybridization probe method|OGRPBCAM
fluorescent DNA hydrolysis probe method|OGRPBCAM
fluorescent DNA intercalation method|OGRPBCAM
fluorescent dye|OGRPBCAM
fluorescent dye transfer|OGRPBCAM
fluorescent intercalator displacement|OGRPBCAM
fluorescent labeling method|OGRPBCAM
fluorescent ligand binding method|OGRPBCAM
fluorescent probe|OGRPBCAM
fluorescent protein induction|OGRPBCAM
fluorescent protein reporter gene assay|OGRPBCAM
fluorescently labeled|OGRPBCAM
fluorochrome|OGRPBCAM
fluorogen|OGRPBCAM
fluorophosphonate-rhodamine|OGRPBCAM
fluozin|OGRPBCAM
fluozin-2|OGRPBCAM
fma_set_term|OGRPBCAM
foaming agent|OGRPBCAM
focal dermal hypoplasia|OGRPBCAM
focal dystonia|OGRPBCAM
focal epilepsy|OGRPBCAM
focal segmental glomerulosclerosis|OGRPBCAM
focus|OGRPBCAM
fold activation|OGRPBCAM
fold change|OGRPBCAM
fold decrease|OGRPBCAM
fold increase|OGRPBCAM
fold inhibition|OGRPBCAM
folic acid deficiency anemia|OGRPBCAM
follicular adenoma|OGRPBCAM
follicular dendritic cell sarcoma|OGRPBCAM
follicular mucinosis|OGRPBCAM
folliculitis|OGRPBCAM
food|OGRPBCAM
food acidity regulator|OGRPBCAM
food additive|OGRPBCAM
food additive carrier|OGRPBCAM
food allergy|OGRPBCAM
food anticaking agent|OGRPBCAM
food antifoaming agent|OGRPBCAM
food antioxidant|OGRPBCAM
food bleaching agent|OGRPBCAM
food bulking agent|OGRPBCAM
food colour retention agent|OGRPBCAM
food colouring|OGRPBCAM
food component|OGRPBCAM
food emulsifier|OGRPBCAM
food firming agent|OGRPBCAM
food gelling agent|OGRPBCAM
food glazing agent|OGRPBCAM
food humectant|OGRPBCAM
food packaging gas|OGRPBCAM
food preservative|OGRPBCAM
food propellant|OGRPBCAM
food stabiliser|OGRPBCAM
food thickening agent|OGRPBCAM
foodborne botulism|OGRPBCAM
foramen magnum meningioma|OGRPBCAM
force field based scoring function|OGRPBCAM
foreign promoter region|OGRPBCAM
forkhead box protein O1 inhibitor|OGRPBCAM
form agnosia|OGRPBCAM
formamide|OGRPBCAM
formyl peptide receptor agonist|OGRPBCAM
forskolin|OGRPBCAM
fossil fuel|OGRPBCAM
fraction metabolised|OGRPBCAM
fraction unbound|OGRPBCAM
fractional factorial design|OGRPBCAM
fragile X syndrome|OGRPBCAM
fragment based structure generation|OGRPBCAM
fragments per kilobase of exon per million mapped reads|OGRPBCAM
fragrance|OGRPBCAM
frequency unit|OGRPBCAM
frontal sinus benign neoplasm|OGRPBCAM
frontal sinus inverted papilloma|OGRPBCAM
frontal sinusitis|OGRPBCAM
frontotemporal dementia|OGRPBCAM
frozen shoulder|OGRPBCAM
fructose-1,6-bisphosphatase deficiency|OGRPBCAM
fruit allergy|OGRPBCAM
fucosidosis|OGRPBCAM
fuel|OGRPBCAM
fuel additive|OGRPBCAM
full activation|OGRPBCAM
full agonism|OGRPBCAM
full factorial design|OGRPBCAM
fumigant|OGRPBCAM
fumigant insecticide|OGRPBCAM
function|OGRPBCAM
function_notes|OGRPBCAM
functional|OGRPBCAM
functional colonic disease|OGRPBCAM
functional gastric disease|OGRPBCAM
functional phenotypic|OGRPBCAM
functional target-based
|OGRPBCAM
functionality|OGRPBCAM
functioning pituitary adenoma|OGRPBCAM
fundamental metabolite|OGRPBCAM
fundus albipunctatus|OGRPBCAM
fundus dystrophy|OGRPBCAM
fungal infectious disease|OGRPBCAM
fungal meningitis|OGRPBCAM
fungal metabolite|OGRPBCAM
fungal xenobiotic metabolite|OGRPBCAM
fungi|OGRPBCAM
fungicide|OGRPBCAM
funisitis|OGRPBCAM
furafylline|OGRPBCAM
fusariosis|OGRPBCAM
fused|OGRPBCAM
gait apraxia|OGRPBCAM
galactokinase deficiency|OGRPBCAM
galactosemia|OGRPBCAM
gallbladder|OGRPBCAM
gallbladder cancer|OGRPBCAM
gallbladder carcinoma|OGRPBCAM
gallbladder disease|OGRPBCAM
gallbladder lymphoma|OGRPBCAM
gallbladder melanoma|OGRPBCAM
gallbladder squamous cell carcinoma|OGRPBCAM
gamma counting method|OGRPBCAM
gamma heavy chain disease|OGRPBCAM
gamma-amino butyric acid metabolism disorder|OGRPBCAM
gamma-secretase modulator|OGRPBCAM
gangliocytoma|OGRPBCAM
ganglioglioma|OGRPBCAM
ganglioneuroblastoma|OGRPBCAM
ganglioneuroma|OGRPBCAM
gangliosidosis|OGRPBCAM
gap junctional intercellular communication inhibitor|OGRPBCAM
gas gangrene|OGRPBCAM
gas laser|OGRPBCAM
gastric adenocarcinoma|OGRPBCAM
gastric antral vascular ectasia|OGRPBCAM
gastric cardia adenocarcinoma|OGRPBCAM
gastric cardia carcinoma|OGRPBCAM
gastric diffuse adenocarcinoma|OGRPBCAM
gastric dilatation|OGRPBCAM
gastric fluid stability assay|OGRPBCAM
gastric inhibitory polypeptide receptor agonist|OGRPBCAM
gastric lymphoma|OGRPBCAM
gastric outlet obstruction|OGRPBCAM
gastrinoma|OGRPBCAM
gastritis|OGRPBCAM
gastroduodenitis|OGRPBCAM
gastroenteritis|OGRPBCAM
gastroesophageal reflux disease|OGRPBCAM
gastrointestinal allergy|OGRPBCAM
gastrointestinal drug|OGRPBCAM
gastrointestinal lymphoma|DOID_903
gastrointestinal stromal tumor|OGRPBCAM
gastrointestinal system benign neoplasm|OGRPBCAM
gastrointestinal system cancer|OGRPBCAM
gastrointestinal system disease|DOID_77
gastrointestinal tuberculosis|DOID_404
gastroparesis|OGRPBCAM
gastroschisis|OGRPBCAM
gastrula 50%-epiboly|OGRPBCAM
gastrula 75%-epiboly|OGRPBCAM
gastrula 80%-epiboly|OGRPBCAM
gastrula 90%-epiboly|OGRPBCAM
gastrula stage|OGRPBCAM
gel|OGRPBCAM
gelator|OGRPBCAM
gemistocytic astrocytoma|OGRPBCAM
gender identity disorder|OGRPBCAM
gene|OGRPBCAM
gene array|OGRPBCAM
gene expression|OGRPBCAM
gene expression assay|OGRPBCAM
gene expression detection method|OGRPBCAM
gene expression modulation method|OGRPBCAM
gene knock in|OGRPBCAM
gene knockdown|OGRPBCAM
gene knockdown by RNA interference|OGRPBCAM
gene knockdown by antisense RNA|OGRPBCAM
gene knockdown by dsRNA transfection|OGRPBCAM
gene knockdown by lentiviral shRNA transduction|OGRPBCAM
gene knockdown by morpholino treatment|OGRPBCAM
gene knockdown by shRNA transfection|OGRPBCAM
gene knockdown by siRNA transfection|OGRPBCAM
gene knockout|OGRPBCAM
gene list enrichment analysis|OGRPBCAM
gene overexpression|OGRPBCAM
gene overexpression by stable transfection|OGRPBCAM
gene overexpression by transient transfection|OGRPBCAM
gene-expression profile endpoint|OGRPBCAM
general anaesthetic|OGRPBCAM
generalized anxiety disorder|OGRPBCAM
generic hydrolase|OGRPBCAM
generic hydrolase enzyme activity assay|OGRPBCAM
generic membrane protein|OGRPBCAM
generic transferase|OGRPBCAM
genetic algorithm method|OGRPBCAM
genetic algorithm search|OGRPBCAM
genetic algorithm similary program|OGRPBCAM
genetic complementation|OGRPBCAM
genetic disease|DOID_630
genetic modification method|OGRPBCAM
genital herpes|OGRPBCAM
genomic DNA|OGRPBCAM
genotoxicity assay|OGRPBCAM
genotoxin|OGRPBCAM
genotyping method|OGRPBCAM
germ cell and embryonal cancer|OGRPBCAM
germ cell benign neoplasm|OGRPBCAM
germ cell cancer|OGRPBCAM
germinoma|OGRPBCAM
geroprotector|OGRPBCAM
gestational choriocarcinoma|OGRPBCAM
gestational diabetes|OGRPBCAM
gestational trophoblastic neoplasm|OGRPBCAM
giant cell reparative granuloma|OGRPBCAM
giardiasis|OGRPBCAM
gibberellin biosynthesis inhibitor|OGRPBCAM
gingival disease|OGRPBCAM
gingival overgrowth|OGRPBCAM
gingival recession|OGRPBCAM
gingivitis|OGRPBCAM
glanders|OGRPBCAM
glaucoma|OGRPBCAM
glioblastoma|OGRPBCAM
glioma-associated oncogene inhibitor|OGRPBCAM
gliosarcoma|OGRPBCAM
global chromatin epigenetic profiling assay|OGRPBCAM
global minimum search|OGRPBCAM
global range molecular matching|OGRPBCAM
global sequence alignment|OGRPBCAM
globe disease|OGRPBCAM
glomangioma|OGRPBCAM
glomerulonephritis|OGRPBCAM
glomerulosclerosis|OGRPBCAM
glossitis|OGRPBCAM
glossopharyngeal nerve disease|OGRPBCAM
glossopharyngeal neuralgia|OGRPBCAM
glottis cancer|OGRPBCAM
glottis carcinoma|OGRPBCAM
glucagon receptor antagonist|OGRPBCAM
glucagon-like peptide-1 receptor agonist|OGRPBCAM
glucagon-like peptide-2 receptor agonist|OGRPBCAM
glucocorticoid receptor agonist|OGRPBCAM
glucocorticoid receptor antagonist|OGRPBCAM
glucose intolerance|OGRPBCAM
glucose metabolism disease|OGRPBCAM
glucose transporter 1 inhibitor|OGRPBCAM
glucose transporter inhibitor|OGRPBCAM
glucosephosphate dehydrogenase deficiency|OGRPBCAM
glutamate|OGRPBCAM
glutamate transporter activator|OGRPBCAM
glutamine antagonist|OGRPBCAM
glutathione depleting agent|OGRPBCAM
glycerin immersion lens|OGRPBCAM
glycerophosphoinositol synthesis inhibitor|OGRPBCAM
glycine encephalopathy|OGRPBCAM
glycine receptor agonist|OGRPBCAM
glycine receptor antagonist|OGRPBCAM
glycine transporter 1 inhibitor|OGRPBCAM
glycine transporter 2 inhibitor|OGRPBCAM
glycine transporter inhibitor|OGRPBCAM
glycogen metabolism disorder|OGRPBCAM
glycogen storage disease|OGRPBCAM
glycogen storage disease II|OGRPBCAM
glycogen storage disease IV|OGRPBCAM
glycogen storage disease V|OGRPBCAM
glycoproteinosis|OGRPBCAM
glycosylated|OGRPBCAM
gnathomiasis|OGRPBCAM
goiter|OGRPBCAM
gonadal disease|OGRPBCAM
gonadal dysgenesis|OGRPBCAM
gonadoblastoma|OGRPBCAM
gonadotropin releasing hormone agonist|OGRPBCAM
gonorrhea|OGRPBCAM
gout|OGRPBCAM
gout suppressant|OGRPBCAM
gpcrMAX℠ GPCR Assay Panel|OGRPBCAM
granular cell tumor|OGRPBCAM
granular corneal dystrophy|OGRPBCAM
granuloma inguinale|OGRPBCAM
granulomatosis with polyangiitis|OGRPBCAM
granulomatous amebic encephalitis|OGRPBCAM
granulosa cell tumor|OGRPBCAM
graphical calculation endpoint|OGRPBCAM
gray zone lymphoma|OGRPBCAM
green flourescent protein gene|OGRPBCAM
greenhouse gas|OGRPBCAM
group a streptococcus|OGRPBCAM
group transfer coenzymes|OGRPBCAM
growth factor|OGRPBCAM
growth hormone|OGRPBCAM
growth inhibition|OGRPBCAM
growth regulator|OGRPBCAM
guanosine diphosphate|OGRPBCAM
guanosine triphosphate|OGRPBCAM
guanylate cyclase 2C agonist|OGRPBCAM
guinea pig ileum (GPI) assay|OGRPBCAM
gut flora metabolite|OGRPBCAM
gut function assay|OGRPBCAM
gut motility assay|OGRPBCAM
gut transit method|OGRPBCAM
gut transit assay|OGRPBCAM
gynecomastia|OGRPBCAM
gyrate atrophy|OGRPBCAM
hERG binding assay|OGRPBCAM
hERG patch clamp assay|OGRPBCAM
haedoxan|OGRPBCAM
hair disease|DOID_421
hair follicle neoplasm|OGRPBCAM
hairy cell leukemia|DOID_285
half life|OGRPBCAM
hallucinogen|OGRPBCAM
hallucinogen dependence|OGRPBCAM
hand dermatosis|OGRPBCAM
hand, foot and mouth disease|OGRPBCAM
hantavirus pulmonary syndrome|OGRPBCAM
hapten|OGRPBCAM
hard palate cancer|OGRPBCAM
has DNA sequence|OGRPBCAM
has ID|OGRPBCAM
has RNA sequence|OGRPBCAM
has absorbance wavelength value|OGRPBCAM
has activity threshold value|OGRPBCAM
has alternate assay conditions|OGRPBCAM
has alternate assay format|OGRPBCAM
has alternate assay type|OGRPBCAM
has alternate cell line assay|OGRPBCAM
has alternate confirmatory assay|OGRPBCAM
has alternate organism assay|OGRPBCAM
has alternate target assay|OGRPBCAM
has anti-sense strand sequence|OGRPBCAM
has antibody source|OGRPBCAM
has artificial regulatory region copy number|OGRPBCAM
has assay control|OGRPBCAM
has assay deposition date|OGRPBCAM
has assay design method|OGRPBCAM
has assay footprint|OGRPBCAM
has assay format|OGRPBCAM
has assay kit|OGRPBCAM
has assay kit component|OGRPBCAM
has assay medium|OGRPBCAM
has assay method|OGRPBCAM
has assay pH value|OGRPBCAM
has assay phase characteristic|OGRPBCAM
has assay pressure value|OGRPBCAM
has assay protocol|OGRPBCAM
has assay readout content|OGRPBCAM
has assay readout content parametricity|OGRPBCAM
has assay readout type|OGRPBCAM
has assay serum|OGRPBCAM
has assay source|OGRPBCAM
has assay stage|OGRPBCAM
has assay supporting method|OGRPBCAM
has assay temperature value|OGRPBCAM
has assay title|OGRPBCAM
has associated disease|OGRPBCAM
has binding site|OGRPBCAM
has bioassay type|OGRPBCAM
has biosafety level|OGRPBCAM
has broad synonym|OGRPBCAM
has cDNA copy number|OGRPBCAM
has cell count|OGRPBCAM
has cell line|OGRPBCAM
has cell modification temperature value|OGRPBCAM
has cell modification time value|OGRPBCAM
has compound aggregation assay|OGRPBCAM
has compound fluorescence assay|OGRPBCAM
has compound redox-activity assay|OGRPBCAM
has compound toxicity assay|OGRPBCAM
has concentration|OGRPBCAM
has concentration throughput|OGRPBCAM
has concentration unit|OGRPBCAM
has concentration value|OGRPBCAM
has concentration-point number|OGRPBCAM
has confirmatory assay|OGRPBCAM
has copy number|OGRPBCAM
has counter assay|OGRPBCAM
has coupled substrate incubation temperature value|OGRPBCAM
has coupled substrate incubation time value|OGRPBCAM
has cross-reference|OGRPBCAM
has curation status|OGRPBCAM
has curve fit specification|OGRPBCAM
has date|OGRPBCAM
has detected entity|OGRPBCAM
has detection method|OGRPBCAM
has display info|OGRPBCAM
has emission wavelength value|OGRPBCAM
has endpoint|OGRPBCAM
has endpoint modifier|OGRPBCAM
has enzyme reaction temperature value|OGRPBCAM
has enzyme reaction time value|OGRPBCAM
has exact match|OGRPBCAM
has exact synonym|OGRPBCAM
has excitation wavelength value|OGRPBCAM
has experimental setting|OGRPBCAM
has form|OGRPBCAM
has function|OGRPBCAM
has function in|OGRPBCAM
has gene copy number|OGRPBCAM
has gene symbol|OGRPBCAM
has id value|OGRPBCAM
has identical assay|OGRPBCAM
has incubation time value|OGRPBCAM
has indicator|OGRPBCAM
has inducer|OGRPBCAM
has lead optimization assay|OGRPBCAM
has ligand incubation time value|OGRPBCAM
has manufacturer|OGRPBCAM
has marker|OGRPBCAM
has measure group|OGRPBCAM
has measured entity|OGRPBCAM
has mode of action|OGRPBCAM
has molecular phenotype|OGRPBCAM
has morphological phenotype|OGRPBCAM
has narrow synonym|OGRPBCAM
has narrower match|OGRPBCAM
has negative control|OGRPBCAM
has nucleic acid sequence|OGRPBCAM
has organism|OGRPBCAM
has orthogonal assay design|OGRPBCAM
has orthogonal assay technology|OGRPBCAM
has parental cell line assay|OGRPBCAM
has part|OGRPBCAM
has participant|OGRPBCAM
has passage number|OGRPBCAM
has percent response|OGRPBCAM
has percent response value|OGRPBCAM
has perturbagen|OGRPBCAM
has perturbagen incubation temperature value|OGRPBCAM
has perturbagen incubation time value|OGRPBCAM
has phenotype|OGRPBCAM
has physicochemical profiling assay|OGRPBCAM
has positive control|OGRPBCAM
has preparation method|OGRPBCAM
has primary assay|OGRPBCAM
has protein sequence|OGRPBCAM
has purity unit|OGRPBCAM
has purity value|OGRPBCAM
has quality|OGRPBCAM
has recommended name|OGRPBCAM
has related synonym|OGRPBCAM
has repetition point-number|OGRPBCAM
has repetition throughput|OGRPBCAM
has response unit|OGRPBCAM
has response value|OGRPBCAM
has role|OGRPBCAM
has selectivity assay|OGRPBCAM
has sense strand sequence|OGRPBCAM
has sequence|OGRPBCAM
has sequence position|OGRPBCAM
has shRNA probe sense sequence position|OGRPBCAM
has shRNA sense sequence|OGRPBCAM
has siRNA probe sense sequence position|OGRPBCAM
has signal direction|OGRPBCAM
has specification|OGRPBCAM
has substrate|OGRPBCAM
has substrate incubation temperature value|OGRPBCAM
has substrate incubation time value|OGRPBCAM
has summary assay|OGRPBCAM
has target|OGRPBCAM
has temperature unit|OGRPBCAM
has temperature value|OGRPBCAM
has time unit|OGRPBCAM
has time value|OGRPBCAM
has transcription factor|OGRPBCAM
has unit|OGRPBCAM
has value|OGRPBCAM
has variant construct assay|OGRPBCAM
has wavelength value|OGRPBCAM
has_alternative_id|OGRPBCAM
has_broad_synonym|OGRPBCAM
has_exact_synonym|OGRPBCAM
has_narrow_synonym|OGRPBCAM
has_obo_namespace|OGRPBCAM
has_related_synonym|OGRPBCAM
has_relational_adjective|OGRPBCAM
head and neck cancer|OGRPBCAM
heart aneurysm|OGRPBCAM
heart cancer|DOID_117
heart conduction disease|OGRPBCAM
heart disease|DOID_114
heart lymphoma|OGRPBCAM
heart septal defect|OGRPBCAM
heart valve disease|OGRPBCAM
heat denaturation|OGRPBCAM
heat shock factor 1 inhibitor|OGRPBCAM
heavy chain disease|OGRPBCAM
helium-cadmium laser|OGRPBCAM
helium-neon laser|OGRPBCAM
hemangioblastoma|OGRPBCAM
hemangioma|DOID_255
hemangioma of lung|DOID_490
hemangiopericytoma|DOID_264
hemarthrosis|DOID_801
hematologic agent|OGRPBCAM
hematologic cancer|OGRPBCAM
hematopoietic system disease|DOID_74
hemiplegia|OGRPBCAM
hemochromatosis|OGRPBCAM
hemoglobin E disease|OGRPBCAM
hemoglobinopathy|OGRPBCAM
hemolymphoid system|OGRPBCAM
hemolytic anemia|DOID_583
hemolytic-uremic syndrome|OGRPBCAM
hemometra|OGRPBCAM
hemopericardium|OGRPBCAM
hemophagocytic lymphohistiocytosis|OGRPBCAM
hemophilia B|OGRPBCAM
hemopneumothorax|OGRPBCAM
hemorrhagic disease|OGRPBCAM
hemosiderosis|OGRPBCAM
hepatic encephalopathy|OGRPBCAM
hepatic steatosis inducing agent|OGRPBCAM
hepatic vascular disease|DOID_272
hepatitis|OGRPBCAM
hepatitis A|OGRPBCAM
hepatitis B|OGRPBCAM
hepatitis C|OGRPBCAM
hepatitis C protease inhibitor|OGRPBCAM
hepatitis C virus nonstructural protein 5A inhibitor|OGRPBCAM
hepatitis D|OGRPBCAM
hepatitis E|OGRPBCAM
hepatobiliary benign neoplasm|OGRPBCAM
hepatobiliary disease|OGRPBCAM
hepatobiliary system cancer|OGRPBCAM
hepatoblastoma|DOID_687
hepatocellular carcinoma|DOID_684
hepatocyte co-culture low clearance assay|OGRPBCAM
hepatocyte low clearance relay assay|OGRPBCAM
hepatocyte relay assay|OGRPBCAM
hepatocyte stability assay|OGRPBCAM
hepatocyte uptake assay|OGRPBCAM
hepatoerythropoietic porphyria|OGRPBCAM
hepatoprotective agent|OGRPBCAM
hepatopulmonary syndrome|DOID_900
hepatotoxic agent|OGRPBCAM
heptacosa-7,11-diene|OGRPBCAM
herbicide|OGRPBCAM
herbicide safener|OGRPBCAM
hereditary Wilms' tumor|OGRPBCAM
hereditary ataxia|OGRPBCAM
hereditary breast ovarian cancer syndrome|OGRPBCAM
hereditary choroidal atrophy|OGRPBCAM
hereditary coproporphyria|OGRPBCAM
hereditary elliptocytosis|OGRPBCAM
hereditary fructose intolerance syndrome|OGRPBCAM
hereditary hemorrhagic telangiectasia|OGRPBCAM
hereditary mucosal leukokeratosis|OGRPBCAM
hereditary night blindness|OGRPBCAM
hereditary renal cell carcinoma|OGRPBCAM
hereditary sensory neuropathy|OGRPBCAM
hereditary spherocytosis|OGRPBCAM
hermaphroditism|OGRPBCAM
heroin dependence|OGRPBCAM
herpangina|OGRPBCAM
herpes simplex|OGRPBCAM
herpes zoster|OGRPBCAM
herpes zoster oticus|OGRPBCAM
hertz|OGRPBCAM
heterogeneous phase|OGRPBCAM
hiatus hernia|OGRPBCAM
hidradenitis|OGRPBCAM
hidradenitis suppurativa|OGRPBCAM
hidradenoma|OGRPBCAM
hidrocystoma|OGRPBCAM
hierarchial clustering|OGRPBCAM
high pressure neurological syndrome|OGRPBCAM
high signal control|OGRPBCAM
high throughput screening|OGRPBCAM
his tag|OGRPBCAM
histamine agonist|OGRPBCAM
histamine antagonist|OGRPBCAM
histamine releasing agent|OGRPBCAM
histaminergic drug|OGRPBCAM
histidine metabolism disease|OGRPBCAM
histidinemia|OGRPBCAM
histiocytic and dendritic cell cancer|OGRPBCAM
histiocytoid hemangioma|DOID_474
histiocytoma|OGRPBCAM
histiocytosis|OGRPBCAM
histological dye|OGRPBCAM
histone acetyltransferase activator|OGRPBCAM
histoplasmosis|OGRPBCAM
histrionic personality disorder|DOID_334
holocarboxylase synthetase deficiency|DOID_859
holoprosencephaly|OGRPBCAM
homocarnosinosis|OGRPBCAM
homocystinuria|OGRPBCAM
homogeneous phase|OGRPBCAM
homogeneous time resolved fluorescence|OGRPBCAM
homology modeling|OGRPBCAM
homology_notes|OGRPBCAM
homopteran inhibitor of chitin biosynthesis|OGRPBCAM
hordeolum|OGRPBCAM
hormone|OGRPBCAM
hormone agonist|OGRPBCAM
hormone antagonist|OGRPBCAM
hormone producing pituitary cancer|OGRPBCAM
hormone receptor modulator|OGRPBCAM
hour|OGRPBCAM
human blood serum metabolite|OGRPBCAM
human granulocytic anaplasmosis|OGRPBCAM
human immunodeficiency virus infectious disease|DOID_526
human mammary epithelial cell permeability assay|OGRPBCAM
human metabolite|OGRPBCAM
human monocytic ehrlichiosis|OGRPBCAM
human urinary metabolite|OGRPBCAM
human xenobiotic metabolite|OGRPBCAM
humectant|OGRPBCAM
hyaluronan synthesis inhibitor|OGRPBCAM
hyaluronic acid synthesis inhibitor|OGRPBCAM
hybrid cell creation method|OGRPBCAM
hybrid screening|OGRPBCAM
hydranencephaly|OGRPBCAM
hydrarthrosis|DOID_528
hydrocele|OGRPBCAM
hydrocephalus|OGRPBCAM
hydrolase|OGRPBCAM
hydrolase activity assay|OGRPBCAM
hydronephrosis|OGRPBCAM
hymenolepiasis|OGRPBCAM
hyper IgE recurrent infection syndrome 1|OGRPBCAM
hyper IgE syndrome|OGRPBCAM
hyper IgM syndrome|OGRPBCAM
hyperandrogenism|OGRPBCAM
hyperargininemia|OGRPBCAM
hypercalcemia|OGRPBCAM
hypercementosis|OGRPBCAM
hypereosinophilic syndrome|DOID_999
hyperglobulinemic purpura|OGRPBCAM
hyperglycemia|OGRPBCAM
hyperglycemic agent|OGRPBCAM
hyperhomocysteinemia|OGRPBCAM
hyperimmunoglobulin syndrome|OGRPBCAM
hyperinsulinemic hypoglycemia|OGRPBCAM
hyperinsulinism|OGRPBCAM
hyperkalemic periodic paralysis|OGRPBCAM
hyperlipoproteinemia type IV|OGRPBCAM
hyperlysinemia|OGRPBCAM
hypermethioninemia|OGRPBCAM
hypermobility syndrome|OGRPBCAM
hyperopia|OGRPBCAM
hyperostosis|DOID_205
hyperparathyroidism|OGRPBCAM
hyperphosphatemia|OGRPBCAM
hyperpituitarism|OGRPBCAM
hyperprolactinemia|OGRPBCAM
hypersensitivity reaction disease|OGRPBCAM
hypersensitivity reaction type III disease|OGRPBCAM
hypersensitivity reaction type IV disease|OGRPBCAM
hypersensitivity vasculitis|OGRPBCAM
hypersplenism|OGRPBCAM
hypertension|OGRPBCAM
hypertensive heart disease|OGRPBCAM
hypertensive retinopathy|OGRPBCAM
hyperthyroidism|OGRPBCAM
hyperthyroxinemia|OGRPBCAM
hypertrichosis|DOID_420
hypertrophic cardiomyopathy|OGRPBCAM
hypertropia|OGRPBCAM
hyperuricemia|OGRPBCAM
hypervitaminosis D|OGRPBCAM
hypoactive sexual desire disorder|OGRPBCAM
hypobetalipoproteinemia|OGRPBCAM
hypochondroplasia|OGRPBCAM
hypochromic anemia|OGRPBCAM
hypoglycemia|OGRPBCAM
hypoglycemic agent|OGRPBCAM
hypoglycemic coma|OGRPBCAM
hypogonadism|OGRPBCAM
hypogonadotropic hypogonadism|OGRPBCAM
hypohidrosis|OGRPBCAM
hypohidrotic ectodermal dysplasia|OGRPBCAM
hypokalemia|OGRPBCAM
hypokalemic periodic paralysis|OGRPBCAM
hypolipoproteinemia|OGRPBCAM
hypomyelinating leukodystrophy|OGRPBCAM
hypoparathyroidism|OGRPBCAM
hypopharynx cancer|OGRPBCAM
hypophosphatasia|OGRPBCAM
hypophosphatemia|OGRPBCAM
hypopituitarism|OGRPBCAM
hypoplastic left heart syndrome|OGRPBCAM
hypospadias|OGRPBCAM
hypothyroidism|OGRPBCAM
hypotonia-cystinuria syndrome|OGRPBCAM
hypotrichosis|OGRPBCAM
hypotrophic|OGRPBCAM
hypotropia|OGRPBCAM
hypoxia-inducible factor pathway activator|OGRPBCAM
iCyte Automated Imaging Cytometer|OGRPBCAM
iMIC platform/ Polychrome V imaging system, (TILL Photonics/ FEI Munic GmbH)|OGRPBCAM
ichthyosis|OGRPBCAM
ichthyosis vulgaris|OGRPBCAM
id|OGRPBCAM
ideomotor apraxia|OGRPBCAM
idiopathic corneal edema|OGRPBCAM
idiopathic generalized epilepsy|OGRPBCAM
idiopathic interstitial pneumonia|OGRPBCAM
idiopathic juvenile osteoporosis|OGRPBCAM
idiopathic pulmonary fibrosis|OGRPBCAM
ileus|OGRPBCAM
image acquisition device|OGRPBCAM
image analysis method|OGRPBCAM
image analysis software|OGRPBCAM
image correction|OGRPBCAM
image resize|OGRPBCAM
image segmentation|OGRPBCAM
image sharpening|OGRPBCAM
image smoothing|OGRPBCAM
image thresholding|OGRPBCAM
image-based readout|OGRPBCAM
imaging cytometer|OGRPBCAM
imaging method|OGRPBCAM
immortal cell line cell|OGRPBCAM
immune system cancer|OGRPBCAM
immune system disease|OGRPBCAM
immunoassay|OGRPBCAM
immunoblot|OGRPBCAM
immunocapture|OGRPBCAM
immunochromatography|OGRPBCAM
immunocytochemistry|OGRPBCAM
immunodepletion|OGRPBCAM
immunofluorescent labeling|OGRPBCAM
immunogen|OGRPBCAM
immunoglobulin alpha deficiency|OGRPBCAM
immunogold labeling|OGRPBCAM
immunohistochemistry|OGRPBCAM
immunolabeling method|OGRPBCAM
immunological adjuvant|OGRPBCAM
immunomagnetic separation method|OGRPBCAM
immunomodulator|OGRPBCAM
immunoprecipitation|OGRPBCAM
immunosuppressive agent|OGRPBCAM
impedance|OGRPBCAM
imperforate anus|OGRPBCAM
impetigo|OGRPBCAM
imported from|OGRPBCAM
impotence|OGRPBCAM
impulse control disorder|OGRPBCAM
impurity|OGRPBCAM
in silico|OGRPBCAM
in situ carcinoma|OGRPBCAM
in situ immunoassay|OGRPBCAM
in subset|OGRPBCAM
in vitro|OGRPBCAM
in vivo|OGRPBCAM
in vivo PK/PD assay|OGRPBCAM
in vivo PK/PD/Tox method|OGRPBCAM
in vivo assay method|OGRPBCAM
in vivo efficacy assay|OGRPBCAM
in vivo efficacy method|OGRPBCAM
in-cell western assay|OGRPBCAM
in_subset|OGRPBCAM
inactive|OGRPBCAM
inappropriate ADH syndrome|OGRPBCAM
inclusion body myositis|OGRPBCAM
inclusion conjunctivitis|OGRPBCAM
increased intensity|OGRPBCAM
increased length|OGRPBCAM
increased width|OGRPBCAM
incremental construction method|OGRPBCAM
incretin mimetic|OGRPBCAM
indicator|OGRPBCAM
indo-1 calcium indicator|OGRPBCAM
indolent systemic mastocytosis|OGRPBCAM
induced pluripotent stem cell|OGRPBCAM
inducer|OGRPBCAM
infancy electroclinical syndrome|OGRPBCAM
infant botulism|OGRPBCAM
infantile Refsum disease|OGRPBCAM
infectious mononucleosis|OGRPBCAM
infective endocarditis|OGRPBCAM
inferior myocardial infarction|OGRPBCAM
infertility|OGRPBCAM
inflamed blood vessel cell phenotype|OGRPBCAM
inflamed cell phenotype|OGRPBCAM
inflammatory and toxic neuropathy|OGRPBCAM
inflammatory bowel disease|OGRPBCAM
inflammatory breast carcinoma|OGRPBCAM
inflammatory response|OGRPBCAM
influenza|OGRPBCAM
influenza virus|OGRPBCAM
infrared imaging|OGRPBCAM
infratentorial cancer|OGRPBCAM
inhalation anaesthetic|OGRPBCAM
inhalation anthrax|OGRPBCAM
inheres in|OGRPBCAM
inherited metabolic disorder|DOID_655
inhibition|OGRPBCAM
inhibitor|OGRPBCAM
inner ear disease|OGRPBCAM
inorganic acid|OGRPBCAM
inositol 1,4,5-trisphosphate|OGRPBCAM
inositol phosphorylceramide synthase inhibitor|OGRPBCAM
inositol-1-phosphate|OGRPBCAM
input data|OGRPBCAM
insect attractant|OGRPBCAM
insect growth regulator|OGRPBCAM
insect repellent|OGRPBCAM
insect sterilant|OGRPBCAM
insecticide|OGRPBCAM
inserted|OGRPBCAM
instrument|OGRPBCAM
instrumentation manufacturer|OGRPBCAM
insulin ELISA kit (Alpco)|OGRPBCAM
insulin release inhibitor|OGRPBCAM
insulin secretagogue|OGRPBCAM
insulin-like growth factor receptor 1 antagonist|OGRPBCAM
insulin-like growth factor-binding protein inhibitor|OGRPBCAM
insulin-sensitizing drug|OGRPBCAM
insulinoma|OGRPBCAM
integrated pathway analysis|OGRPBCAM
integumentary system benign neoplasm|OGRPBCAM
integumentary system cancer|OGRPBCAM
integumentary system disease|DOID_16
intellectual disability|OGRPBCAM
intensity|OGRPBCAM
intensity parameter|OGRPBCAM
intercalator|OGRPBCAM
interferon inducer|OGRPBCAM
intermediate coronary syndrome|OGRPBCAM
intermediate neglect of differential overlap|OGRPBCAM
intermittent claudication|OGRPBCAM
intermittent explosive disorder|OGRPBCAM
internal coordinate mechanics method|OGRPBCAM
interstitial cystitis|OGRPBCAM
interstitial fluid stability assay|OGRPBCAM
interstitial lung disease|OGRPBCAM
interstitial nephritis|OGRPBCAM
interval angle-closure glaucoma|OGRPBCAM
intestinal atresia|OGRPBCAM
intestinal benign neoplasm|OGRPBCAM
intestinal botulism|OGRPBCAM
intestinal cancer|OGRPBCAM
intestinal disaccharidase deficiency|OGRPBCAM
intestinal disease|OGRPBCAM
intestinal fluid stability assay|OGRPBCAM
intestinal infectious disease|DOID_100
intestinal obstruction|OGRPBCAM
intestinal perforation|OGRPBCAM
intestinal pseudo-obstruction|OGRPBCAM
intestinal schistosomiasis|OGRPBCAM
intestinal tuberculosis|OGRPBCAM
intestinal volvulus|OGRPBCAM
intestine|OGRPBCAM
intestine carcinoma in situ|OGRPBCAM
intracranial abscess|OGRPBCAM
intracranial aneurysm|OGRPBCAM
intracranial arterial disease|OGRPBCAM
intracranial embolism|OGRPBCAM
intracranial hypertension|OGRPBCAM
intracranial hypotension|OGRPBCAM
intracranial primitive neuroectodermal tumor|OGRPBCAM
intracranial sinus thrombosis|OGRPBCAM
intracranial thrombosis|OGRPBCAM
intracranial vasospasm|OGRPBCAM
intraductal breast benign neoplasm|OGRPBCAM
intraductal papilloma|OGRPBCAM
intrahepatic cholangiocarcinoma|OGRPBCAM
intrahepatic cholestasis|OGRPBCAM
intramuscular hemangioma|DOID_468
intraocular lymphoma|DOID_775
intravenous anaesthetic|OGRPBCAM
intrinsic cardiomyopathy|OGRPBCAM
intussusception|OGRPBCAM
invasive aspergillosis|OGRPBCAM
invasive lobular carcinoma|OGRPBCAM
inverse agonism|OGRPBCAM
inverse agonist|OGRPBCAM
inversely correlated|OGRPBCAM
invertebrate|OGRPBCAM
inverted papilloma|OGRPBCAM
involves biological process|OGRPBCAM
involves molecular function|OGRPBCAM
ion channel|OGRPBCAM
ion channel assay|OGRPBCAM
ion laser|OGRPBCAM
ion redistribution assay|OGRPBCAM
ion redistribution determination method|OGRPBCAM
ion transport inhibitor|OGRPBCAM
ionomycin|OGRPBCAM
ionophore|OGRPBCAM
iridocyclitis|OGRPBCAM
iris disease|DOID_240
iritis|OGRPBCAM
iron chelator|OGRPBCAM
iron ionophore|OGRPBCAM
iron metabolism disease|OGRPBCAM
iron(2+) chelator|OGRPBCAM
iron(3+) chelator|OGRPBCAM
irregular astigmatism|OGRPBCAM
irreversible binding|OGRPBCAM
irritable bowel syndrome|OGRPBCAM
irritant dermatitis|OGRPBCAM
is alternate assay conditions of|OGRPBCAM
is alternate assay format of|OGRPBCAM
is alternate assay type of|OGRPBCAM
is alternate cell line assay of|OGRPBCAM
is alternate confirmatory assay of|OGRPBCAM
is alternate organism assay of|OGRPBCAM
is alternate target assay of|OGRPBCAM
is assay format of|OGRPBCAM
is assay method of|OGRPBCAM
is assay protocol of|OGRPBCAM
is associated disease of|OGRPBCAM
is binding site of|OGRPBCAM
is bioassay type of|OGRPBCAM
is cell line of|OGRPBCAM
is compound aggregation assay of|OGRPBCAM
is compound fluorescence assay of|OGRPBCAM
is compound redox-activity assay of|OGRPBCAM
is compound toxicity assay of|OGRPBCAM
is confirmatory assay of|OGRPBCAM
is counter assay of|OGRPBCAM
is derived from|OGRPBCAM
is described by|OGRPBCAM
is detected by|OGRPBCAM
is detection method of|OGRPBCAM
is endpoint of|OGRPBCAM
is grown in|OGRPBCAM
is identical assay of|OGRPBCAM
is indicator of|OGRPBCAM
is input data value of|OGRPBCAM
is lead optimization assay of|OGRPBCAM
is localized in|OGRPBCAM
is marker of|OGRPBCAM
is measure group of|OGRPBCAM
is measured entity of|OGRPBCAM
is opposite of|OGRPBCAM
is orthogonal assay design of|OGRPBCAM
is orthogonal assay technology of|OGRPBCAM
is parental cell line assay of|OGRPBCAM
is perturbagen of|OGRPBCAM
is phenotype of|OGRPBCAM
is physicochemical profiling assay of|OGRPBCAM
is primary assay of|OGRPBCAM
is regulated by|OGRPBCAM
is regulator of|OGRPBCAM
is related assay to|OGRPBCAM
is role of|OGRPBCAM
is selectivity assay of|OGRPBCAM
is specification of|OGRPBCAM
is substrate of|OGRPBCAM
is summary assay of|OGRPBCAM
is target of|OGRPBCAM
is transfected into|OGRPBCAM
is unit of|OGRPBCAM
is variant construct assay of|OGRPBCAM
is_opposite_of|OGRPBCAM
ischemia|DOID_326
ischemic bone disease|OGRPBCAM
ischemic neuropathy|OGRPBCAM
islet cell tumor|OGRPBCAM
isobaric labeling|OGRPBCAM
isoform|OGRPBCAM
isolated aorta assay|OGRPBCAM
isomerase|OGRPBCAM
isomerase activity assay|OGRPBCAM
isometric tension recording method|OGRPBCAM
isoproterenol|OGRPBCAM
isothermal titration calorimetry|OGRPBCAM
isotope labeling method|OGRPBCAM
isotopic tracer|OGRPBCAM
isovaleric acidemia|OGRPBCAM
jasmonates|OGRPBCAM
jaw cancer|OGRPBCAM
john hopkins ion channel center|OGRPBCAM
jugular foramen meningioma|OGRPBCAM
junctional epidermolysis bullosa|OGRPBCAM
juvenile absence epilepsy|OGRPBCAM
juvenile hormone antagonists|OGRPBCAM
juvenile hormone mimic|OGRPBCAM
juvenile myelomonocytic leukemia|OGRPBCAM
juvenile pilocytic astrocytoma|OGRPBCAM
juvenile rheumatoid arthritis|DOID_676
juvenile type testicular granulosa cell tumor|OGRPBCAM
juvenile xanthogranuloma|OGRPBCAM
juxtacortical osteosarcoma|OGRPBCAM
k means clustering|OGRPBCAM
kairomone|OGRPBCAM
kappa-opioid agent|OGRPBCAM
kappa-opioid receptor agonist|OGRPBCAM
kappa-opioid receptor antagonist|OGRPBCAM
katal per cubic meter|OGRPBCAM
katal per liter|OGRPBCAM
kcat|OGRPBCAM
kelvin|OGRPBCAM
keratitis|OGRPBCAM
keratoconjunctivitis|OGRPBCAM
keratoconjunctivitis sicca|OGRPBCAM
keratoconus|OGRPBCAM
keratolytic drug|OGRPBCAM
keratomalacia|OGRPBCAM
keratopathy|OGRPBCAM
keratosis|DOID_161
keratosis follicularis|OGRPBCAM
kernicterus|OGRPBCAM
ketoconazole|OGRPBCAM
kidney|OGRPBCAM
kidney angiomyolipoma|OGRPBCAM
kidney benign neoplasm|OGRPBCAM
kidney cancer|DOID_263
kidney cortex disease|OGRPBCAM
kidney disease|DOID_557
kidney failure|OGRPBCAM
kidney hemangiopericytoma|DOID_262
kidney hypertrophy|OGRPBCAM
kidney leiomyosarcoma|OGRPBCAM
kidney sarcoma|OGRPBCAM
kinase|OGRPBCAM
kinase active-site binding method|OGRPBCAM
kinase activity|OGRPBCAM
kinase activity assay|OGRPBCAM
kinase competitive binding method|OGRPBCAM
kinetic assay|OGRPBCAM
kinome activity assay|OGRPBCAM
kisspeptin receptor agonist|OGRPBCAM
kleptomania|OGRPBCAM
km|OGRPBCAM
knowledge based scoring function|OGRPBCAM
kobs|OGRPBCAM
koff|OGRPBCAM
kon|OGRPBCAM
krypton-ion laser|OGRPBCAM
kuru|DOID_648
kynuramine|OGRPBCAM
label|OGRPBCAM
label free method|OGRPBCAM
label-free receptor assay|OGRPBCAM
labeled|OGRPBCAM
labeling method|OGRPBCAM
labyrinthine dysfunction|DOID_566
labyrinthitis|OGRPBCAM
lachrymator|OGRPBCAM
lacrimal apparatus disease|OGRPBCAM
lacrimal duct obstruction|OGRPBCAM
lacrimal gland cancer|DOID_294
lacrimal system cancer|DOID_292
lactic acidosis|OGRPBCAM
lactose intolerance|OGRPBCAM
lagophthalmos|OGRPBCAM
lamellipodium|OGRPBCAM
lance TR-FRET kinase assay kit|OGRPBCAM
language disorder|DOID_93
large cell medulloblastoma|OGRPBCAM
large intestine cancer|OGRPBCAM
large intestine lipoma|OGRPBCAM
laryngeal benign neoplasm|OGRPBCAM
laryngeal carcinoma|OGRPBCAM
laryngeal disease|DOID_786
laryngeal squamous cell carcinoma|OGRPBCAM
laryngeal tuberculosis|OGRPBCAM
laryngitis|OGRPBCAM
laryngostenosis|OGRPBCAM
laryngotracheitis|OGRPBCAM
larynx cancer|OGRPBCAM
larynx verrucous carcinoma|OGRPBCAM
laser|OGRPBCAM
laser capture microdissection microscope|OGRPBCAM
laser scanning confocal microscope|OGRPBCAM
latent syphilis|OGRPBCAM
lateral cystocele|OGRPBCAM
lateral sclerosis|DOID_230
lateral sinus thrombosis|OGRPBCAM
lattice corneal dystrophy|OGRPBCAM
laxative|OGRPBCAM
lead optimization assay|OGRPBCAM
learning disability|OGRPBCAM
legionellosis|OGRPBCAM
legume allergy|OGRPBCAM
leiomyoma|DOID_127
leiomyoma cutis|OGRPBCAM
leiomyomatosis|OGRPBCAM
leiomyosarcoma|OGRPBCAM
leishmaniasis|OGRPBCAM
length|OGRPBCAM
length unit|OGRPBCAM
lens disease|DOID_110
lens subluxation|OGRPBCAM
lepidopteran inhibitor of chitin biosynthesis|OGRPBCAM
leprostatic drug|OGRPBCAM
leprosy|OGRPBCAM
leptospirosis|OGRPBCAM
lethal midline granuloma|OGRPBCAM
leukemia|OGRPBCAM
leukocoria|OGRPBCAM
leukocyte adhesion deficiency|OGRPBCAM
leukocyte disease|OGRPBCAM
leukodystrophy|OGRPBCAM
leukopenia|DOID_615
leukorrhea|OGRPBCAM
leukostasis|OGRPBCAM
leukotriene antagonist|OGRPBCAM
library design|OGRPBCAM
lice infestation|OGRPBCAM
lichen disease|OGRPBCAM
lichen metabolite|OGRPBCAM
lichen nitidus|OGRPBCAM
lichen planus|OGRPBCAM
life cycle stage|OGRPBCAM
ligand|OGRPBCAM
ligand based pharmacophore model|OGRPBCAM
ligand based virtual screening|OGRPBCAM
ligand binding mode of action|OGRPBCAM
ligand covalent binding method|OGRPBCAM
ligand function mode of action|OGRPBCAM
ligase|OGRPBCAM
light source|OGRPBCAM
light-emitting diode|OGRPBCAM
limb-girdle muscular dystrophy|OGRPBCAM
linear QSAR|OGRPBCAM
lip cancer|OGRPBCAM
lip disease|OGRPBCAM
lipid|OGRPBCAM
lipid abundance method|OGRPBCAM
lipid kinase inhibitor|OGRPBCAM
lipid metabolism disorder|OGRPBCAM
lipid pneumonia|OGRPBCAM
lipid storage disease|OGRPBCAM
lipid-rich carcinoma|OGRPBCAM
lipoadenoma|OGRPBCAM
lipodystrophy|DOID_811
lipofectamine 2000|OGRPBCAM
lipofectin|OGRPBCAM
lipoid proteinosis|OGRPBCAM
lipoma|OGRPBCAM
lipoma of colon|OGRPBCAM
lipomatosis|OGRPBCAM
lipomatous cancer|OGRPBCAM
lipophilicity assay|OGRPBCAM
lipopolysaccharide|OGRPBCAM
lipopolysaccharide biosynthesis inhibitor|OGRPBCAM
liposarcoma|OGRPBCAM
liposome format|OGRPBCAM
liposome reconstitution|OGRPBCAM
lipoxygenase inhibitor|OGRPBCAM
liquid chromatography |OGRPBCAM
liquid chromatography-tandem mass spectrometry|OGRPBCAM
liquid phase|OGRPBCAM
lissencephaly|OGRPBCAM
listeriosis|OGRPBCAM
lithium chloride|OGRPBCAM
liver|OGRPBCAM
liver X receptor agonist|OGRPBCAM
liver X receptor inverse agonist|OGRPBCAM
liver benign neoplasm|DOID_916
liver cancer|OGRPBCAM
liver carcinoma|DOID_686
liver cirrhosis|OGRPBCAM
liver disease|DOID_409
liver inflammatory pseudotumor|DOID_918
liver sarcoma|DOID_270
ln|OGRPBCAM
lobular neoplasia|OGRPBCAM
local anaesthetic|OGRPBCAM
local minimum search|OGRPBCAM
local sequence alignment|OGRPBCAM
localization assay|OGRPBCAM
localized|OGRPBCAM
localized osteosarcoma|OGRPBCAM
localized scleroderma|OGRPBCAM
locked-in syndrome|OGRPBCAM
log|OGRPBCAM
log change|OGRPBCAM
log10 molar|OGRPBCAM
logD|OGRPBCAM
logP|OGRPBCAM
loiasis|OGRPBCAM
long QT syndrome|OGRPBCAM
loop diuretic|OGRPBCAM
louping ill|OGRPBCAM
low compliance bladder|OGRPBCAM
low signal control|OGRPBCAM
low tension glaucoma|OGRPBCAM
low throughput screening|OGRPBCAM
low-grade glioma|OGRPBCAM
lower respiratory tract disease|OGRPBCAM
luciferase enzyme activity assay|OGRPBCAM
luciferase enzyme activity measurement method|OGRPBCAM
luciferase gene|OGRPBCAM
luciferase induction|OGRPBCAM
luciferase reporter gene assay|OGRPBCAM
luciferin|OGRPBCAM
luciferin 6-ME|OGRPBCAM
luciferin coupled enzyme activity measurement method|OGRPBCAM
luciferin-BE|OGRPBCAM
luciferin-H|OGRPBCAM
luciferin-H EGE|OGRPBCAM
luciferin-PPXE|OGRPBCAM
luminescence ligand binding method|OGRPBCAM
luminescence method|OGRPBCAM
lumiphore|OGRPBCAM
lung|OGRPBCAM
lung adenoma|OGRPBCAM
lung benign neoplasm|OGRPBCAM
lung cancer|OGRPBCAM
lung carcinoma|OGRPBCAM
lung carcinoma in situ|OGRPBCAM
lung disease|DOID_850
lung large cell carcinoma|OGRPBCAM
lung lymphoma|OGRPBCAM
lung non-small cell carcinoma|OGRPBCAM
lung sarcoma|OGRPBCAM
lung small cell carcinoma|OGRPBCAM
lung squamous cell carcinoma|OGRPBCAM
lupus erythematosus|OGRPBCAM
luteoma|OGRPBCAM
lyase|OGRPBCAM
lyase activity assay|OGRPBCAM
lymph|OGRPBCAM
lymph node disease|OGRPBCAM
lymph node tuberculosis|OGRPBCAM
lymphadenitis|OGRPBCAM
lymphangioleiomyomatosis|OGRPBCAM
lymphangioma|OGRPBCAM
lymphangiosarcoma|OGRPBCAM
lymphangitis|OGRPBCAM
lymphatic system cancer|OGRPBCAM
lymphatic system disease|DOID_75
lymphedema|OGRPBCAM
lymphocele|OGRPBCAM
lymphocyte function-associated antigen-1 antagonist|OGRPBCAM
lymphocytic choriomeningitis|OGRPBCAM
lymphocytic gastritis|OGRPBCAM
lymphogranuloma venereum|OGRPBCAM
lymphoid leukemia|OGRPBCAM
lymphoma|OGRPBCAM
lymphopenia|DOID_614
lymphoplasmacyte-rich meningioma|OGRPBCAM
lysate array|OGRPBCAM
lysate based|OGRPBCAM
lysine ligand covalent binding method|OGRPBCAM
lysophosphatidic acid receptor 3 agonist|OGRPBCAM
lysophosphatidic acid receptor antagonist|OGRPBCAM
lysophosphatidylinositol|OGRPBCAM
lysosomal and lipase deficiency|OGRPBCAM
lysosomal storage disease|OGRPBCAM
lysosome|OGRPBCAM
mRNA|OGRPBCAM
mTOR inhibitor|OGRPBCAM
macrocytic anemia|OGRPBCAM
macroglobulinemia|OGRPBCAM
macronutrient|OGRPBCAM
macrophage migration inhibitory factor inhibitor|OGRPBCAM
macular corneal dystrophy|OGRPBCAM
macular degeneration|OGRPBCAM
macular holes|OGRPBCAM
macular retinal edema|OGRPBCAM
mad-score normalization|OGRPBCAM
magnesium chloride|OGRPBCAM
major depressive disorder|OGRPBCAM
malachite green|OGRPBCAM
malaria|OGRPBCAM
male|OGRPBCAM
male infertility|OGRPBCAM
male reproductive organ benign neoplasm|OGRPBCAM
male reproductive organ cancer|OGRPBCAM
male reproductive system disease|DOID_48
malignant adenoma|OGRPBCAM
malignant cystadenoma|OGRPBCAM
malignant ependymoma|OGRPBCAM
malignant exocrine pancreas neoplasm|OGRPBCAM
malignant fibrous histiocytoma|OGRPBCAM
malignant glioma|OGRPBCAM
malignant granular cell myoblastoma|OGRPBCAM
malignant hyperthermia|OGRPBCAM
malignant mesenchymoma|OGRPBCAM
malignant mesothelioma|OGRPBCAM
malignant ovarian Brenner tumor|OGRPBCAM
malignant ovarian surface epithelial-stromal neoplasm|OGRPBCAM
malignant peripheral nerve sheath tumor|OGRPBCAM
malignant pleural mesothelioma|OGRPBCAM
malignant syringoma|OGRPBCAM
malignant triton tumor|OGRPBCAM
mammalian|OGRPBCAM
mammalian metabolite|OGRPBCAM
mammalian two-hybrid assay|OGRPBCAM
mammalian vulva|OGRPBCAM
mammary Paget's disease|OGRPBCAM
mandibular cancer|OGRPBCAM
mantle cell lymphoma|OGRPBCAM
manufacturer role|OGRPBCAM
maple syrup urine disease|OGRPBCAM
marginal zone B-cell lymphoma|OGRPBCAM
marine metabolite|OGRPBCAM
marine xenobiotic metabolite|OGRPBCAM
mass balance assay|OGRPBCAM
mass per unit volume|OGRPBCAM
mass percentage|OGRPBCAM
mass spectrometer degradation product|OGRPBCAM
mass spectrometry|OGRPBCAM
mast cell neoplasm|OGRPBCAM
mast-cell leukemia|OGRPBCAM
mast-cell sarcoma|DOID_355
mastitis|OGRPBCAM
mastocytosis|DOID_350
matching molecular models obtained from theory|OGRPBCAM
material entity|OGRPBCAM
matrix metalloproteinase inhibitor|OGRPBCAM
mature B-cell neoplasm|DOID_706
mature T-cell and NK-cell lymphoma|OGRPBCAM
mature cataract|OGRPBCAM
mature teratoma|OGRPBCAM
maturity-onset diabetes of the young|OGRPBCAM
max fold increase|OGRPBCAM
maxillary sinusitis|OGRPBCAM
maximal activation|OGRPBCAM
maximal effect|OGRPBCAM
maximal inhibition|OGRPBCAM
mean|OGRPBCAM
measles|OGRPBCAM
measure group|OGRPBCAM
measure group specification|OGRPBCAM
measured concentration|OGRPBCAM
measured entity|OGRPBCAM
measured profile|OGRPBCAM
measured value|OGRPBCAM
mechanical nociception assay|OGRPBCAM
meconium aspiration syndrome|OGRPBCAM
media binding assay|OGRPBCAM
media component|OGRPBCAM
median|OGRPBCAM
median neuropathy|DOID_571
median rhomboid glossitis|OGRPBCAM
mediastinitis|DOID_819
medium throughput screening|OGRPBCAM
medulloblastoma|OGRPBCAM
medulloepithelioma|OGRPBCAM
medullomyoblastoma|OGRPBCAM
megacolon|OGRPBCAM
megaloblastic anemia|OGRPBCAM
meiotic G1 phase|OGRPBCAM
meiotic G2 phase|OGRPBCAM
meiotic M phase|OGRPBCAM
meiotic S phase|OGRPBCAM
meiotic cell cycle|OGRPBCAM
meiotic cell cycle state assay|OGRPBCAM
melancholia|OGRPBCAM
melanin synthesis inhibitor|OGRPBCAM
melanin-concentrating hormone receptor antagonist|OGRPBCAM
melanoacanthoma|OGRPBCAM
melanoma|OGRPBCAM
melanomatosis|OGRPBCAM
melanotic neurilemmoma|OGRPBCAM
melanotic neuroectodermal tumor|DOID_166
melatonin receptor agonist|OGRPBCAM
melatonin receptor antagonist|OGRPBCAM
melioidosis|OGRPBCAM
melorheostosis|OGRPBCAM
membrane permeability assessment|OGRPBCAM
membrane potential assay|OGRPBCAM
membrane potential measurement method|OGRPBCAM
membrane protein|OGRPBCAM
membrane transport modulator|OGRPBCAM
membranoproliferative glomerulonephritis|OGRPBCAM
membranous glomerulonephritis|OGRPBCAM
meningioma|OGRPBCAM
meningitis|OGRPBCAM
meningocele|OGRPBCAM
meningoencephalitis|OGRPBCAM
mental depression|OGRPBCAM
meperfluthrin|OGRPBCAM
mercury-vapor lamp|OGRPBCAM
mesenchymal cell neoplasm|OGRPBCAM
mesenchymal chondrosarcoma|OGRPBCAM
mesenchymoma|OGRPBCAM
metabaloid profile|OGRPBCAM
metabolic acidosis|OGRPBCAM
metabolic stability assay|OGRPBCAM
metabolite|OGRPBCAM
metabolite abundance method|OGRPBCAM
metabolite identification and profiling assay|OGRPBCAM
metabolomic assay|OGRPBCAM
metabolomic profiling assay|OGRPBCAM
metabotropic glutamate receptor agonist|OGRPBCAM
metabotropic glutamate receptor antagonist|OGRPBCAM
metachromatic leukodystrophy|OGRPBCAM
metagonimiasis|DOID_884
metal ion redistribution assay|OGRPBCAM
metal metabolism disorder|DOID_896
metal salt|OGRPBCAM
metal vapor laser|OGRPBCAM
metanephric adenoma|OGRPBCAM
metaphyseal dysplasia|OGRPBCAM
metastasis assay|OGRPBCAM
metazoa|OGRPBCAM
meter|OGRPBCAM
metformin|OGRPBCAM
methemoglobinemia|OGRPBCAM
methionine aminopeptidase 2 inhibitor|OGRPBCAM
methionine ligand covalent binding method|OGRPBCAM
method development and validation|OGRPBCAM
methylated|OGRPBCAM
methylated histone assay|OGRPBCAM
methyllycaconitine citrate|OGRPBCAM
methylmalonic acidemia|OGRPBCAM
mevalonate|OGRPBCAM
mevalonic aciduria|OGRPBCAM
miRNA|OGRPBCAM
miRNA library|OGRPBCAM
micro-Quant Plate Reader (BioTek)|OGRPBCAM
microarray analysis reagent|OGRPBCAM
microcephaly|OGRPBCAM
microcystic adenoma|OGRPBCAM
microelectrode measurement|OGRPBCAM
micrometer|OGRPBCAM
micromolar|OGRPBCAM
micronucleus assay|OGRPBCAM
micronutrient|OGRPBCAM
microphthalmia|OGRPBCAM
microplate|OGRPBCAM
microscope|OGRPBCAM
microscope slide|OGRPBCAM
microscopy|OGRPBCAM
microsecond|OGRPBCAM
microsomal binding assay|OGRPBCAM
microsomal stability assay|OGRPBCAM
microsome format|OGRPBCAM
microsporidiosis|OGRPBCAM
microtubule-destabilising agent|OGRPBCAM
microtubule-stabilising agent|OGRPBCAM
micturition assay|OGRPBCAM
micturition assessment method|OGRPBCAM
mid-infrared imaging|OGRPBCAM
midazolam|OGRPBCAM
middle cerebral artery infarction|OGRPBCAM
middle ear adenoma|OGRPBCAM
middle ear disease|OGRPBCAM
migraine|OGRPBCAM
migraine with aura|OGRPBCAM
migraine without aura|OGRPBCAM
miliaria|OGRPBCAM
miliaria rubra|OGRPBCAM
millimeter|OGRPBCAM
millimolar|OGRPBCAM
millisecond|OGRPBCAM
mimotope|OGRPBCAM
mineral metabolism disease|OGRPBCAM
minute|OGRPBCAM
miotic|OGRPBCAM
mite growth regulator|OGRPBCAM
mite infestation|OGRPBCAM
mitochondrial DNA depletion syndrome|OGRPBCAM
mitochondrial DNA depletion syndrome 7|OGRPBCAM
mitochondrial NADH:ubiquinone reductase inhibitor|OGRPBCAM
mitochondrial calcium uniporter inhibitor|OGRPBCAM
mitochondrial cytochrome-bc1 complex inhibitor|OGRPBCAM
mitochondrial encephalomyopathy|DOID_890
mitochondrial membrane potential assay|OGRPBCAM
mitochondrial membrane potential assessment|OGRPBCAM
mitochondrial metabolism disease|DOID_700
mitochondrial myopathy|DOID_699
mitochondrial respiratory-chain inhibitor|OGRPBCAM
mitochondrion|OGRPBCAM
mitochondrion format|OGRPBCAM
mitogen|OGRPBCAM
mitosis/apoptosis assay|OGRPBCAM
mitotic G1 phase|OGRPBCAM
mitotic G2 phase|OGRPBCAM
mitotic M phase|OGRPBCAM
mitotic S phase|OGRPBCAM
mitotic cell cycle|OGRPBCAM
mitotic cell cycle state assay|OGRPBCAM
mitral valve disease|DOID_61
mitral valve insufficiency|OGRPBCAM
mitral valve prolapse|DOID_988
mitral valve stenosis|OGRPBCAM
mixed|OGRPBCAM
mixed argon-krypton gas laser|OGRPBCAM
mixed cell type cancer|DOID_154
mixed connective tissue disease|OGRPBCAM
mixed endometrial stromal and smooth muscle tumor|OGRPBCAM
mixed glioma|OGRPBCAM
mixed gonadal dysgenesis|OGRPBCAM
mixed malaria|OGRPBCAM
mixture of perturbagens|OGRPBCAM
mobility shift assessment method|OGRPBCAM
mode of action|OGRPBCAM
modification method|OGRPBCAM
modified neglect of differential overlap|OGRPBCAM
modulation|OGRPBCAM
molar|OGRPBCAM
molar attenuation coefficient|OGRPBCAM
molecular abundance method|OGRPBCAM
molecular beacon|OGRPBCAM
molecular docking|OGRPBCAM
molecular docking by method|OGRPBCAM
molecular docking by scoring function|OGRPBCAM
molecular dynamics simulation|OGRPBCAM
molecular entity|OGRPBCAM
molecular expression phenotype|OGRPBCAM
molecular function|OGRPBCAM
molecular localization phenotype|OGRPBCAM
molecular messenger|OGRPBCAM
molecular phenotype|OGRPBCAM
molecular quality|OGRPBCAM
molecular redistribution determination method|OGRPBCAM
molecular structure|OGRPBCAM
molluscicide|OGRPBCAM
molluscum contagiosum|OGRPBCAM
mongolian spot|OGRPBCAM
monilethrix|OGRPBCAM
monkeypox|OGRPBCAM
monoamine oxidase inhibition assay|OGRPBCAM
monoclonal|OGRPBCAM
monoclonal gammopathy of uncertain significance|OGRPBCAM
monocytic leukemia|OGRPBCAM
monodermal teratoma|OGRPBCAM
monogenic disease|OGRPBCAM
monolignol|OGRPBCAM
mononeuritis|OGRPBCAM
mononeuritis of upper limb and mononeuritis multiplex|DOID_572
mononeuropathy|OGRPBCAM
montelukast|OGRPBCAM
month|OGRPBCAM
mood disorder|OGRPBCAM
morbid obesity|OGRPBCAM
mordant|OGRPBCAM
morphine dependence|OGRPBCAM
morpholino oligonucleotide|OGRPBCAM
morphological phenotype|OGRPBCAM
morphology|OGRPBCAM
morphology assessment method|OGRPBCAM
morphometric parameter|OGRPBCAM
motion sickness|OGRPBCAM
motor neuron disease|DOID_231
motor peripheral neuropathy|OGRPBCAM
mouse metabolite|OGRPBCAM
mouse vas deferens (MVD) assay|OGRPBCAM
mouth disease|DOID_403
movement disease|DOID_480
mu chain disease|OGRPBCAM
mu-opioid agent|OGRPBCAM
mu-opioid receptor agonist|OGRPBCAM
mu-opioid receptor antagonist|OGRPBCAM
mucinoses|OGRPBCAM
mucinous adenocarcinoma|OGRPBCAM
mucinous cystadenocarcinoma|OGRPBCAM
mucocele of salivary gland|OGRPBCAM
mucocutaneous leishmaniasis|OGRPBCAM
mucoepidermoid carcinoma|OGRPBCAM
mucolipidosis|OGRPBCAM
mucolytic|OGRPBCAM
mucopolysaccharidosis|OGRPBCAM
mucopolysaccharidosis III|OGRPBCAM
mucopolysaccharidosis IV|OGRPBCAM
mucopolysaccharidosis VI|OGRPBCAM
mucosulfatidosis|OGRPBCAM
mulibrey nanism|OGRPBCAM
multi parameter readout|OGRPBCAM
multi-localised|OGRPBCAM
multicellular anatomical structure|OGRPBCAM
multicellular fungi|OGRPBCAM
multicentric reticulohistiocytosis|OGRPBCAM
multichannel ion channel screening|OGRPBCAM
multidrug-resistant tuberculosis|DOID_401
multilocular clear cell renal cell carcinoma|OGRPBCAM
multiple carboxylase deficiency|DOID_857
multiple chemical sensitivity|OGRPBCAM
multiple concentration|OGRPBCAM
multiple cranial nerve palsy|OGRPBCAM
multiple endocrine neoplasia|OGRPBCAM
multiple endocrine neoplasia type 1|OGRPBCAM
multiple endocrine neoplasia type 2A|OGRPBCAM
multiple epiphyseal dysplasia|OGRPBCAM
multiple intestinal atresia|OGRPBCAM
multiple myeloma|OGRPBCAM
multiple personality disorder|OGRPBCAM
multiple repetition|OGRPBCAM
multiple sclerosis|OGRPBCAM
multiple sequence alignment|OGRPBCAM
multiple system atrophy|OGRPBCAM
multiplexed readout|OGRPBCAM
mumps|OGRPBCAM
muscarinic agonist|OGRPBCAM
muscarinic antagonist|OGRPBCAM
muscle benign neoplasm|DOID_461
muscle cancer|OGRPBCAM
muscle relaxant|OGRPBCAM
muscle tissue|OGRPBCAM
muscle tissue disease|DOID_66
muscular atrophy|DOID_767
muscular disease|OGRPBCAM
muscular dystrophy|OGRPBCAM
muscular dystrophy-dystroglycanopathy|OGRPBCAM
musculoskeletal system benign neoplasm|OGRPBCAM
musculoskeletal system cancer|OGRPBCAM
musculoskeletal system disease|DOID_17
mutagen|OGRPBCAM
mutated|OGRPBCAM
mutism|OGRPBCAM
mutually spatially disjoint with|OGRPBCAM
myasthenia gravis|DOID_437
myc tag|OGRPBCAM
mycoestrogen|OGRPBCAM
mycosis fungoides|OGRPBCAM
mycotoxin|OGRPBCAM
mydriatic agent|OGRPBCAM
myelitis|DOID_322
myelodysplastic/myeloproliferative neoplasm|OGRPBCAM
myelofibrosis|OGRPBCAM
myeloid leukemia|OGRPBCAM
myeloid neoplasm|OGRPBCAM
myeloid sarcoma|OGRPBCAM
myelophthisic anemia|OGRPBCAM
myeloproliferative neoplasm|OGRPBCAM
myiasis|OGRPBCAM
myoblastoma|OGRPBCAM
myocardial infarction|OGRPBCAM
myocardial stunning|OGRPBCAM
myocarditis|DOID_820
myoepithelial carcinoma|OGRPBCAM
myoepithelioma|OGRPBCAM
myofascial pain syndrome|DOID_431
myofibroma|OGRPBCAM
myoma|OGRPBCAM
myopathy|DOID_423
myopia|OGRPBCAM
myositis|DOID_633
myositis ossificans|DOID_668
myotonia congenita|OGRPBCAM
myotonic disease|DOID_450
myotonic dystrophy type 1|OGRPBCAM
myotonic dystrophy type 2|OGRPBCAM
myxoid liposarcoma|OGRPBCAM
nail disease|OGRPBCAM
nail-patella syndrome|OGRPBCAM
nanometer|OGRPBCAM
nanomolar|OGRPBCAM
nanosecond|OGRPBCAM
narcissistic personality disorder|OGRPBCAM
nasal cavity cancer|OGRPBCAM
nasal cavity disease|OGRPBCAM
nasal cavity lymphoma|OGRPBCAM
nasal cavity squamous cell carcinoma|OGRPBCAM
nasal decongestant|OGRPBCAM
nasopharyngeal disease|OGRPBCAM
nasopharyngitis|OGRPBCAM
nasopharynx carcinoma|OGRPBCAM
native conformation|OGRPBCAM
native form|OGRPBCAM
native promoter region|OGRPBCAM
natural language processing|OGRPBCAM
near-infrared imaging|OGRPBCAM
necatoriasis|OGRPBCAM
necroptosis inhibitor|OGRPBCAM
necrosis of pituitary|OGRPBCAM
necrotic cell death|OGRPBCAM
necrotic cell phenotype|OGRPBCAM
necrotizing fasciitis|OGRPBCAM
necrotizing sialometaplasia|OGRPBCAM
negative allosteric modulation|OGRPBCAM
negative control|OGRPBCAM
negative log10 molar|OGRPBCAM
negative regulation of catalytic activity|OGRPBCAM
negative regulation of lipid storage|OGRPBCAM
negative regulation of membrane potential|OGRPBCAM
nemaline myopathy|OGRPBCAM
nematicide|OGRPBCAM
nematode metabolite|OGRPBCAM
neoantigen|OGRPBCAM
neodymium-yttrium aluminum garnet laser|OGRPBCAM
neoglycolipid probe|OGRPBCAM
neonatal abstinence syndrome|OGRPBCAM
neonatal anemia|OGRPBCAM
neonatal candidiasis|OGRPBCAM
neonatal diabetes|OGRPBCAM
neonatal jaundice|OGRPBCAM
neonatal period electroclinical syndrome|OGRPBCAM
neonatal thyrotoxicosis|OGRPBCAM
neonicotinoid insectide|OGRPBCAM
neovascular glaucoma|OGRPBCAM
neovascular inflammatory vitreoretinopathy|OGRPBCAM
nephritis|OGRPBCAM
nephroblastoma|OGRPBCAM
nephrocalcinosis|OGRPBCAM
nephrogenic adenofibroma|OGRPBCAM
nephrogenic adenoma|OGRPBCAM
nephrogenic adenoma of urinary bladder|OGRPBCAM
nephrogenic diabetes insipidus|OGRPBCAM
nephrolithiasis|DOID_585
nephroma|OGRPBCAM
nephronophthisis|OGRPBCAM
nephroprotective agent|OGRPBCAM
nephrosis|OGRPBCAM
nephrotic syndrome|OGRPBCAM
nephrotoxic agent|OGRPBCAM
nephrotoxicity biomarker assay|OGRPBCAM
nephrotoxin|OGRPBCAM
nerve compression syndrome|DOID_573
nerve growth factor stimulator|OGRPBCAM
nervous system|OGRPBCAM
nervous system benign neoplasm|OGRPBCAM
nervous system cancer|OGRPBCAM
nervous system disease|DOID_863
network analysis|OGRPBCAM
neural network QSAR|OGRPBCAM
neural network model|OGRPBCAM
neural tube defect|OGRPBCAM
neurilemmoma|OGRPBCAM
neurite blebbing|OGRPBCAM
neurite branching|OGRPBCAM
neurite outgrowth|OGRPBCAM
neurite outgrowth assay|OGRPBCAM
neurite shortening|OGRPBCAM
neuritis|OGRPBCAM
neuroacanthocytosis|OGRPBCAM
neuroaxonal dystrophy|OGRPBCAM
neuroblastoma|DOID_769
neurocirculatory asthenia|OGRPBCAM
neurodegeneration with brain iron accumulation|OGRPBCAM
neurodegenerative disease|OGRPBCAM
neuroectodermal tumor|DOID_171
neuroendocrine carcinoma|OGRPBCAM
neuroendocrine tumor|DOID_169
neurofibroma|DOID_962
neurofibromatosis|OGRPBCAM
neurofibrosarcoma|OGRPBCAM
neurogenic bladder|OGRPBCAM
neurohypophyseal diabetes insipidus|OGRPBCAM
neurokinin-1 receptor agonist|OGRPBCAM
neurokinin-1 receptor antagonist|OGRPBCAM
neurokinin-3 receptor antagonist|OGRPBCAM
neuroleptic malignant syndrome|OGRPBCAM
neuroma|OGRPBCAM
neuromuscular agent|OGRPBCAM
neuromuscular disease|DOID_440
neuromuscular junction disease|DOID_439
neuromyelitis optica|OGRPBCAM
neuron development|OGRPBCAM
neuron projection|OGRPBCAM
neuron projection development|OGRPBCAM
neuron projection morphogenesis|OGRPBCAM
neuron projection regeneration|OGRPBCAM
neuronal cell phenotype|OGRPBCAM
neuronal ceroid lipofuscinosis|OGRPBCAM
neuronal ceroid lipofuscinosis 3|OGRPBCAM
neuronal morphology phenotype|OGRPBCAM
neuropathy|DOID_870
neuropeptide FF receptor agonist|OGRPBCAM
neuropeptide FF receptor antagonist|OGRPBCAM
neuropeptide Y receptor antagonist|OGRPBCAM
neuropeptide Y2 receptor agonist|OGRPBCAM
neuropilin receptor antagonist|OGRPBCAM
neuroprotective agent|OGRPBCAM
neuroschistosomiasis|OGRPBCAM
neurotic disorder|OGRPBCAM
neurotic excoriation|OGRPBCAM
neurotoxin|OGRPBCAM
neurotransmitter|OGRPBCAM
neurotransmitter agent|OGRPBCAM
neurotransmitter secretion|OGRPBCAM
neurotransmitter transporter modulator|OGRPBCAM
neutral lipid storage disease|OGRPBCAM
neutropenia|OGRPBCAM
never in taxon|OGRPBCAM
nevoid basal cell carcinoma syndrome|OGRPBCAM
new mexico molecular libraries screening center|OGRPBCAM
newborn respiratory distress syndrome|OGRPBCAM
nicotine dependence|OGRPBCAM
nicotinic acetylcholine receptor agonist|OGRPBCAM
nicotinic acid adenine dinucleotide phosphate receptor antagonist|OGRPBCAM
nicotinic antagonist|OGRPBCAM
nifedipine|OGRPBCAM
night blindness|OGRPBCAM
nitric oxide donor|OGRPBCAM
nitric oxide synthase activator|OGRPBCAM
nitrification inhibitor|OGRPBCAM
nitrogen laser|OGRPBCAM
nmol/sec|OGRPBCAM
nocardiosis|OGRPBCAM
nodular basal cell carcinoma|OGRPBCAM
nodular hidradenoma|OGRPBCAM
nodular malignant melanoma|OGRPBCAM
nodular tenosynovitis|OGRPBCAM
nodulation factor|OGRPBCAM
non-Hodgkin lymphoma|OGRPBCAM
non-Langerhans-cell histiocytosis|OGRPBCAM
non-competitive binding|OGRPBCAM
non-competitive inhibition|OGRPBCAM
non-invasive bladder papillary urothelial neoplasm|OGRPBCAM
non-linear QSAR|OGRPBCAM
non-mammalian|OGRPBCAM
non-narcotic analgesic|OGRPBCAM
non-polar solvent|OGRPBCAM
non-rodent IV clearance|OGRPBCAM
non-rodent IV half-life|OGRPBCAM
non-rodent PK|OGRPBCAM
non-rodent Vdss|OGRPBCAM
non-rodent excretion in urine|OGRPBCAM
non-rodent oral bioavailability|OGRPBCAM
non-rodent oral half-life|OGRPBCAM
non-specific protein binding assay|OGRPBCAM
non-steroidal anti-inflammatory drug|OGRPBCAM
non-suppurative otitis media|OGRPBCAM
non-syndromic X-linked intellectual disability|OGRPBCAM
non-syndromic intellectual disability|OGRPBCAM
nonepidermolytic palmoplantar keratoderma|OGRPBCAM
nonionic surfactant|OGRPBCAM
nonnucleoside hepatitis C virus polymerase inhibitor|OGRPBCAM
nonphotosensitive trichothiodystrophy|OGRPBCAM
nonphotosensitive trichothiodystrophy 4|OGRPBCAM
nonstructural protein 5A inhibitor|OGRPBCAM
nonsyndromic deafness|OGRPBCAM
nootropic agent|OGRPBCAM
normal pressure hydrocephalus|OGRPBCAM
normalization based on control|OGRPBCAM
normalization without control|OGRPBCAM
normalized data|OGRPBCAM
normocytic anemia|DOID_720
norwegian scabies|OGRPBCAM
nose disease|OGRPBCAM
notochordal cancer|OGRPBCAM
nuclear envelope|OGRPBCAM
nuclear extract format|OGRPBCAM
nuclear fuel|OGRPBCAM
nuclear magnetic resonance|OGRPBCAM
nuclear membrane potential assay|OGRPBCAM
nuclear receptor|OGRPBCAM
nuclear receptor modulator|OGRPBCAM
nucleic acid|OGRPBCAM
nucleic acid amplification method|OGRPBCAM
nucleic acid array|OGRPBCAM
nucleic acid array method|OGRPBCAM
nucleic acid conformation assessment|OGRPBCAM
nucleic acid format|OGRPBCAM
nucleic acid hybridization-based method|OGRPBCAM
nucleic acid identification and quantitation method|OGRPBCAM
nucleic acid sequencing method|OGRPBCAM
nucleophilic reagent|OGRPBCAM
nucleoside antibiotic|OGRPBCAM
nucleosome|OGRPBCAM
nucleosome format|OGRPBCAM
nucleotide|OGRPBCAM
nucleus|OGRPBCAM
nutraceutical|OGRPBCAM
nutrient|OGRPBCAM
nutrition disease|DOID_374
nutritional deficiency disease|OGRPBCAM
obesity|OGRPBCAM
objective lens|OGRPBCAM
obsessive-compulsive personality disorder|OGRPBCAM
obsolete MAPK import into nucleus|OGRPBCAM
obsolete bright|OGRPBCAM
obsolete glucocorticoid receptor import into nucleus|OGRPBCAM
obsolete steroid hormone receptor import into nucleus|OGRPBCAM
obsolete transcription factor import into nucleus|OGRPBCAM
obsolete: U87 MG cell|OGRPBCAM
obsolete_fetus|OGRPBCAM
obstructive lung disease|OGRPBCAM
occlusion of gallbladder|OGRPBCAM
occlusion precerebral artery|OGRPBCAM
occult macular dystrophy|OGRPBCAM
occurs in|OGRPBCAM
ochronosis|OGRPBCAM
octyl glucoside|OGRPBCAM
ocular albinism|OGRPBCAM
ocular cancer|OGRPBCAM
ocular hypertension|OGRPBCAM
ocular hypotension|DOID_790
ocular motility disease|OGRPBCAM
oculocerebrorenal syndrome|OGRPBCAM
oculocutaneous albinism|OGRPBCAM
odorant receptor agonist|OGRPBCAM
odorant receptor antagonist|OGRPBCAM
off plate control|OGRPBCAM
oil immersion lens|OGRPBCAM
olfactory nerve neoplasm|DOID_366
olfactory neuroblastoma|DOID_369
oligodendroglioma|OGRPBCAM
oligohydramnios|OGRPBCAM
oligonucleotide array|OGRPBCAM
oligospermia|OGRPBCAM
on plate control|OGRPBCAM
onchocerciasis|OGRPBCAM
one cell type|OGRPBCAM
one-colour indicator|OGRPBCAM
one-hybrid assay|OGRPBCAM
oneirogen|OGRPBCAM
oophoritis|OGRPBCAM
open-angle glaucoma|OGRPBCAM
ophthalmia neonatorum|OGRPBCAM
ophthalmology drug|OGRPBCAM
ophthalmomyiasis|OGRPBCAM
ophthalmoplegia|DOID_539
opiate dependence|OGRPBCAM
opioid abuse|OGRPBCAM
opioid agent|OGRPBCAM
opioid analgesic|OGRPBCAM
opioid receptor agonist|OGRPBCAM
opioid receptor antagonist|OGRPBCAM
opisthorchiasis|OGRPBCAM
opportunistic bacterial infectious disease|OGRPBCAM
opportunistic mycosis|OGRPBCAM
optic atrophy|OGRPBCAM
optic disk drusen|OGRPBCAM
optic nerve disease|OGRPBCAM
optic nerve glioma|OGRPBCAM
optic nerve neoplasm|OGRPBCAM
optic nerve sheath meningioma|OGRPBCAM
optic neuritis|OGRPBCAM
optical based|OGRPBCAM
optical microscope|OGRPBCAM
optical microscopy|OGRPBCAM
optical quality|OGRPBCAM
optical waveguide grating|OGRPBCAM
oral cavity cancer|OGRPBCAM
oral contraceptive|OGRPBCAM
oral submucous fibrosis|OGRPBCAM
orbital cancer|OGRPBCAM
orbital cellulitis|OGRPBCAM
orbital disease|DOID_930
orchitis|OGRPBCAM
orexin receptor antagonist|OGRPBCAM
organ|OGRPBCAM
organ bath method|OGRPBCAM
organ function assay|OGRPBCAM
organ system benign neoplasm|OGRPBCAM
organ system cancer|OGRPBCAM
organic acidemia|OGRPBCAM
organism|OGRPBCAM
organism behavior assay|OGRPBCAM
organism substance|OGRPBCAM
organism-based format|OGRPBCAM
organismal quality|OGRPBCAM
organization|OGRPBCAM
organization role|OGRPBCAM
ornithine carbamoyltransferase deficiency|OGRPBCAM
ornithine translocase deficiency|OGRPBCAM
ornithosis|OGRPBCAM
orofacial cleft|OGRPBCAM
orofaciodigital syndrome|OGRPBCAM
oropharynx cancer|OGRPBCAM
orphan drug|OGRPBCAM
orthogonal assay design|OGRPBCAM
orthogonal assay technology|OGRPBCAM
orthotopic tumor model|OGRPBCAM
osmolyte|OGRPBCAM
osmotic diuretic|OGRPBCAM
ossifying fibroma|DOID_180
ossifying fibromyxoid tumor|OGRPBCAM
osteitis fibrosa|OGRPBCAM
osteoarthritis|OGRPBCAM
osteoblastoma|OGRPBCAM
osteochondritis dissecans|DOID_84
osteochondrodysplasia|OGRPBCAM
osteochondrosis|OGRPBCAM
osteogenesis imperfecta|OGRPBCAM
osteogenesis regulator|OGRPBCAM
osteomalacia|OGRPBCAM
osteomyelitis|OGRPBCAM
osteonecrosis|OGRPBCAM
osteopetrosis|OGRPBCAM
osteopoikilosis|OGRPBCAM
osteoporosis|OGRPBCAM
osteosarcoma|OGRPBCAM
osteosclerosis|OGRPBCAM
ostertagiasis|OGRPBCAM
other pharmacokinetic studies|OGRPBCAM
otitis externa|OGRPBCAM
otitis interna|OGRPBCAM
otitis media|OGRPBCAM
otomycosis|OGRPBCAM
otosclerosis|OGRPBCAM
ovarian Brenner tumor|OGRPBCAM
ovarian benign neoplasm|OGRPBCAM
ovarian cancer|OGRPBCAM
ovarian carcinoma|OGRPBCAM
ovarian clear cell adenocarcinoma|OGRPBCAM
ovarian cystadenocarcinoma|OGRPBCAM
ovarian cystadenoma|OGRPBCAM
ovarian disease|OGRPBCAM
ovarian dysfunction|OGRPBCAM
ovarian germ cell cancer|OGRPBCAM
ovarian germ cell monodermal and highly specialized teratoma|OGRPBCAM
ovarian germ cell teratoma|OGRPBCAM
ovarian hyperstimulation syndrome|OGRPBCAM
ovarian mucinous adenocarcinoma|OGRPBCAM
ovarian mucinous adenofibroma|OGRPBCAM
ovarian mucinous cystadenocarcinoma|OGRPBCAM
ovarian mucinous neoplasm|OGRPBCAM
ovarian serous cystadenocarcinoma|OGRPBCAM
ovarian small cell carcinoma|OGRPBCAM
ovary|OGRPBCAM
ovary adenocarcinoma|OGRPBCAM
ovary epithelial cancer|OGRPBCAM
overnutrition|DOID_654
ovicide|OGRPBCAM
oxazepam|OGRPBCAM
oxidative phosphorylation assay|OGRPBCAM
oxidative phosphorylation inhibitor|OGRPBCAM
oxidative stress assay|OGRPBCAM
oxidising agent|OGRPBCAM
oxidized luciferins|OGRPBCAM
oxidoreductase|OGRPBCAM
oxidoreductase activity assay|OGRPBCAM
oxyphilic adenoma|OGRPBCAM
oxytocic|OGRPBCAM
p|OGRPBCAM
p-gp induction assay|OGRPBCAM
p53 activator|OGRPBCAM
p53 inhibitor|OGRPBCAM
pA2|OGRPBCAM
pEC50|OGRPBCAM
pH|OGRPBCAM
pH stability assay|OGRPBCAM
pIC50|OGRPBCAM
pKa|OGRPBCAM
pKa determination|OGRPBCAM
pKb|OGRPBCAM
pKd|OGRPBCAM
pKi|OGRPBCAM
pachyonychia congenita|OGRPBCAM
pain agnosia|OGRPBCAM
pain disorder|OGRPBCAM
pairwise sequence alignment|OGRPBCAM
palindromic rheumatism|OGRPBCAM
palmoplantar keratosis|OGRPBCAM
pancreas|OGRPBCAM
pancreas disease|DOID_26
pancreatic acinar cell adenocarcinoma|OGRPBCAM
pancreatic adenocarcinoma|OGRPBCAM
pancreatic cancer|OGRPBCAM
pancreatic carcinoma|OGRPBCAM
pancreatic cholera|OGRPBCAM
pancreatic cystadenocarcinoma|OGRPBCAM
pancreatic cystadenoma|OGRPBCAM
pancreatic ductal adenocarcinoma|OGRPBCAM
pancreatic endocrine carcinoma|OGRPBCAM
pancreatic gastrinoma|OGRPBCAM
pancreatic steatorrhea|OGRPBCAM
pancreatitis|OGRPBCAM
pancytopenia|OGRPBCAM
panel-assay profile endpoint|OGRPBCAM
panic disorder|DOID_594
panniculitis|OGRPBCAM
panophthalmitis|OGRPBCAM
pantothenate kinase-associated neurodegeneration|OGRPBCAM
panuveitis|OGRPBCAM
papillary adenocarcinoma|OGRPBCAM
papillary adenoma|OGRPBCAM
papillary ependymoma|OGRPBCAM
papillary renal cell carcinoma|OGRPBCAM
papillary transitional carcinoma|OGRPBCAM
papilledema|DOID_146
papilloma|OGRPBCAM
para-nitrophenol|OGRPBCAM
para-nitrophenylphosphate|OGRPBCAM
parachordoma|OGRPBCAM
paracoccidioidomycosis|OGRPBCAM
paraganglioma|OGRPBCAM
paragonimiasis|OGRPBCAM
parallel artificial membrane permeability assay|OGRPBCAM
paralytic squint|OGRPBCAM
parameterized model number 3|OGRPBCAM
parametritis|OGRPBCAM
paranasal sinus benign neoplasm|OGRPBCAM
paranasal sinus cancer|OGRPBCAM
paranasal sinus disease|OGRPBCAM
paranoid personality disorder|OGRPBCAM
paraphilia disorder|OGRPBCAM
paraplegia|DOID_607
parapsoriasis|OGRPBCAM
parasitic ectoparasitic infectious disease|OGRPBCAM
parasitic helminthiasis infectious disease|DOID_883
parasitic infectious disease|OGRPBCAM
parasitic protozoa infectious disease|OGRPBCAM
parasympatholytic|OGRPBCAM
parathyroid adenoma|OGRPBCAM
parathyroid carcinoma|OGRPBCAM
parathyroid gland benign neoplasm|OGRPBCAM
parathyroid gland disease|OGRPBCAM
paratyphoid fever|OGRPBCAM
parental cell line assay|OGRPBCAM
parotid disease|OGRPBCAM
parotid gland cancer|OGRPBCAM
parotitis|OGRPBCAM
parovarian cyst|OGRPBCAM
paroxetine|OGRPBCAM
part of|OGRPBCAM
partial activation|OGRPBCAM
partial agonism|OGRPBCAM
partial central choroid dystrophy|OGRPBCAM
partial fetal alcohol syndrome|OGRPBCAM
partial inhibition|OGRPBCAM
partial least squares QSAR|OGRPBCAM
partial prostacyclin agonist|OGRPBCAM
partially purified|OGRPBCAM
participates in|OGRPBCAM
pasteurellosis|OGRPBCAM
patch clamp|OGRPBCAM
patellar tendinitis|OGRPBCAM
patellofemoral pain syndrome|OGRPBCAM
patent ductus arteriosus|OGRPBCAM
patent foramen ovale|OGRPBCAM
pathogenic virus transduction method|OGRPBCAM
pathologic nystagmus|OGRPBCAM
pathological gambling|OGRPBCAM
pathway analysis|OGRPBCAM
pathway analysis by knowledge base|OGRPBCAM
pathway analysis by method|OGRPBCAM
pathway inhibitor|OGRPBCAM
patulous eustachian tube|OGRPBCAM
peanut allergy|OGRPBCAM
pediatric fibrosarcoma|OGRPBCAM
pediatric low-grade glioma|OGRPBCAM
pediculicide|OGRPBCAM
pedophilia|OGRPBCAM
peliosis hepatis|DOID_914
pellagra|OGRPBCAM
pelvic inflammatory disease|OGRPBCAM
pelvic lipomatosis|OGRPBCAM
pelvic varices|OGRPBCAM
pemphigoid gestationis|OGRPBCAM
pemphigus|OGRPBCAM
penile benign neoplasm|OGRPBCAM
penile cancer|OGRPBCAM
penile disease|OGRPBCAM
penis carcinoma|OGRPBCAM
people|OGRPBCAM
peptic ulcer disease|DOID_750
peptic ulcer perforation|DOID_752
peptide|OGRPBCAM
peptide allergen|OGRPBCAM
peptide aptamer|OGRPBCAM
peptide coupling reagent|OGRPBCAM
peptide probe|OGRPBCAM
peptide-aminoluciferin|OGRPBCAM
peptidomimetic|OGRPBCAM
peptoid|OGRPBCAM
percent|OGRPBCAM
percent DNA replicated cells|OGRPBCAM
percent G2 arrested cells|OGRPBCAM
percent activation|OGRPBCAM
percent activation normalization|OGRPBCAM
percent activity|OGRPBCAM
percent apoptotic cells|OGRPBCAM
percent bound|OGRPBCAM
percent cell viability|OGRPBCAM
percent change|OGRPBCAM
percent control|OGRPBCAM
percent control normalization|OGRPBCAM
percent cytotoxicity|OGRPBCAM
percent dead cells|OGRPBCAM
percent growth|OGRPBCAM
percent growth inhibition|OGRPBCAM
percent inhibition|OGRPBCAM
percent inhibition normalization|OGRPBCAM
percent interphase cells|OGRPBCAM
percent mitotic arrested cells|OGRPBCAM
percent mitotic cells|OGRPBCAM
percent neurite branch point|OGRPBCAM
percent neurite count|OGRPBCAM
percent neurite outgrowth|OGRPBCAM
percent non-arrested cells|OGRPBCAM
percent protection|OGRPBCAM
percent purity|OGRPBCAM
percent recovery|OGRPBCAM
percent remaining|OGRPBCAM
percent response|OGRPBCAM
periapical periodontitis|DOID_823
pericardial effusion|DOID_118
pericardial mesothelioma|OGRPBCAM
pericarditis|OGRPBCAM
pericardium cancer|DOID_116
pericardium disease|OGRPBCAM
perinatal necrotizing enterocolitis|OGRPBCAM
perinephritis|OGRPBCAM
perineurioma|OGRPBCAM
periodontal disease|OGRPBCAM
periodontitis|DOID_824
peripheral T-cell lymphoma|OGRPBCAM
peripheral nerve sheath neoplasm|OGRPBCAM
peripheral nervous system benign neoplasm|OGRPBCAM
peripheral nervous system disease|DOID_574
peripheral nervous system drug|OGRPBCAM
peripheral nervous system neoplasm|OGRPBCAM
peripheral osteosarcoma|OGRPBCAM
peripheral retinal degeneration|OGRPBCAM
peripheral vascular disease|DOID_341
peripheral vertigo|OGRPBCAM
peritoneal carcinoma|OGRPBCAM
peritoneal mesothelioma|OGRPBCAM
peritoneum cancer|OGRPBCAM
peritonitis|OGRPBCAM
perivascular epithelioid cell tumor|OGRPBCAM
perivascular tumor|OGRPBCAM
periventricular leukomalacia|OGRPBCAM
periventricular nodular heterotopia|OGRPBCAM
permanent cell line|OGRPBCAM
permeability assay|OGRPBCAM
permeable|OGRPBCAM
pernicious anemia|OGRPBCAM
peroneal nerve paralysis|OGRPBCAM
peroneal neuropathy|OGRPBCAM
peroxisomal biogenesis disorder|OGRPBCAM
peroxisomal disease|DOID_906
persistent fetal circulation syndrome|OGRPBCAM
persistent organic pollutant|OGRPBCAM
personality disorder|OGRPBCAM
perturbagen|OGRPBCAM
perturbagen / positive control ratio endpoint|OGRPBCAM
perturbagen delivery method|OGRPBCAM
perturbagen library|OGRPBCAM
pertussis|OGRPBCAM
pervasive developmental disorder|OGRPBCAM
pesticide|OGRPBCAM
pesticide synergist|OGRPBCAM
petroclival meningioma|OGRPBCAM
phacogenic glaucoma|OGRPBCAM
phaeohyphomycosis|OGRPBCAM
phagocyte bactericidal dysfunction|OGRPBCAM
pharmaceutical|OGRPBCAM
pharmacodynamic assay|OGRPBCAM
pharmacokinetic assay|OGRPBCAM
pharmacological role|OGRPBCAM
pharmacometrics|OGRPBCAM
pharyngitis|OGRPBCAM
pharynx cancer|OGRPBCAM
phase contrast microscopy|OGRPBCAM
phase-transfer catalyst|OGRPBCAM
phenacetin|OGRPBCAM
phencyclidine abuse|OGRPBCAM
phenothiazine antipsychotic drug|OGRPBCAM
phenotype of|OGRPBCAM
phenotypic mode of action|OGRPBCAM
phenotypic switching|OGRPBCAM
phenoxy herbicide|OGRPBCAM
phenylketonuria|OGRPBCAM
pheochromocytoma|OGRPBCAM
pheromone|OGRPBCAM
phimosis|OGRPBCAM
phlyctenulosis|OGRPBCAM
phobic disorder|DOID_591
phorbol myristate acetate|OGRPBCAM
phosphatase|OGRPBCAM
phosphatase activity assay|OGRPBCAM
phosphate buffer|OGRPBCAM
phosphate buffered saline|OGRPBCAM
phosphate protecting group|OGRPBCAM
phosphatidylinositol (3,4,5)-triphosphate|OGRPBCAM
phosphoantigen|OGRPBCAM
phosphodiesterase IV inhibitor|OGRPBCAM
phosphoenolpyruvate|OGRPBCAM
phosphoethanolamine|OGRPBCAM
phospholipid biosynthesis inhibitor|OGRPBCAM
phospholipid redistribution estimation|OGRPBCAM
phosphomevalonate|OGRPBCAM
phosphoprotein detection method|OGRPBCAM
phosphoprotein-specific antibody-coated bead based method|OGRPBCAM
phosphorimaging|OGRPBCAM
phosphorus containing antibiotics|OGRPBCAM
phosphorus metabolism disease|OGRPBCAM
phosphorylated|OGRPBCAM
phosphorylation|OGRPBCAM
phosphorylation assay|OGRPBCAM
photoaffinity labeling|OGRPBCAM
photoallergic dermatitis|OGRPBCAM
photobiochemical role|OGRPBCAM
photochemical role|OGRPBCAM
photodiode|OGRPBCAM
photokeratitis|OGRPBCAM
photomultiplier tube|OGRPBCAM
photosensitive trichothiodystrophy|OGRPBCAM
photosensitizing agent|OGRPBCAM
photosynthetic electron-transport chain inhibitor|OGRPBCAM
photosystem-I inhibitor|OGRPBCAM
photosystem-II inhibitor|OGRPBCAM
phylogenetic analysis using parsimony|OGRPBCAM
phylogeny inference package|OGRPBCAM
physical detection method|OGRPBCAM
physical disorder|OGRPBCAM
physical property endpoint|OGRPBCAM
physical quality|OGRPBCAM
physical tracer|OGRPBCAM
physical urticaria|OGRPBCAM
physicochemical|OGRPBCAM
physicochemical assay|OGRPBCAM
physiological endpoint|OGRPBCAM
physiological role|OGRPBCAM
phytoalexin|OGRPBCAM
phytochrome chromophore|OGRPBCAM
phytoestrogen|OGRPBCAM
phytogenic insecticide|OGRPBCAM
phytosiderophore|OGRPBCAM
phytotoxin|OGRPBCAM
pi-electron computational method|OGRPBCAM
picometer|OGRPBCAM
picomolar|OGRPBCAM
picosecond|OGRPBCAM
piebaldism|OGRPBCAM
piezo1 agonist|OGRPBCAM
pigmentation disease|OGRPBCAM
pigmented villonodular synovitis|OGRPBCAM
pilocytic astrocytoma|OGRPBCAM
pilomatrixoma|OGRPBCAM
pilomyxoid astrocytoma|OGRPBCAM
pineal gland cancer|OGRPBCAM
pineal region meningioma|OGRPBCAM
pineoblastoma|OGRPBCAM
pinguecula|OGRPBCAM
piscicide|OGRPBCAM
pituitary adenoma|OGRPBCAM
pituitary apoplexy|OGRPBCAM
pituitary cancer|OGRPBCAM
pituitary carcinoma|OGRPBCAM
pituitary gland benign neoplasm|OGRPBCAM
pituitary gland disease|DOID_53
pituitary hypoplasia|OGRPBCAM
pituitary infarct|OGRPBCAM
pituitary-dependent Cushing's disease|OGRPBCAM
pityriasis rubra pilaris|OGRPBCAM
pityriasis versicolor|OGRPBCAM
placenta accreta|OGRPBCAM
placenta cancer|OGRPBCAM
placenta disease|DOID_780
placenta praevia|OGRPBCAM
placental abruption|OGRPBCAM
placental insufficiency|OGRPBCAM
placental site trophoblastic tumor|OGRPBCAM
placental transfer assay|OGRPBCAM
plague|OGRPBCAM
plant|OGRPBCAM
plant activator|OGRPBCAM
plant growth regulator|OGRPBCAM
plant growth retardant|OGRPBCAM
plant growth stimulator|OGRPBCAM
plant hormone|OGRPBCAM
plant metabolite|OGRPBCAM
plantar fasciitis|OGRPBCAM
plasma cell neoplasm|OGRPBCAM
plasma format|OGRPBCAM
plasma membrane|OGRPBCAM
plasma membrane potential assay|OGRPBCAM
plasma protein binding assay|OGRPBCAM
plasma protein metabolism disease|OGRPBCAM
plasma stability assay|OGRPBCAM
plasma stability with inhibitors|OGRPBCAM
plasmacytoma|OGRPBCAM
plasmid DNA|OGRPBCAM
plasmid DNA construct|OGRPBCAM
plasticiser|OGRPBCAM
plated human hepatocytes assay|OGRPBCAM
platelet activation|OGRPBCAM
platelet activation assay|OGRPBCAM
platelet aggregation assay|OGRPBCAM
platelet aggregation inhibitor|OGRPBCAM
platelet glycoprotein-IIb/IIIa receptor antagonist|OGRPBCAM
platelet storage pool deficiency|OGRPBCAM
platelet-activating factor receptor agonist|OGRPBCAM
platelet-activating factor receptor antagonist|OGRPBCAM
pleomorphic adenoma|DOID_452
pleomorphic adenoma carcinoma|DOID_297
pleural cancer|OGRPBCAM
pleural disease|OGRPBCAM
pleural empyema|OGRPBCAM
pleurisy|OGRPBCAM
pleuropulmonary blastoma|OGRPBCAM
pluronic F-127|OGRPBCAM
pneumoconiosis|OGRPBCAM
pneumocystosis|OGRPBCAM
pneumonia|DOID_552
pneumonic plague|OGRPBCAM
pneumothorax|OGRPBCAM
point mutated|OGRPBCAM
poison|OGRPBCAM
polar aprotic solvent|OGRPBCAM
polar solvent|OGRPBCAM
polarizable force field simulation|OGRPBCAM
poliomyelitis|OGRPBCAM
polyarteritis nodosa|OGRPBCAM
polyclonal|OGRPBCAM
polyclonal hypergammaglobulinemia|OGRPBCAM
polycystic kidney disease|OGRPBCAM
polycystic liver disease|OGRPBCAM
polycystic ovary syndrome|OGRPBCAM
polycythemia|OGRPBCAM
polycythemia vera|OGRPBCAM
polydactyly|OGRPBCAM
polyhydramnios|OGRPBCAM
polymerase chain reaction|OGRPBCAM
polymerisation monomer|OGRPBCAM
polyneuropathy|OGRPBCAM
pompholyx|OGRPBCAM
porphyria|OGRPBCAM
porphyria cutanea tarda|OGRPBCAM
portal hypertension|OGRPBCAM
portal vein study|OGRPBCAM
portal vein thrombosis|OGRPBCAM
positive allosteric modulation|OGRPBCAM
positive control|OGRPBCAM
positive regulation of lipid storage|OGRPBCAM
positive regulation of membrane potential|OGRPBCAM
positively correlated|OGRPBCAM
post Hartree-Fock method|OGRPBCAM
post-juvenile adult stage|OGRPBCAM
post-translational modification assay|OGRPBCAM
post-traumatic stress disorder|OGRPBCAM
postcholecystectomy syndrome|OGRPBCAM
posterior myocardial infarction|OGRPBCAM
posterior polar cataract|OGRPBCAM
postgastrectomy syndrome|OGRPBCAM
postnatal|OGRPBCAM
posttranscriptionally modified|OGRPBCAM
posttranslationally modified|OGRPBCAM
potassium channel blocker|OGRPBCAM
potassium channel modulator|OGRPBCAM
potassium channel opener|OGRPBCAM
potassium chloride|OGRPBCAM
potassium ionophore|OGRPBCAM
potassium phosphoenolpyruvate|OGRPBCAM
potentials of mean force scoring function|OGRPBCAM
potentiator|OGRPBCAM
pre-eclampsia|OGRPBCAM
pre-malignant neoplasm|OGRPBCAM
preclinical development stage|OGRPBCAM
preclinical study|OGRPBCAM
precocenes|OGRPBCAM
prediabetes syndrome|OGRPBCAM
pregnane X receptor agonist|OGRPBCAM
premature ejaculation|OGRPBCAM
premature ovarian failure|OGRPBCAM
preparation method|OGRPBCAM
preretinal fibrosis|OGRPBCAM
presbyopia|OGRPBCAM
present|OGRPBCAM
present in taxon|OGRPBCAM
priapism|OGRPBCAM
primary amebic meningoencephalitis|OGRPBCAM
primary angle-closure glaucoma|OGRPBCAM
primary antibody|OGRPBCAM
primary assay|OGRPBCAM
primary bacterial infectious disease|OGRPBCAM
primary biliary cholangitis|OGRPBCAM
primary cell|OGRPBCAM
primary ciliary dyskinesia|OGRPBCAM
primary cutaneous amyloidosis|OGRPBCAM
primary hyperaldosteronism|DOID_446
primary hyperoxaluria|OGRPBCAM
primary hypertrophic osteoarthropathy|OGRPBCAM
primary immunodeficiency disease|DOID_612
primary neuron|OGRPBCAM
primary open angle glaucoma|OGRPBCAM
primary pulmonary hypertension|OGRPBCAM
primary structure|OGRPBCAM
primary structure analysis method|OGRPBCAM
primary syphilis|OGRPBCAM
primary systemic mycosis|OGRPBCAM
primary thrombocytopenia|OGRPBCAM
principal component analysis|OGRPBCAM
prion disease|DOID_649
pro-agent|OGRPBCAM
pro-angiogenic agent|OGRPBCAM
proacaricide|OGRPBCAM
probe|OGRPBCAM
probenecid|OGRPBCAM
processing method|OGRPBCAM
proctitis|OGRPBCAM
prodrug|OGRPBCAM
product|OGRPBCAM
production of miRNAs involved in gene silencing by miRNA|OGRPBCAM
profile endpoint|OGRPBCAM
profluorescent 1-AMA|OGRPBCAM
profungicide|OGRPBCAM
progeria|OGRPBCAM
progesterone receptor agonist|OGRPBCAM
progesterone receptor modulator|OGRPBCAM
progestin|OGRPBCAM
progestogen|OGRPBCAM
progressive bulbar palsy|DOID_681
progressive multifocal leukoencephalopathy|DOID_643
progressive muscular atrophy|DOID_318
progressive myoclonus epilepsy|DOID_891
progressive supranuclear palsy|DOID_678
progressive system alignment|OGRPBCAM
proherbicide|OGRPBCAM
prohormone|OGRPBCAM
proinsecticide|OGRPBCAM
prokaryotic metabolite|OGRPBCAM
prolapse of female genital organ|OGRPBCAM
proliferative diabetic retinopathy|OGRPBCAM
prolymphocytic leukemia|OGRPBCAM
pronematicide|OGRPBCAM
propellant|OGRPBCAM
propesticide|OGRPBCAM
propidium iodide DNA staining|OGRPBCAM
propidium iodide exclusion|OGRPBCAM
propionic acidemia|OGRPBCAM
propofol|OGRPBCAM
prosafener|OGRPBCAM
prosopagnosia|OGRPBCAM
prostacyclin receptor agonist|OGRPBCAM
prostaglandin|OGRPBCAM
prostaglandin E2|OGRPBCAM
prostaglandin antagonist|OGRPBCAM
prostaglandin receptor agonist|OGRPBCAM
prostaglandin receptor antagonist|OGRPBCAM
prostate cancer|OGRPBCAM
prostate carcinoma in situ|OGRPBCAM
prostate disease|DOID_47
prostate gland|OGRPBCAM
prostate leiomyosarcoma|OGRPBCAM
prostate rhabdomyosarcoma|OGRPBCAM
prostate sarcoma|OGRPBCAM
prostate small cell carcinoma|OGRPBCAM
prostatic adenoma|OGRPBCAM
prostatic hypertrophy|OGRPBCAM
prostatitis|OGRPBCAM
prosthetic group|OGRPBCAM
protease|OGRPBCAM
protease activity assay|OGRPBCAM
protease activity determination|OGRPBCAM
protease coupled enzyme activity measurement method|OGRPBCAM
protease inhibitor|OGRPBCAM
protease-activated receptor-1 agonist|OGRPBCAM
protease-activated receptor-1 antagonist|OGRPBCAM
protease-activated receptor-2 antagonist|OGRPBCAM
proteasome inhibitor|OGRPBCAM
protecting group|OGRPBCAM
protective agent|OGRPBCAM
protein|OGRPBCAM
protein A-based affinity purification method|OGRPBCAM
protein A/G-based affinity purification method|OGRPBCAM
protein C deficiency|OGRPBCAM
protein C-terminal methylesterase activity|OGRPBCAM
protein G-based affinity purification method|OGRPBCAM
protein L-based affinity purification method|OGRPBCAM
protein S deficiency|OGRPBCAM
protein abundance method|OGRPBCAM
protein array|OGRPBCAM
protein binding|OGRPBCAM
protein binding ligand|OGRPBCAM
protein complementation|OGRPBCAM
protein complex|OGRPBCAM
protein complex format|OGRPBCAM
protein conformation assessment|OGRPBCAM
protein denaturant|OGRPBCAM
protein denaturation method|OGRPBCAM
protein dephosphorylation|OGRPBCAM
protein expression assay|OGRPBCAM
protein folding assay|OGRPBCAM
protein format|OGRPBCAM
protein fragment complementation method|OGRPBCAM
protein import into nucleus|OGRPBCAM
protein kinase A agonist|OGRPBCAM
protein kinase A signaling|OGRPBCAM
protein kinase B signaling|OGRPBCAM
protein kinase C agonist|OGRPBCAM
protein kinase C signaling|OGRPBCAM
protein kinase G agonist|OGRPBCAM
protein kinase agonist|OGRPBCAM
protein kinase inhibitor|OGRPBCAM
protein level|OGRPBCAM
protein modification method|OGRPBCAM
protein phosphorylation|OGRPBCAM
protein preparation method|OGRPBCAM
protein profiling assay|OGRPBCAM
protein redistribution assay|OGRPBCAM
protein stability assay|OGRPBCAM
protein stabilization|OGRPBCAM
protein substrate and ligand constant|OGRPBCAM
protein subunit|OGRPBCAM
protein synthesis inhibitor|OGRPBCAM
protein tag|OGRPBCAM
protein threading|OGRPBCAM
protein unfolding assay|OGRPBCAM
protein-DNA interaction assay|OGRPBCAM
protein-RNA interaction assay|OGRPBCAM
protein-deficiency anemia|OGRPBCAM
protein-energy malnutrition|OGRPBCAM
protein-losing enteropathy|OGRPBCAM
protein-nucleotide interaction assay|OGRPBCAM
protein-protein docking|OGRPBCAM
protein-protein interaction assay|OGRPBCAM
protein-sequencing agent|OGRPBCAM
protein-small molecule interaction assay|OGRPBCAM
protein-turnover assay|OGRPBCAM
proteinuria|DOID_576
protic solvent|OGRPBCAM
protophilic solvent|OGRPBCAM
protozoan|OGRPBCAM
provitamin|OGRPBCAM
provitamin A|OGRPBCAM
provitamin B1|OGRPBCAM
proximity-based method|OGRPBCAM
psammomatous meningioma|OGRPBCAM
pseudo-TORCH syndrome 1|OGRPBCAM
pseudoachondroplasia|OGRPBCAM
pseudobulbar palsy|OGRPBCAM
pseudohermaphroditism|OGRPBCAM
pseudohypoaldosteronism|OGRPBCAM
pseudohypoparathyroidism|OGRPBCAM
pseudomyxoma peritonei|OGRPBCAM
pseudopapilledema|OGRPBCAM
pseudopseudohypoparathyroidism|OGRPBCAM
pseudopterygium|OGRPBCAM
pseudosarcomatous fibromatosis|OGRPBCAM
pseudotumor cerebri|OGRPBCAM
pseudoxanthoma elasticum|OGRPBCAM
psoriasis|OGRPBCAM
psoriatic arthritis|OGRPBCAM
psychosexual disorder|OGRPBCAM
psychotic disorder|OGRPBCAM
psychotropic drug|OGRPBCAM
pulmonary alveolar microlithiasis|OGRPBCAM
pulmonary alveolar proteinosis|OGRPBCAM
pulmonary artery disease|OGRPBCAM
pulmonary aspergilloma|OGRPBCAM
pulmonary blastoma|OGRPBCAM
pulmonary coin lesion|OGRPBCAM
pulmonary embolism|OGRPBCAM
pulmonary emphysema|OGRPBCAM
pulmonary fibrosis|OGRPBCAM
pulmonary hypertension|OGRPBCAM
pulmonary immaturity|DOID_424
pulmonary large cell neuroendocrine carcinoma|OGRPBCAM
pulmonary valve disease|OGRPBCAM
pulmonary valve insufficiency|OGRPBCAM
pulmonary valve stenosis|OGRPBCAM
pulmonary venoocclusive disease|OGRPBCAM
pulpitis|OGRPBCAM
punctate epithelial keratoconjunctivitis|OGRPBCAM
pure red-cell aplasia|OGRPBCAM
purification from natural source|OGRPBCAM
purified|OGRPBCAM
purified protein array|OGRPBCAM
purine nucleoside phosphorylase deficiency|OGRPBCAM
purine-pyrimidine metabolic disorder|DOID_653
purinergic receptor P2 antagonist|OGRPBCAM
purinergic receptor P2X antagonist|OGRPBCAM
purity|OGRPBCAM
purpura|OGRPBCAM
purulent endophthalmitis|OGRPBCAM
pustulosis of palm and sole|OGRPBCAM
pycnodysostosis|OGRPBCAM
pyelitis|OGRPBCAM
pyelonephritis|OGRPBCAM
pyloric stenosis|OGRPBCAM
pyoderma|OGRPBCAM
pyoderma gangrenosum|OGRPBCAM
pyosalpinx|OGRPBCAM
pyrethroid ester acaricide|OGRPBCAM
pyrethroid ester insecticide|OGRPBCAM
pyrethroid ether acaricide|OGRPBCAM
pyrethroid ether insecticide|OGRPBCAM
pyrethroid insecticide|OGRPBCAM
pyridoxine-responsive sideroblastic anemia|OGRPBCAM
pyrimidine synthesis inhibitor|OGRPBCAM
pyrimidine-4,6-dicarboxylic acid|OGRPBCAM
pyromania|OGRPBCAM
pyruvate decarboxylase deficiency|OGRPBCAM
pyuria|OGRPBCAM
qScript One-step Fast qRT-PCR kit (QuantaBioSciences)|OGRPBCAM
quadratic configuration interaction method|OGRPBCAM
quadriplegia|OGRPBCAM
qualitative|OGRPBCAM
quality|OGRPBCAM
quantified endpoint|OGRPBCAM
quantified entity|OGRPBCAM
quantifies|OGRPBCAM
quantitative PCR|OGRPBCAM
quantitative reverse transcription PCR|OGRPBCAM
quantitative structure activity relationship analysis|OGRPBCAM
quantum chemistry computational method|OGRPBCAM
quartz crystal microbalance|OGRPBCAM
quencher|OGRPBCAM
quinidine|OGRPBCAM
quinol oxidation site inhibitor|OGRPBCAM
quinone outside inhibitor|OGRPBCAM
quorum sensing|OGRPBCAM
quorum sensing inhibitor|OGRPBCAM
rRNA|OGRPBCAM
rabbit reticulocyte lysate format|OGRPBCAM
rabbit vas deferens (RVD) assay|OGRPBCAM
rabies|OGRPBCAM
racemetirosine|OGRPBCAM
radiation protective agent|OGRPBCAM
radical scavenger|OGRPBCAM
radiculopathy|OGRPBCAM
radioactive imaging agent|OGRPBCAM
radioactive label|OGRPBCAM
radioactive tracer|OGRPBCAM
radioimmunoassay|OGRPBCAM
radiolabeled|OGRPBCAM
radioligand binding assay|OGRPBCAM
radioligand binding method|OGRPBCAM
radiometric imaging method|OGRPBCAM
radiometry method|OGRPBCAM
radiometry separation method|OGRPBCAM
radioopaque medium|OGRPBCAM
radiopharmaceutical|OGRPBCAM
radiosensitizing agent|OGRPBCAM
radioulnar synostosis|OGRPBCAM
raising agent|OGRPBCAM
random conformational search|OGRPBCAM
randomized block design|OGRPBCAM
rapadilino syndrome|OGRPBCAM
rapid overlay of chemical structures|OGRPBCAM
rat metabolite|OGRPBCAM
rate|OGRPBCAM
ratio|OGRPBCAM
ratio endpoint|OGRPBCAM
rauwolscine|OGRPBCAM
raw activity|OGRPBCAM
raw data|OGRPBCAM
rdfs:isDefinedBy|OGRPBCAM
reaction intermediate|OGRPBCAM
reactive arthritis|OGRPBCAM
reactive oxygen species generator|OGRPBCAM
reading disorder|OGRPBCAM
reagent|OGRPBCAM
real-time PCR |OGRPBCAM
receptor|OGRPBCAM
receptor based pharmacophore search|OGRPBCAM
receptor induction assay|OGRPBCAM
receptor internalization assay|OGRPBCAM
receptor modulator|OGRPBCAM
receptor signaling pathway via JAK-STAT|OGRPBCAM
recombinant CYP reaction phenotyping assay|OGRPBCAM
recombinant UGT reaction phenotyping assay|OGRPBCAM
recombinant esterases|OGRPBCAM
recombinant expression|OGRPBCAM
recombinant virus transduction method|OGRPBCAM
recombinantly expressed in|OGRPBCAM
reconstitution method|OGRPBCAM
rectal benign neoplasm|OGRPBCAM
rectal disease|OGRPBCAM
rectal prolapse|OGRPBCAM
rectum adenocarcinoma|OGRPBCAM
rectum cancer|OGRPBCAM
recurrent corneal erosion|OGRPBCAM
recurrent hypersomnia|OGRPBCAM
recursive partitioning QSAR|OGRPBCAM
red color blindness|OGRPBCAM
redistribution assay|OGRPBCAM
reducing agent|OGRPBCAM
reference compound|OGRPBCAM
reflex sympathetic dystrophy|OGRPBCAM
refractive error|OGRPBCAM
refrigerant|OGRPBCAM
regenerating neuron|OGRPBCAM
regeneration|OGRPBCAM
regression QSAR|OGRPBCAM
regular astigmatism|OGRPBCAM
regulation of DNA-binding transcription factor activity|OGRPBCAM
regulation of RNA splicing|OGRPBCAM
regulation of acute inflammatory response|OGRPBCAM
regulation of catalytic activity|OGRPBCAM
regulation of cell migration|OGRPBCAM
regulation of gene expression|OGRPBCAM
regulation of gene expression, epigenetic|OGRPBCAM
regulation of gene silencing by miRNA|OGRPBCAM
regulation of membrane potential|OGRPBCAM
regulation of mitochondrial membrane potential|OGRPBCAM
regulation of molecular function|OGRPBCAM
regulation of proteasomal protein catabolic process|OGRPBCAM
regulation of transcription, DNA-templated|OGRPBCAM
regulation of translation|OGRPBCAM
regulation of ubiquitin-protein transferase activity|OGRPBCAM
regulatory region|OGRPBCAM
relapsing fever|OGRPBCAM
relapsing polychondritis|OGRPBCAM
relative bias|OGRPBCAM
renal adenoma|OGRPBCAM
renal agenesis|OGRPBCAM
renal agent|OGRPBCAM
renal artery disease|OGRPBCAM
renal carcinoma|OGRPBCAM
renal cell carcinoma|OGRPBCAM
renal excretion assay|OGRPBCAM
renal function assay|OGRPBCAM
renal glycosuria|OGRPBCAM
renal oncocytoma|OGRPBCAM
renal osteodystrophy|OGRPBCAM
renal pelvis carcinoma|OGRPBCAM
renal tuberculosis|OGRPBCAM
renal tubular acidosis|OGRPBCAM
renal tubular transport disease|DOID_447
renoprotective agent|OGRPBCAM
repetition throughput|OGRPBCAM
reporter gene|OGRPBCAM
reporter gene assay|OGRPBCAM
reporter gene method|OGRPBCAM
reporter protein|OGRPBCAM
reports|OGRPBCAM
reports assay measurment value|OGRPBCAM
reproductive control drug|OGRPBCAM
reproductive organ benign neoplasm|OGRPBCAM
reproductive organ cancer|DOID_193
reproductive system disease|DOID_15
resazurin reduction assay|OGRPBCAM
rescue treatment|OGRPBCAM
research institute|OGRPBCAM
researcher|OGRPBCAM
researcher role|OGRPBCAM
residence time|OGRPBCAM
resonant waveguide grating|OGRPBCAM
resorufin|OGRPBCAM
respiratory allergy|OGRPBCAM
respiratory failure|OGRPBCAM
respiratory syncytial virus infectious disease|OGRPBCAM
respiratory system benign neoplasm|OGRPBCAM
respiratory system cancer|OGRPBCAM
respiratory system disease|OGRPBCAM
respiratory-chain inhibitor|OGRPBCAM
response endpoint|OGRPBCAM
response to drug|OGRPBCAM
response to hypoxia|OGRPBCAM
response to reactive oxygen species|OGRPBCAM
response to stress|OGRPBCAM
restricted open-shell Hartree-Fock|OGRPBCAM
restriction enzyme-based method|OGRPBCAM
restrictive cardiomyopathy|DOID_397
reticular dysgenesis|OGRPBCAM
reticulosarcoma|OGRPBCAM
retinal artery occlusion|OGRPBCAM
retinal cancer|OGRPBCAM
retinal cell cancer|DOID_771
retinal degeneration|OGRPBCAM
retinal detachment|OGRPBCAM
retinal disease|OGRPBCAM
retinal drusen|OGRPBCAM
retinal edema|OGRPBCAM
retinal perforation|OGRPBCAM
retinal telangiectasia|OGRPBCAM
retinal vascular disease|OGRPBCAM
retinal vascular occlusion|OGRPBCAM
retinal vein occlusion|OGRPBCAM
retinitis|OGRPBCAM
retinitis pigmentosa|OGRPBCAM
retinoblastoma|DOID_768
retinoic acid|OGRPBCAM
retinoic acid receptor agonist|OGRPBCAM
retinoic acid receptor alpha antagonist|OGRPBCAM
retinoic acid receptor alpha/beta agonist|OGRPBCAM
retinoic acid receptor antagonist|OGRPBCAM
retinoic acid receptor beta agonist|OGRPBCAM
retinoic acid receptor gamma agonist|OGRPBCAM
retinoic acid receptor gamma antagonist|OGRPBCAM
retinoic acid receptor modulator|OGRPBCAM
retinoid X receptor agonist|OGRPBCAM
retinopathy of prematurity|OGRPBCAM
retinoschisis|OGRPBCAM
retrocochlear disease|OGRPBCAM
retrograde amnesia|OGRPBCAM
retroperitoneal cancer|OGRPBCAM
retroperitoneal leiomyosarcoma|OGRPBCAM
retroperitoneal sarcoma|OGRPBCAM
reverse transcription PCR|OGRPBCAM
reversible binding|OGRPBCAM
reversible inhibition|OGRPBCAM
rhabdoid cancer|OGRPBCAM
rhabdomyosarcoma|OGRPBCAM
rheumatic disease|OGRPBCAM
rheumatic fever|OGRPBCAM
rheumatic myocarditis|OGRPBCAM
rheumatoid arthritis|OGRPBCAM
rhinitis|OGRPBCAM
rhinoscleroma|OGRPBCAM
rhizomelic chondrodysplasia punctata|OGRPBCAM
rhodamine|OGRPBCAM
rhodamine-conjugated sulfonate ester|OGRPBCAM
riboflavin deficiency|OGRPBCAM
riboswitch|OGRPBCAM
rickets|OGRPBCAM
right bundle branch block|OGRPBCAM
rna splicing assay|OGRPBCAM
rna-seq method|OGRPBCAM
robust z-prime factor|OGRPBCAM
rodent IV clearance|OGRPBCAM
rodent IV half-life|OGRPBCAM
rodent PK|OGRPBCAM
rodent Vdss|OGRPBCAM
rodent excretion in urine|OGRPBCAM
rodent oral bioavailability|OGRPBCAM
rodent oral half-life|OGRPBCAM
rodenticide|OGRPBCAM
role|OGRPBCAM
rolipram|OGRPBCAM
root caries|OGRPBCAM
root resorption|OGRPBCAM
rosacea|OGRPBCAM
rosuvastatin|OGRPBCAM
rotational frequency unit|OGRPBCAM
rounded cell phenotype|OGRPBCAM
rubella|OGRPBCAM
rule based structure generation|OGRPBCAM
ryanodine receptor agonist|OGRPBCAM
ryanodine receptor antagonist|OGRPBCAM
ryanodine receptor modulator|OGRPBCAM
ryanoid insecticide|OGRPBCAM
safety pharmacology assay|OGRPBCAM
sagittal sinus thrombosis|OGRPBCAM
salivary gland adenoid cystic carcinoma|OGRPBCAM
salivary gland cancer|OGRPBCAM
salivary gland carcinoma|OGRPBCAM
salivary gland disease|OGRPBCAM
salmonellosis|OGRPBCAM
salpingitis|OGRPBCAM
salpingo-oophoritis|OGRPBCAM
salt-inducible kinase 2 inhibitor|OGRPBCAM
sandwich ELISA|OGRPBCAM
sandwich cultured human hepatocyte assay|OGRPBCAM
saponin|OGRPBCAM
sarcocystosis|OGRPBCAM
sarcoidosis|OGRPBCAM
sarcoma|OGRPBCAM
sarcomatosis|OGRPBCAM
saredutant|OGRPBCAM
saturation binding|OGRPBCAM
scabicide|OGRPBCAM
scabies|OGRPBCAM
scaffold hopping|OGRPBCAM
scalp dermatosis|OGRPBCAM
scanning electron microscopy|OGRPBCAM
scanning force microscope|OGRPBCAM
scanning near-field optical microscopy|OGRPBCAM
scanning probe microscopy|OGRPBCAM
scanning tunneling microscopy|OGRPBCAM
scarlet fever|OGRPBCAM
schistosomiasis|OGRPBCAM
schistosomicide drug|OGRPBCAM
schizoaffective disorder|OGRPBCAM
schizoid personality disorder|OGRPBCAM
schizophrenia|OGRPBCAM
schizotypal personality disorder|OGRPBCAM
schneckenbecken dysplasia|OGRPBCAM
scimitar syndrome|OGRPBCAM
scintillation counting|OGRPBCAM
scintillation proximity assay|OGRPBCAM
scleral disease|OGRPBCAM
scleral staphyloma|OGRPBCAM
scleritis|OGRPBCAM
scleroderma|DOID_419
scleromalacia perforans|OGRPBCAM
sclerosing cholangitis|OGRPBCAM
sclerosing hemangioma|DOID_495
sclerosing keratitis|OGRPBCAM
sclerotherapy agent|OGRPBCAM
scotoma|OGRPBCAM
scrapie|OGRPBCAM
screened entity|OGRPBCAM
screened entity role|OGRPBCAM
screening campaign|OGRPBCAM
screening concentration|OGRPBCAM
screening lab investigator|OGRPBCAM
screening principal investigator|OGRPBCAM
scrub typhus|OGRPBCAM
scurvy|OGRPBCAM
sea urchin|OGRPBCAM
sea-blue histiocytosis|OGRPBCAM
sebaceous adenoma|OGRPBCAM
sebaceous carcinoma|OGRPBCAM
sebaceous gland disease|OGRPBCAM
sebaceous gland neoplasm|OGRPBCAM
seborrheic dermatitis|OGRPBCAM
seborrheic keratosis|OGRPBCAM
second|OGRPBCAM
second generation antipsychotic|OGRPBCAM
second generation force field simulation|OGRPBCAM
second messenger|OGRPBCAM
second messenger abundance|OGRPBCAM
second messenger accumulation assay|OGRPBCAM
second messenger assay|OGRPBCAM
second messenger competitive binding assessment method|OGRPBCAM
second messenger redistribution assay|OGRPBCAM
second-messenger-mediated signaling|OGRPBCAM
secondary antibody|OGRPBCAM
secondary assay|OGRPBCAM
secondary hypertrophic osteoarthropathy|OGRPBCAM
secondary structure|OGRPBCAM
secondary structure analysis method|OGRPBCAM
secretagogue|OGRPBCAM
secreted|OGRPBCAM
secreted frizzled-related protein 1 inhibitor|OGRPBCAM
secretory diarrhea|OGRPBCAM
sedative|OGRPBCAM
see also|OGRPBCAM
selectable marker|OGRPBCAM
selective immunoglobulin deficiency disease|OGRPBCAM
selectivity assay|OGRPBCAM
self organizing molecular field analysis|OGRPBCAM
semi-empirical quantum chemistry computational method|OGRPBCAM
seminal vesicle tumor|OGRPBCAM
seminoma|OGRPBCAM
semiochemical|OGRPBCAM
senile angioma|OGRPBCAM
senile cataract|OGRPBCAM
sennetsu fever|OGRPBCAM
sensitiser|OGRPBCAM
sensitizer|OGRPBCAM
sensitizer assay|OGRPBCAM
sensorineural hearing loss|OGRPBCAM
sensory organ benign neoplasm|OGRPBCAM
sensory peripheral neuropathy|OGRPBCAM
sensory system cancer|OGRPBCAM
sensory system disease|OGRPBCAM
separation method|OGRPBCAM
septic arthritis|DOID_813
sequence alignment|OGRPBCAM
sequence alignment by method|OGRPBCAM
sequence alignment by type|OGRPBCAM
sequencing data alignment software|OGRPBCAM
sequencing data analysis software|OGRPBCAM
sequestrant|OGRPBCAM
serial analysis of gene expression|OGRPBCAM
serine deficiency|OGRPBCAM
serine ligand covalent binding method|OGRPBCAM
serine protease inhibitor|OGRPBCAM
serine proteinase inhibitor|OGRPBCAM
serotonergic agonist|OGRPBCAM
serotonergic antagonist|OGRPBCAM
serotonergic drug|OGRPBCAM
serotonin uptake inhibitor|OGRPBCAM
serous cystadenocarcinoma|OGRPBCAM
serum format|OGRPBCAM
severe acute respiratory syndrome|OGRPBCAM
severe combined immunodeficiency|DOID_627
severe congenital neutropenia|OGRPBCAM
severe nonproliferative diabetic retinopathy|OGRPBCAM
sex cord-gonadal stromal tumor|DOID_192
sex hormone|OGRPBCAM
sexual disorder|OGRPBCAM
sexual dysfunction|OGRPBCAM
shRNA|OGRPBCAM
shRNA library|OGRPBCAM
shape|OGRPBCAM
shape fingerprint search|OGRPBCAM
shigellosis|OGRPBCAM
shipyard eye|OGRPBCAM
short bowel syndrome|OGRPBCAM
shortened|OGRPBCAM
shortened neurite phenotype|OGRPBCAM
shorthand|OGRPBCAM
shotgun MS protein profiling assay|OGRPBCAM
shrunken cell phenotype|OGRPBCAM
siRNA|OGRPBCAM
siRNA library|OGRPBCAM
sialadenitis|OGRPBCAM
sialuria|OGRPBCAM
sialyltransferase inhibitor|OGRPBCAM
sick building syndrome|OGRPBCAM
sick sinus syndrome|OGRPBCAM
sickle cell anemia|OGRPBCAM
sideramine|OGRPBCAM
sideroblastic anemia|OGRPBCAM
siderophore|OGRPBCAM
siderosis|OGRPBCAM
sigma receptor modulator|OGRPBCAM
sigma-1 receptor agonist|OGRPBCAM
sigma-2 receptor agonist|OGRPBCAM
sigmoid colon cancer|OGRPBCAM
signal decrease|OGRPBCAM
signal decrease corresponding to activation|OGRPBCAM
signal decrease corresponding to inhibition|OGRPBCAM
signal direction|OGRPBCAM
signal increase|OGRPBCAM
signal increase corresponding to activation|OGRPBCAM
signal increase corresponding to inhibition|OGRPBCAM
signal quantitation method|OGRPBCAM
signal to noise|OGRPBCAM
signal transducer and activator of transcription 5 protein inhibitor|OGRPBCAM
signal transduction|OGRPBCAM
signal transduction assay|OGRPBCAM
signal transduction by protein phosphorylation|OGRPBCAM
signal window|OGRPBCAM
signaling|OGRPBCAM
signaling pathway assay|OGRPBCAM
signaling receptor binding|OGRPBCAM
signalling molecule|OGRPBCAM
signet ring cell adenocarcinoma|OGRPBCAM
silences|OGRPBCAM
silencing RNA delivery method|OGRPBCAM
silencing RNA modification method|OGRPBCAM
silicosis|OGRPBCAM
simple measurement method|OGRPBCAM
simulated annealing|OGRPBCAM
simulated gastric fluid stability assay|OGRPBCAM
simulated gastric fluid stability assay (with enzymes)|OGRPBCAM
simulated interstitial fluid stability assay|OGRPBCAM
simulated intestinal fluid stability assay|OGRPBCAM
simulated intestinal fluid stability assay (with enzymes)|OGRPBCAM
simultanagnosia|OGRPBCAM
single cell protein secretion microfluidic assay|OGRPBCAM
single concentration|OGRPBCAM
single nucleotide polymorphism genotyping|OGRPBCAM
single parameter readout|OGRPBCAM
single perturbagen|OGRPBCAM
single protein format|OGRPBCAM
single readout|OGRPBCAM
single repetition|OGRPBCAM
sinoatrial node disease|OGRPBCAM
sinusitis|OGRPBCAM
situs inversus|DOID_758
size|OGRPBCAM
size separation method|OGRPBCAM
skeletal muscle cancer|OGRPBCAM
skeletal muscle neoplasm|OGRPBCAM
skeletal system|OGRPBCAM
skin atrophy|OGRPBCAM
skin benign neoplasm|OGRPBCAM
skin cancer|OGRPBCAM
skin carcinoma|OGRPBCAM
skin carcinoma in situ|OGRPBCAM
skin disease|DOID_37
skin hemangioma|DOID_471
skin lightening agent|OGRPBCAM
skin lipoma|OGRPBCAM
skin melanoma|OGRPBCAM
skin of body|OGRPBCAM
skin papilloma|OGRPBCAM
skin pilomatrix carcinoma|OGRPBCAM
skin sarcoidosis|OGRPBCAM
skull base cancer|OGRPBCAM
skull base meningioma|OGRPBCAM
skull cancer|OGRPBCAM
sleep apnea|OGRPBCAM
sleep disorder|DOID_535
sleeping sickness|OGRPBCAM
slope|OGRPBCAM
small cell carcinoma|OGRPBCAM
small cell osteogenic sarcoma|OGRPBCAM
small intestinal sarcoma|OGRPBCAM
small intestine adenocarcinoma|OGRPBCAM
small intestine cancer|OGRPBCAM
small intestine carcinoma|OGRPBCAM
small intestine lymphoma|OGRPBCAM
small molecule|OGRPBCAM
small molecule abundance method|OGRPBCAM
small molecule array|OGRPBCAM
small molecule preparation method|OGRPBCAM
small molecule probe|OGRPBCAM
small-molecule physicochemical format|OGRPBCAM
smallpox|OGRPBCAM
smooth muscle cancer|OGRPBCAM
smooth muscle contraction assay|OGRPBCAM
smooth muscle tumor|OGRPBCAM
sodium channel blocker|OGRPBCAM
sodium channel modulator|OGRPBCAM
sodium chloride|OGRPBCAM
sodium orthovanadate|OGRPBCAM
sodium-dependent Pi-transporter inhibitor|OGRPBCAM
sodium-glucose transport protein subtype 1 inhibitor|OGRPBCAM
sodium-glucose transport protein subtype 2 inhibitor|OGRPBCAM
soft palate cancer|OGRPBCAM
software|OGRPBCAM
solid phase|OGRPBCAM
solid state laser|OGRPBCAM
solubility|OGRPBCAM
solubility assay|OGRPBCAM
soluble guanylate cyclase activator|OGRPBCAM
solvent|OGRPBCAM
somatoform disorder|OGRPBCAM
somatostatin receptor agonist|OGRPBCAM
somatostatinoma|OGRPBCAM
southern research institute|OGRPBCAM
space motion sickness|OGRPBCAM
sparganosis|OGRPBCAM
spastic cerebral palsy|OGRPBCAM
spastic diplegia|OGRPBCAM
spastic hemiplegia|OGRPBCAM
spastic quadriplegia|OGRPBCAM
spatial pattern|OGRPBCAM
specialised pro-resolving mediator|OGRPBCAM
specific developmental disorder|OGRPBCAM
specific phobia|DOID_599
spectrophotometric reagent|OGRPBCAM
spectrophotometry method|OGRPBCAM
speech disorder|DOID_92
spermatic cord torsion|OGRPBCAM
spermatocele|OGRPBCAM
spermatocytoma|OGRPBCAM
sphenoid sinusitis|OGRPBCAM
sphingolipidosis|OGRPBCAM
sphingosine-1-phosphate receptor 1 antagonist|OGRPBCAM
sphingosine-1-phosphate receptor 2 antagonist|OGRPBCAM
sphingosine-1-phosphate receptor 3 antagonist|OGRPBCAM
sphingosine-1-phosphate receptor agonist|OGRPBCAM
sphingosine-1-phosphate receptor antagonist|OGRPBCAM
spin label|OGRPBCAM
spin probe|OGRPBCAM
spin trapping reagent|OGRPBCAM
spina bifida|OGRPBCAM
spinal canal and spinal cord meningioma|OGRPBCAM
spinal cancer|OGRPBCAM
spinal cord disease|DOID_319
spinal cord ependymoma|OGRPBCAM
spinal cord glioma|OGRPBCAM
spinal disease|OGRPBCAM
spinal meningioma|OGRPBCAM
spinal muscular atrophy|OGRPBCAM
spinal stenosis|OGRPBCAM
spindle cell hemangioma|DOID_496
spindle cell sarcoma|OGRPBCAM
spinning-disk confocal microscope|OGRPBCAM
spiradenoma|OGRPBCAM
spleen cancer|DOID_672
splenic abscess|OGRPBCAM
splenic artery aneurysm|OGRPBCAM
splenic disease|OGRPBCAM
splenic infarction|OGRPBCAM
splenic marginal zone lymphoma|OGRPBCAM
splenic sequestration|OGRPBCAM
spondylocostal dysostosis|OGRPBCAM
spondyloepimetaphyseal dysplasia|OGRPBCAM
spondyloepimetaphyseal dysplasia, Sponastrime type|OGRPBCAM
spondyloepiphyseal dysplasia congenita|OGRPBCAM
spondylolisthesis|OGRPBCAM
spondylolysis|OGRPBCAM
spondylosis|OGRPBCAM
spontaneous ocular nystagmus|OGRPBCAM
sporadic breast cancer|OGRPBCAM
sporotrichosis|OGRPBCAM
spot detector|OGRPBCAM
spotted fever|OGRPBCAM
squamous cell carcinoma|OGRPBCAM
squamous cell neoplasm|OGRPBCAM
squamous cell papilloma|DOID_139
squamous papillomatosis|OGRPBCAM
squaraine dye|OGRPBCAM
stable transfection|OGRPBCAM
stains|OGRPBCAM
standard deviation|OGRPBCAM
staphyloenterotoxemia|DOID_96
star shaped|OGRPBCAM
statistical classification method|OGRPBCAM
statistical endpoint|OGRPBCAM
statistical method|OGRPBCAM
status asthmaticus|OGRPBCAM
staurosporine|OGRPBCAM
steadylite HTS Reagent|OGRPBCAM
steatosis inducing agent|OGRPBCAM
steepest descent method|OGRPBCAM
stereotypic movement disorder|OGRPBCAM
steroid inherited metabolic disorder|OGRPBCAM
steroid receptor coactivator stimulator|OGRPBCAM
steroid-induced glaucoma|OGRPBCAM
sterol biosynthesis inhibitor|OGRPBCAM
sterol demethylation inhibitor|OGRPBCAM
sterol methyltransferase inhibitor|OGRPBCAM
stibavirin|OGRPBCAM
stimulation|OGRPBCAM
stochastic simulation|OGRPBCAM
stomach|OGRPBCAM
stomach cancer|OGRPBCAM
stomach carcinoma|OGRPBCAM
stomach carcinoma in situ|OGRPBCAM
stomach disease|DOID_76
stomatitis|OGRPBCAM
strabismus|DOID_540
striatonigral degeneration|OGRPBCAM
stromal dystrophy|OGRPBCAM
strongyloidiasis|OGRPBCAM
structural|OGRPBCAM
structure|OGRPBCAM
structure activity relationship analysis|OGRPBCAM
structure alignment|OGRPBCAM
structure analysis method|OGRPBCAM
structure based virtual screening|OGRPBCAM
structure database search|OGRPBCAM
structure generation|OGRPBCAM
structure similarity search|OGRPBCAM
structure_notes|OGRPBCAM
struma ovarii|OGRPBCAM
sub-cellular morphology assessment method|OGRPBCAM
subacute lymphocytic thyroiditis|OGRPBCAM
subacute sclerosing panencephalitis|OGRPBCAM
subacute thyroiditis|OGRPBCAM
subcellular format|OGRPBCAM
subclavian artery aneurysm|DOID_342
subclavian steal syndrome|OGRPBCAM
subcorneal pustular dermatosis|OGRPBCAM
subcutaneous mycosis|OGRPBCAM
subependymal giant cell astrocytoma|OGRPBCAM
subependymal glioma|OGRPBCAM
subglottis neoplasm|OGRPBCAM
substance P receptor antagonist|OGRPBCAM
substance abuse|DOID_302
substance dependence|OGRPBCAM
substance-induced psychosis|OGRPBCAM
substance-related disorder|DOID_303
substernal goiter|OGRPBCAM
substrate|OGRPBCAM
substrate coupled enzyme activity measurement method|OGRPBCAM
substructure search|OGRPBCAM
subvalvular aortic stenosis|OGRPBCAM
succinic semialdehyde dehydrogenase deficiency|OGRPBCAM
sudden infant death syndrome|OGRPBCAM
sulfaphenazole|OGRPBCAM
sulfhemoglobinemia|OGRPBCAM
sulfite ester acaricide|OGRPBCAM
sulforhodamine B staining|OGRPBCAM
summary assay|OGRPBCAM
summary comment|OGRPBCAM
superficial mycosis|OGRPBCAM
superior mesenteric artery syndrome|OGRPBCAM
suppression amblyopia|OGRPBCAM
suppurative lymphadenitis|OGRPBCAM
suppurative otitis media|OGRPBCAM
suppurative thyroiditis|OGRPBCAM
suprasellar meningioma|OGRPBCAM
supratentorial cancer|OGRPBCAM
supratentorial primitive neuroectodermal tumor|OGRPBCAM
supravalvular aortic stenosis|OGRPBCAM
surface plasmon resonance|OGRPBCAM
surfactant|OGRPBCAM
survivin dimerisation modulator|OGRPBCAM
survivin suppressant|OGRPBCAM
suspension|OGRPBCAM
sweat gland benign neoplasm|OGRPBCAM
sweat gland cancer|OGRPBCAM
sweat gland disease|OGRPBCAM
sweetening agent|OGRPBCAM
swelling agent|OGRPBCAM
sympatholytic agent|OGRPBCAM
sympathomimetic agent|OGRPBCAM
synaptosomal P2 fraction format|OGRPBCAM
synaptosomal fraction format|OGRPBCAM
syndactyly|OGRPBCAM
syndrome|DOID_225
syndromic X-linked intellectual disability|OGRPBCAM
syndromic intellectual disability|OGRPBCAM
syngeneic tumor model|OGRPBCAM
synostosis|OGRPBCAM
synovial sarcoma|OGRPBCAM
synovitis|OGRPBCAM
synovium cancer|OGRPBCAM
synthesis by a chemical process|OGRPBCAM
synthetic|OGRPBCAM
synthetic auxin|OGRPBCAM
synthetic oral contraceptive|OGRPBCAM
synthetic small molecule ligand|OGRPBCAM
synucleinopathy|OGRPBCAM
syphilis|OGRPBCAM
syringocystadenoma papilliferum|OGRPBCAM
syringoma|OGRPBCAM
syringomyelia|DOID_327
systematic conformational search|OGRPBCAM
systemic acquired resistance inducing compounds|OGRPBCAM
systemic lupus erythematosus|OGRPBCAM
systemic mastocytosis|DOID_349
systemic mycosis|OGRPBCAM
systemic primary carnitine deficiency disease|OGRPBCAM
systemic scleroderma|DOID_418
systems biology method|OGRPBCAM
systolic heart failure|OGRPBCAM
tRNA|OGRPBCAM
tabes dorsalis|OGRPBCAM
tabu docking method|OGRPBCAM
tactile agnosia|OGRPBCAM
taeniasis|OGRPBCAM
tagged|OGRPBCAM
tagged with|OGRPBCAM
tankyrase inhibitor|OGRPBCAM
tanycytic ependymoma|OGRPBCAM
target|OGRPBCAM
target engagement assay|OGRPBCAM
target family knowledge analysis|OGRPBCAM
target mediated drug dispositioning|OGRPBCAM
targeted epigenetic assay|OGRPBCAM
targeted metabolomic assay|OGRPBCAM
targeted transcriptional assay|OGRPBCAM
tarsal tunnel syndrome|OGRPBCAM
tau aggregation inhibitor|OGRPBCAM
tauopathy|DOID_680
taurocholate|OGRPBCAM
taxon_notes|OGRPBCAM
teeth hard tissue disease|DOID_214
teichoic acid biosynthesis inhibitor|OGRPBCAM
telangiectasis|OGRPBCAM
telangiectatic osteogenic sarcoma|OGRPBCAM
telemetry ECG in conscious animals|OGRPBCAM
temperature endpoint|OGRPBCAM
temperature profile|OGRPBCAM
temperature unit|OGRPBCAM
tendinitis|DOID_971
tenosynovitis|DOID_970
teratocarcinoma|OGRPBCAM
teratogenic agent|OGRPBCAM
teratoma|OGRPBCAM
term editor|OGRPBCAM
term replaced by|OGRPBCAM
term tracker item|OGRPBCAM
tertiary neurosyphilis|OGRPBCAM
tertiary structure|OGRPBCAM
tertiary syphilis|OGRPBCAM
testicular cancer|OGRPBCAM
testicular disease|OGRPBCAM
testicular fibroma|OGRPBCAM
testicular gonadoblastoma|OGRPBCAM
testicular granulosa cell tumor|OGRPBCAM
testicular leukemia|OGRPBCAM
testicular lymphoma|OGRPBCAM
testis|OGRPBCAM
testis seminoma|OGRPBCAM
testosterone|OGRPBCAM
tetanus|OGRPBCAM
tetanus neonatorum|OGRPBCAM
tethered spinal cord syndrome|OGRPBCAM
tetracycline|OGRPBCAM
tetrahydroindazole|OGRPBCAM
tetralogy of Fallot|OGRPBCAM
tetrazine acaricide|OGRPBCAM
texas Red|OGRPBCAM
textual definition|OGRPBCAM
texture|OGRPBCAM
thalassemia|OGRPBCAM
thallium|OGRPBCAM
thanatophoric dysplasia|OGRPBCAM
thapsigargin|OGRPBCAM
the penn center for molecular discovery|OGRPBCAM
the scripps research institute molecular screening center|OGRPBCAM
the structural genomics consortium|OGRPBCAM
theileriasis|OGRPBCAM
thermal degradation product|OGRPBCAM
thermal nociception assay|OGRPBCAM
thermal shift|OGRPBCAM
thermal shift assay|OGRPBCAM
thermal shift assessment method|OGRPBCAM
thermodynamic solubility assay|OGRPBCAM
thiamine deficiency disease|OGRPBCAM
thioflavine S|OGRPBCAM
thioredoxin inhibitor|OGRPBCAM
thoracic benign neoplasm|OGRPBCAM
thoracic cancer|OGRPBCAM
thoracic disease|OGRPBCAM
thoracic outlet syndrome|OGRPBCAM
three dimensional QSAR|OGRPBCAM
three-hybrid assay|OGRPBCAM
threonine ligand covalent binding method|OGRPBCAM
thrombocyte differentiation|OGRPBCAM
thrombocytopenia|OGRPBCAM
thrombocytopenia due to platelet alloimmunization|OGRPBCAM
thrombocytopenia-absent radius syndrome|OGRPBCAM
thrombocytosis|OGRPBCAM
thrombophilia|OGRPBCAM
thrombopoietin receptor agonist|OGRPBCAM
thrombosis|OGRPBCAM
thrombotic thrombocytopenic purpura|OGRPBCAM
thromboxane A2 agonist|OGRPBCAM
thromboxane A2 antagonist|OGRPBCAM
thymic carcinoma|OGRPBCAM
thymoma|OGRPBCAM
thymus adenocarcinoma|OGRPBCAM
thymus cancer|OGRPBCAM
thymus gland disease|DOID_533
thyroid Hurthle cell adenoma|OGRPBCAM
thyroid adenoma|OGRPBCAM
thyroid crisis|OGRPBCAM
thyroid gland|OGRPBCAM
thyroid gland adenocarcinoma|OGRPBCAM
thyroid gland cancer|OGRPBCAM
thyroid gland carcinoma|OGRPBCAM
thyroid gland disease|DOID_50
thyroid gland medullary carcinoma|OGRPBCAM
thyroid gland papillary carcinoma|OGRPBCAM
thyroid hormone|OGRPBCAM
thyroid hormone agonist|OGRPBCAM
thyroid hormone resistance syndrome|OGRPBCAM
thyroid lymphoma|OGRPBCAM
thyroiditis|OGRPBCAM
thyrotoxicosis|OGRPBCAM
tibial neuropathy|OGRPBCAM
tic disorder|OGRPBCAM
tick infestation|OGRPBCAM
tick-borne encephalitis|OGRPBCAM
tick-borne relapsing fever|OGRPBCAM
tienilic acid|OGRPBCAM
tight binding inhibition|OGRPBCAM
time|OGRPBCAM
time course profile|OGRPBCAM
time dependent inhibition|OGRPBCAM
time endpoint|OGRPBCAM
time resolved fluorescence resonance energy transfer|OGRPBCAM
time unit|OGRPBCAM
tinea capitis|OGRPBCAM
tinea cruris|OGRPBCAM
tinea favosa|OGRPBCAM
tinea manuum|OGRPBCAM
tinea nigra|OGRPBCAM
tinea pedis|OGRPBCAM
tinea unguium|OGRPBCAM
tissue|OGRPBCAM
tissue adhesive|OGRPBCAM
tissue binding assay|OGRPBCAM
tissue culture flask|OGRPBCAM
tissue distribution assay|OGRPBCAM
tissue fixation method|OGRPBCAM
tissue homogenate stability assay|OGRPBCAM
tissue membrane format|OGRPBCAM
tissue processing method|OGRPBCAM
tissue-based format|OGRPBCAM
titanium-doped sapphire laser|OGRPBCAM
titration method|OGRPBCAM
tocolytic agent|OGRPBCAM
tolerogen|OGRPBCAM
tolosa-hunt syndrome|OGRPBCAM
tomography|OGRPBCAM
tongue cancer|OGRPBCAM
tongue disease|OGRPBCAM
tonsillitis|OGRPBCAM
tooth agenesis|OGRPBCAM
tooth and nail syndrome|OGRPBCAM
tooth disease|OGRPBCAM
tooth erosion|OGRPBCAM
tooth resorption|OGRPBCAM
topical anaesthetic|OGRPBCAM
topoisomerase II inhibitor|OGRPBCAM
topoisomerase IV inhibitor|OGRPBCAM
topoisomerase inhibitor|OGRPBCAM
topomer search|OGRPBCAM
total internal reflection fluorescence microscopy|OGRPBCAM
toxic diffuse goiter|OGRPBCAM
toxic encephalopathy|OGRPBCAM
toxic megacolon|OGRPBCAM
toxic shock syndrome|OGRPBCAM
toxicity assay|OGRPBCAM
toxicology|OGRPBCAM
toxin|OGRPBCAM
toxocariasis|OGRPBCAM
toxoplasmosis|OGRPBCAM
trace amine-associated receptor 1 agonist|OGRPBCAM
tracer|OGRPBCAM
trachea leiomyoma|DOID_248
tracheal cancer|OGRPBCAM
tracheal disease|OGRPBCAM
tracheal stenosis|OGRPBCAM
tracheitis|OGRPBCAM
trachoma|OGRPBCAM
tranquilizing drug|OGRPBCAM
transcribed region|OGRPBCAM
transcription factor|OGRPBCAM
transcription factor binding site|OGRPBCAM
transcription factor occupancy|OGRPBCAM
transcription, DNA-templated|OGRPBCAM
transcriptional phenotype|OGRPBCAM
transcriptional profiling assay|OGRPBCAM
transfection agent|OGRPBCAM
transfection method|OGRPBCAM
transferase|OGRPBCAM
transferase activity assay|OGRPBCAM
transient arthritis|OGRPBCAM
transient cerebral ischemia|DOID_224
transient global amnesia|OGRPBCAM
transient hypogammaglobulinemia|DOID_625
transient transfection|OGRPBCAM
transitional cell carcinoma|OGRPBCAM
translation|OGRPBCAM
transmembrane receptor|OGRPBCAM
transmission electron microscopy|OGRPBCAM
transmittance|OGRPBCAM
transporter|OGRPBCAM
transporter assay|OGRPBCAM
transporter induction assay|OGRPBCAM
transporter inhibition assay|OGRPBCAM
transporter substrate assay|OGRPBCAM
transsexualism|OGRPBCAM
transvestism|OGRPBCAM
trench fever|OGRPBCAM
triazine insecticide|OGRPBCAM
trichinosis|OGRPBCAM
trichomoniasis|OGRPBCAM
trichorhinophalangeal syndrome type I|OGRPBCAM
trichosporonosis|OGRPBCAM
trichostrongyloidiasis|OGRPBCAM
trichostrongylosis|OGRPBCAM
trichothiodystrophy|OGRPBCAM
trichotillomania|OGRPBCAM
trichuriasis|OGRPBCAM
tricine|OGRPBCAM
tricuspid valve disease|OGRPBCAM
tricuspid valve insufficiency|OGRPBCAM
tricuspid valve prolapse|OGRPBCAM
tricuspid valve stenosis|OGRPBCAM
triflumezopyrim|OGRPBCAM
trifluoperazine|OGRPBCAM
trigeminal nerve disease|DOID_561
trigeminal neuralgia|OGRPBCAM
trigonitis|OGRPBCAM
triiodothyronine|OGRPBCAM
triple flask|OGRPBCAM
triple-A syndrome|OGRPBCAM
tris|OGRPBCAM
tris(2-carboxyethyl)phosphine hydrochloride|OGRPBCAM
triton X-100|OGRPBCAM
troleandomycin|OGRPBCAM
trophoblastic neoplasm|OGRPBCAM
tropical spastic paraparesis|DOID_321
tropical sprue|OGRPBCAM
tropomyosin-related kinase B receptor agonist|OGRPBCAM
tropomyosin-related kinase B receptor antagonist|OGRPBCAM
truncated|OGRPBCAM
trypan blue cell staining|OGRPBCAM
trypanocidal drug|OGRPBCAM
trypanosomiasis|OGRPBCAM
tube|OGRPBCAM
tuberculosis|DOID_399
tuberculous empyema|OGRPBCAM
tuberculous epididymitis|OGRPBCAM
tuberous sclerosis|OGRPBCAM
tubulin modulator|OGRPBCAM
tularemia|OGRPBCAM
tumour antigen|OGRPBCAM
tungiasis|OGRPBCAM
tungsten halogen lamp|OGRPBCAM
tunicamycin|OGRPBCAM
turbidimetric solubility assay|OGRPBCAM
turns per second|OGRPBCAM
tween 20|OGRPBCAM
twin-to-twin transfusion syndrome|OGRPBCAM
two dimensional QSAR|OGRPBCAM
two site enzyme immunoassay|OGRPBCAM
two-colour indicator|OGRPBCAM
two-hybrid assay|OGRPBCAM
tympanic membrane disease|OGRPBCAM
type 2 diabetes mellitus|OGRPBCAM
typhoid fever|OGRPBCAM
typhus|OGRPBCAM
tyrosine kinase inhibitor|OGRPBCAM
tyrosine ligand covalent binding method|OGRPBCAM
tyrosinemia|OGRPBCAM
tyrosinemia type III|OGRPBCAM
ulcerative colitis|OGRPBCAM
ulcerative stomatitis|OGRPBCAM
ulnar nerve lesion|OGRPBCAM
ulnar neuropathy|OGRPBCAM
ultrasound contrast agent|OGRPBCAM
ultraviolet filter|OGRPBCAM
uncompetitive inhibition|OGRPBCAM
uncoupling protein inhibitor|OGRPBCAM
unfolded conformation|OGRPBCAM
unicellular fungi|OGRPBCAM
unit of measurement|OGRPBCAM
unit of molarity|OGRPBCAM
university of pittsburgh molecular libraries screening center|OGRPBCAM
unlabeled|OGRPBCAM
unnatural amino acid ligand covalent binding method|OGRPBCAM
unpurified|OGRPBCAM
unrestricted Hartree-Fock|OGRPBCAM
upper respiratory tract disease|DOID_974
uptake|OGRPBCAM
uptake transporter inhibition assay|OGRPBCAM
uptake transporter substrate assay|OGRPBCAM
urea cycle disorder|OGRPBCAM
urea herbicide|OGRPBCAM
uremic toxin|OGRPBCAM
ureter|OGRPBCAM
ureter cancer|OGRPBCAM
ureter carcinoma|OGRPBCAM
ureteral benign neoplasm|OGRPBCAM
ureteral disease|OGRPBCAM
ureteral obstruction|OGRPBCAM
ureterocele|OGRPBCAM
ureterolithiasis|OGRPBCAM
urethra cancer|DOID_734
urethral disease|DOID_732
urethral intrinsic sphincter deficiency|OGRPBCAM
urethral obstruction|OGRPBCAM
urethral stricture|OGRPBCAM
urethral syndrome|OGRPBCAM
urethritis|OGRPBCAM
uric acid nephrolithiasis|DOID_580
uricosuric drug|OGRPBCAM
urinary bladder|OGRPBCAM
urinary bladder cancer|OGRPBCAM
urinary schistosomiasis|OGRPBCAM
urinary system benign neoplasm|DOID_731
urinary system cancer|OGRPBCAM
urinary system disease|DOID_18
urinary tract obstruction|OGRPBCAM
urinary tract papillary transitional cell benign neoplasm|OGRPBCAM
urine output|OGRPBCAM
urogenital tuberculosis|OGRPBCAM
urticaria|OGRPBCAM
uses as substrate|OGRPBCAM
uses assay kit|OGRPBCAM
uses detection instrument|OGRPBCAM
uterine benign neoplasm|OGRPBCAM
uterine cancer|DOID_363
uterine cervix|OGRPBCAM
uterine corpus cancer|OGRPBCAM
uterine disease|DOID_345
uterine fibroid|OGRPBCAM
uterine inversion|DOID_997
uterus|OGRPBCAM
uterus carcinoma in situ|OGRPBCAM
uveal cancer|OGRPBCAM
uveal disease|OGRPBCAM
uveitis|OGRPBCAM
vaccinia|OGRPBCAM
vaginal cancer|DOID_119
vaginal discharge|OGRPBCAM
vaginal disease|DOID_121
vaginitis|OGRPBCAM
valence electron computational method|OGRPBCAM
vanderbilt screening center for gpcrs, ion channels and transporters|OGRPBCAM
variable age at onset electroclinical syndrome|OGRPBCAM
variant Creutzfeldt-Jakob disease|OGRPBCAM
variant construct assay|OGRPBCAM
varicocele|OGRPBCAM
varicose veins|DOID_799
variegate porphyria|OGRPBCAM
vascular cancer|DOID_175
vascular dementia|OGRPBCAM
vascular disease|DOID_178
vascular endothelial growth factor receptor antagonist|OGRPBCAM
vascular hemostatic disease|DOID_484
vasculitis|DOID_865
vasoconstrictor agent|OGRPBCAM
vasodilator agent|OGRPBCAM
vasopressin|OGRPBCAM
vasopressin receptor agonist|OGRPBCAM
vasopressin receptor antagonist|OGRPBCAM
vein disease|DOID_866
velocardiofacial syndrome|OGRPBCAM
venom|OGRPBCAM
venous insufficiency|OGRPBCAM
ventricular septal defect|OGRPBCAM
verbal auditory agnosia|OGRPBCAM
verruciform xanthoma of skin|OGRPBCAM
verrucous carcinoma|OGRPBCAM
verrucous papilloma|OGRPBCAM
vertebral artery insufficiency|OGRPBCAM
vertebrate|OGRPBCAM
vertebrobasilar insufficiency|OGRPBCAM
vesicant|OGRPBCAM
vesicoureteral reflux|OGRPBCAM
vesicular glutamate transport inhibitor|OGRPBCAM
vesiculitis|OGRPBCAM
vesiculobullous skin disease|OGRPBCAM
vestibular disease|OGRPBCAM
vestibular neuronitis|OGRPBCAM
vestibular nystagmus|OGRPBCAM
vestibulocochlear nerve disease|OGRPBCAM
viability indicator|OGRPBCAM
viability measurement method|OGRPBCAM
vial|OGRPBCAM
vibrational spectroscopic imaging|OGRPBCAM
vibriostatic agent|OGRPBCAM
viral encephalitis|DOID_646
viral entry into host cell|OGRPBCAM
viral exanthem|OGRPBCAM
viral genome replication|OGRPBCAM
viral hepatitis|OGRPBCAM
viral infectious disease|DOID_934
viral pneumonia|OGRPBCAM
viral process|OGRPBCAM
viral transduction method|OGRPBCAM
virtual screening|OGRPBCAM
virulence factor|OGRPBCAM
virus|OGRPBCAM
visceral heterotaxy|OGRPBCAM
visceral leishmaniasis|OGRPBCAM
visual agnosia|OGRPBCAM
visual cortex disease|OGRPBCAM
visual epilepsy|OGRPBCAM
visual indicator|OGRPBCAM
visual observation method|OGRPBCAM
visual pathway disease|OGRPBCAM
vital dye staining|OGRPBCAM
vital staining of cells|OGRPBCAM
vital staining of organelles|OGRPBCAM
vitamin (role)|OGRPBCAM
vitamin B1 antagonist|OGRPBCAM
vitamin B12 deficiency|OGRPBCAM
vitamin D receptor agonist|OGRPBCAM
vitamin K antagonist|OGRPBCAM
vitamin K deficiency bleeding|OGRPBCAM
vitamin metabolic disorder|OGRPBCAM
vitelliform macular dystrophy|OGRPBCAM
vitiligo|OGRPBCAM
vitreoretinal dystrophy|OGRPBCAM
vitreous detachment|OGRPBCAM
vitreous disease|OGRPBCAM
vitreous syneresis|OGRPBCAM
vmax|OGRPBCAM
volatile oil component|OGRPBCAM
voltage clamp|OGRPBCAM
voltage-dependent anion channel inhibitor|OGRPBCAM
voltage-gated sodium channel blocker|OGRPBCAM
volume|OGRPBCAM
volume endpoint|OGRPBCAM
volumetric titration|OGRPBCAM
von Hippel-Lindau disease|OGRPBCAM
von Willebrand's disease|OGRPBCAM
voyeurism|OGRPBCAM
vulnerary|OGRPBCAM
vulva adenocarcinoma|OGRPBCAM
vulva cancer|OGRPBCAM
vulva carcinoma|OGRPBCAM
vulval Paget's disease|OGRPBCAM
vulvar benign neoplasm|OGRPBCAM
vulvar disease|OGRPBCAM
vulvar leiomyoma|OGRPBCAM
vulvar melanoma|OGRPBCAM
vulvitis|OGRPBCAM
vulvovaginal candidiasis|OGRPBCAM
water immersion lens|OGRPBCAM
water-soluble vitamin (role)|OGRPBCAM
wavelength|OGRPBCAM
wee1-like protein-luciferin 4-monooxygenase|OGRPBCAM
week|OGRPBCAM
western blot|OGRPBCAM
whole blood stability assay|OGRPBCAM
whole cell lysate format|OGRPBCAM
whole organism|OGRPBCAM
whole-body plethysmography|OGRPBCAM
wide-field microscope|OGRPBCAM
width|OGRPBCAM
wild type|OGRPBCAM
withdrawal disorder|OGRPBCAM
wound botulism|OGRPBCAM
writing disorder|OGRPBCAM
x ray crystallography|OGRPBCAM
xCELLigence RTCA DP cellular impedance instrument (Acea Biosciences)|OGRPBCAM
xMap kit|OGRPBCAM
xanthogranulomatous cholecystitis|OGRPBCAM
xanthogranulomatous pyelonephritis|OGRPBCAM
xanthomatosis|OGRPBCAM
xenoantigen|OGRPBCAM
xenobiotic|OGRPBCAM
xenobiotic metabolite|OGRPBCAM
xenobiotic organic ethers|OGRPBCAM
xenoestrogen|OGRPBCAM
xenon lamp|OGRPBCAM
xeroderma pigmentosum|OGRPBCAM
xerophthalmia|OGRPBCAM
yaws|OGRPBCAM
year|OGRPBCAM
yeast two-hybrid assay|OGRPBCAM
yellow fever|OGRPBCAM
yellow nail syndrome|OGRPBCAM
z factor|OGRPBCAM
z-prime factor|OGRPBCAM
z-score normalization|OGRPBCAM
zaprinast|OGRPBCAM
zidovudine|OGRPBCAM
γH2AX, pNBS1, and β-catenin Multiplex Immunofluorescence Assay|OGRPBCAM
γH2Ax immunoassay|OGRPBCAM